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5Introduction générale:
Une fistule artérioveineuse (FAV) est un accès vasculaire permanent créé
par voie chirurgicale en connectant une veine et une artère chez le patient
en hémodialyse. Cet accès vasculaire permet de mettre en place une cir-
culation extracorporelle partielle afin de remplacer les fonctions exocrines
des reins. En France, environ 36000 patients sont atteint d’insuffisance
rénale chronique en phase terminale, stade de la maladie le plus grave
qui nécessite la mise en place d’un traitement de suppléance des reins :
l’hémodialyse.
La création et présence de la FAV modifient significativement l’hémo-
dynamique dans les vaisseaux sanguins, au niveau local et systémique ainsi
qu’à court et à plus long terme. Ces modifications de l’hémodynamiques
peuvent induire différents pathologies vasculaires, comme la formation
d’anévrysmes et de sténoses. L’objectif de cette étude est de mieux com-
prendre le comportement mécanique et l’hémodynamique dans les vais-
seaux de la FAV.
Nous avons étudié numériquement les interactions fluide-structure (IFS)
au sein d’une FAV patient-spécifique, dont la géométrie a été reconstruite
à partir d’images médicales acquises lors d’un précédent doctorat. Cette
FAV a été créée chez le patient en connectant la veine céphalique du patient
à l’artère radiale et présente une sténose artérielle réduisant de 80% la lu-
mière du vaisseau. Nous avons imposé le profil de vitesse mesuré sur le pa-
tient comme conditions aux limites en entrée et un modèle de Windkessel
au niveau des sorties artérielle et veineuse. Nous avons considéré des pro-
priétés mécaniques différentes pour l’artère et la veine et pris en compte
le comportement non-Newtonien du sang. Les simulations IFS permettent
de calculer l’évolution temporelle des contraintes hémodynamiques et des
contraintes internes à la paroi des vaisseaux. Nous nous sommes demandé
aussi si des simulations non couplées des équations fluides et solides per-
mettaient d’obtenir des résultats suffisamment précis tout en réduisant sig-
6nificativement le temps de calcul, afin d’envisager son utilisation par les
chirurgiens.
Dans la deuxième partie de l’étude, nous nous sommes intéressés à
l’effet de la présence d’une sténose artérielle sur l’hémodynamique et en
particulier à ses traitements endovasculaires. Nous avons dans un premier
temps simulé numériquement le traitement de la sténose par angioplas-
tie. En clinique, les sténoses résiduelles après angioplastie sont consid-
érées comme acceptables si elles obstruent moins de 30% de la lumière du
vaisseau. Nous avons donc gonflé le ballonnet pour angioplastie avec dif-
férentes pressions de manière à obtenir des degrés de sténoses résiduelles
compris entre 0 et 30%.
Une autre possibilité pour traiter la sténose est de placer un stent après
l’angioplastie. Nous avons donc dans un deuxième temps simulé ce traite-
ment numériquement et résolu le problème d’IFS dans la fistule après la
pose du stent. Dans ces simulations, la présence du stent a été prise en
compte en imposant les propriétés mécaniques équivalentes du vaisseau
après la pose du stent à une portion de l’artère.
Dans la dernière partie de l’étude nous avons mis en place un dispositif
de mesure par PIV (Particle Image Velocimetry). Un moule rigide et trans-
parent de la géométrie a été obtenu par prototypage rapide. Les résultats
expérimentales ont été validés par comparaison avec les résultats des sim-
ulations numériques.
Mots clés:
Fistule artérioveineuse
Compliance vasculaire
Simulation des interaction fluide-structure
Sténose artérielle
Angioplastie par ballonnet
Positionnement d’un stent
7Summary:
An arteriovenous fistula (AVF) is a permanent vascular access created
surgically connecting a vein onto an artery. It enables to circulate blood
extra-corporeally in order to clean it from metabolic waste products and ex-
cess of water for patients with end-stage renal disease undergoing hemodial-
ysis. The hemodynamics results to be significantly altered within the arte-
riovenous fistula compared to the physiological situation. Several studies
have been carried out in order to better understand the consequences of
AVF creation, maturation and frequent use, but many clinical questions
still lie unanswered. The aim of the present study is to better understand
the hemodynamics within the AVF, when the compliance of the vascular
wall is taken into account. We also propose to quantify the effect of a steno-
sis at the afferent artery, the incidence of which has been underestimated
for many years.
The fluid-structure interactions (FSI) within a patient-specific radio-ce-
phalic arteriovenous fistula are investigated numerically. The considered
AVF presents an 80% stenosis at the afferent artery. The patient-specific ve-
locity profile is imposed at the boundary inlet, and a Windkessel model is
set at the arterial and venous outlets. The mechanical properties of the vein
and the artery are differentiated. The non-Newtonian blood behavior has
been taken into account. The FSI simulation advantageously provides the
time-evolution of both the hemodynamic and structural stresses, and guar-
antees the equilibrium of the solution at the interface between the fluid and
solid domains. The FSI results show the presence of large zones of blood
flow recirculation within the cephalic vein, which might promote neoin-
tima formation. Large internal stresses are also observed at the venous
wall, which may lead to wall remodeling.
The fully-coupled FSI simulation results to be costly in computational
time, which can so far limit its clinical use. We have investigated whether
uncoupled fluid and structure simulations can provide accurate results and
8significantly reduce the computational time. The uncoupled simulations
have the advantage to run 5 times faster than the fully-coupled FSI. We
show that an uncoupled fluid simulation provides informative qualitative
maps of the hemodynamic conditions in the AVF. Quantitatively, the maxi-
mum error on the hemodynamic parameters is 20%. The uncoupled struc-
tural simulation with non-uniform wall properties along the vasculature
provides the accurate distribution of internal wall stresses, but only at one
instant of time within the cardiac cycle. Although partially inaccurate or
incomplete, the results of the uncoupled simulations could still be infor-
mative enough to guide clinicians in their decision-making.
In the second part of the study we have investigated the effects of
the arterial stenosis on the hemodynamics, and simulated its treatment
by balloon-angioplasty. Clinically, balloon-angioplasty rarely corrects the
stenosis fully and a degree of stenosis remains after treatment. Residual
degrees of stenosis below 30% are considered as successful. We have in-
flated the balloon with different pressures to simulate residual stenoses
ranging from 0 to 30%. The arterial stenosis has little impact on the blood
flow distribution: the venous flow rate remains unchanged before and af-
ter the treatment and thus permits hemodialysis. But an increase in the
pressure difference across the stenosis is observed, which could cause the
heart work load to increase. To guarantee a pressure drop below 5 mmHg,
which is considered as the threshold stenosis pressure difference clinically,
we find that the residual stenosis degree must be 20% maximum.
To correct arterial stenoses, another option is to place a stent after an-
gioplasty. We have simulated the procedure of balloon-angioplasty with
stenting numerically and solved for the fluid-structure interactions within
the stented vessel. In the FSI simulation, we have accounted for the pres-
ence of the stent by imposing previously evaluated equivalent mechanical
properties to the stented portion of the artery. Comparing the hemody-
namic and structural stresses with the case of balloon-angioplasty alone,
we have found no significant differences between the two treatments, ex-
cept for the larger wall internal stresses observed locally at the stent loca-
9tion. Still stenting has been shown to improve the patient’s patency. One
can therefore conclude that the stent has a favorable action in the long run
by pertaining the vessel opening.
Keywords:
Arteriovenous fistula
Wall compliance
Fluid-structure interaction simulation
Arterial stenosis
Balloon-angioplasty
Stent positioning
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Chapter 1
Introduction
The kidneys are in charge of eliminating toxic metabolic products and ex-
cess of water from blood, as well as ensuring electrolyte and buffer bal-
ance. When these functions are altered, the kidneys cannot provide their
exocrine functions, and metabolic waste products accumulate in the pa-
tient’s tissues. Renal disease can either be acute or chronic. When acute
the renal function needs to be supplied temporarily; if chronic the patient
kidneys degenerate progressively and the only curing option is a renal
transplantation.
Because of the lack of donors, two main techniques have been devel-
oped to supply the detoxification function of kidneys: peritoneal dialy-
sis and hemodialysis. Both dialysis techniques use mass exchange across
a membrane between blood and an artificial fluid, the dialysate, to filter
waste products from blood, restore its physiological composition and re-
move the excess of water. They differ by the type of membrane used as
filter. In the case of peritoneal dialysis, filtering occurs through the peri-
toneum, the membrane that envelops the intestine. The peritoneum is a
tissue highly vascularized by capillaries for the portal system. Hemodial-
ysis relies instead on an artificial membrane, whose structure and surface
are designed to optimize mass exchanges. It is placed inside an external
device called dialyzer or artificial kidney and separates two compartments.
The patient blood is directed towards the lumen compartment of the dia-
lyzer by an extra-corporeal circulation loop. At the same time the dialysate
flows through the outer compartment in counter-current.
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The remaining part of the chapter is focused on hemodialysis, which is
the treatment option chosen in 85% of patients with chronic kidneys dis-
ease [1]. The objective is to review in particular what has been understood
on the hemodynamics within the vascular access created to enable the par-
tial extracorporeal circulation from the patient to the dialysis machine. We
will summarize what is known on the treatment by hemodialysis and the
evolution of the hemodynamics after the creation of the AVF. We will re-
view potential flow-related complications and their treatment and see how
in vitro and in silico models have contributed to the investigation of the
hemodynamic consequences.
1 Hemodialysis
The principle of hemodialysis involves the diffusion and convection of so-
lutes and water across a semi-permeable membrane. A schematic of the
hemodialysis machine and constituents is shown in figure 1.1.
A membrane or dialysis filter separates blood from the dialysate fluid.
The transfer of substances from blood to the dialysate is driven by concen-
tration and pressure gradients. The dialysate has the physiological concen-
tration in electrolytes to prevent unexpected removal from blood. The two
fluids flow in counter-current, which optimizes mass transfer. The excess
of water is removed from blood by adjusting the transmembrane pressure
between blood and dialysate [2].
The hemodialysis treatment is adapted to each patient. The nephrolo-
gist decides on the frequency of hemodialysis sessions, their duration, the
flow rate to be set for the blood and dialysate flows and the dialyzer size.
The composition of the dialysate solution may also be adjusted in terms of
its ionic and bicarbonate concentrations.
In general, three sessions are prescribed per week. Two weekly sessions
are restricted to patients who have substantial residual kidney functions.
Four weekly sessions are often prescribed in the case of overweight pa-
tients, since the larger the patient body size the longer the dialysis needs
2 – Vascular accesses 21
Figure 1.1: Schematic of the hemodialysis machine when connected to the patient
[3].
to be. It is also used for patients with fluid overload. There is otherwise a
growing interest in nocturnal dialysis, which consists in dialyzing a patient
at night if possible at home. Three to six sessions of 8-10 hours are then
required per week. Nocturnal in-center dialysis is offered at a handful of
units in the United States.
2 Vascular accesses
A permanent vascular access is needed in chronic end-stage renal disease
patients in order to treat blood extra-corporeally. Since the artificial mem-
brane has an optimal exchange rate for blood flows larger than 250-300
ml.min−1, the vascular access needs to provide a flow rate of at least 500
ml.min−1. It needs to be easily accessible and able to bear frequent punc-
ture. Such an access does not exist in the human body and needs to be
created surgically. Permanent access can rely on a central venous catheter
(CVC), an arteriovenous graft (AVG) or a native arteriovenous fistula (AVF).
2.1 Central venous catheter
The central venous catheter (CVC) access consists in the insertion of a two-
lumen catheter inside a large vein (vena cava, jugular vein or femoral vein)
as shown in figure 1.2. It is usually adopted when a rapid, sudden access
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to the patient vasculature is required. One such instance occurs in the case
of acute renal failure, usually after an intoxication or an infection. The CVC
can in some cases be the only viable option, when the vasculature of the
patient is too degraded for the creation of an arteriovenous connection.
However CVCs are not systematically used because of the high risk of
complications and bad tolerance by the patient [4]. In clinics it is preferred
to use different access types: the arteriovenous graft or the arteriovenous
fistula [5].
Figure 1.2: Schematic of a central venous catheter as access for hemodialysis [6].
2.2 Arteriovenous graft
An arteriovenous graft is created by connecting the arterial tree to the ve-
nous one with a conduct (graft) of appropriate caliber made in an artificial
or biological material (figure 1.3). The suture of the graft onto the artery
is called anastomosis. Synthetic grafts are usually in polytetrafluoroethy-
lene (PTFE) or silicone. Biological grafts can either be made of one of the
patient’s vessel (i.e. an homologous vein), from a bovine or sheep vessel
or from tissue engineering. Grafts entirely made with patient cells have
recently been developed (Cytograft Tissue Engineering(1)) and are in clini-
cal tests. Preliminary results on patients having a high risk of graft failure
show a primary patency of 76% at 1 month after implantation and of 50%
at 6 months [7].
(1)http://www.cytograft.com/learn.html
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AVG have a high risk of aneurysm formation with an occurrence rate
around 70-80% during the first year after creation [8]. Moreover, they
present a large risk of stenosis and thrombosis occurrence [9]. Therefore
grafts are used primarily when the quality of the native vessels is too poor.
In Europe they are used in less than 10% of the patients [10]. Their main
advantage is to be immediately available for puncture and to necessitate a
relatively easy surgical procedure to be implanted. This explains why AVG
are created in around 80% of the patients in the United States [11].
Figure 1.3: Schematic of an arteriovenous graft connecting an artery and a vein
(modified from [12]).
2.3 Autologous arteriovenous fistula
An autologous AVF is created by connecting an artery and a vein directly
onto one another bypassing the peripheral capillary circulation. AVF re-
quire smaller blood flow rates than the arteriovenous grafts: they are con-
sidered functional for venous flow rates larger than 500 ml.min−1, which
is to be compared to 650 ml.min−1 for grafts [8]. The creation of this
type of permanent access is nowadays considered as a standard procedure
[13, 14, 15, 16] because of its low complication rate [17]. The suture between
the two vessels is called the anastomosis [18].
There exists four types of anastomosis [8]. The nomenclature follows
the direction of the blood flow in the circulation:
• the end-to-end anastomosis, when the end of the artery is connected
to the end of the vein (A in figure 1.4);
• the side-to-end anastomosis, when the side of the artery is connected
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to the end of the vein (B in figure 1.4);
• the end-to-side anastomosis, when the end of the artery is connected
to the side of the vein (C in figure 1.4);
• the side-to-side anastomosis, when the side of the artery is connected
to the side of the vein (D in figure 1.4).
The nomenclature of the different regions next to the anastomosis is
indicated in figure 1.5 [19]. One can distinguish the floor, which is the
outer wall of the artery (A) in the side-to-end anastomosis; the toe is the
region at the outer wall junction between the artery and the vein (V); the
heel is the region at the inner wall between the artery and the vein; the
anastomosis angle θ is the angle existing between the artery and the vein
at the heel region.
Figure 1.4: A) end-to-end anastomosis; B) side-to-end anastomosis; C) end-to-side
anastomosis; D) side-to-side anastomosis [8].
Each configuration presents its own advantages and disadvantages. Chrono-
logically the side-to-side anastomosis has first been created in 1966 [18].
The surgery has been improved in the following years. The end-to-end
anastomosis, created for the first time in 1967, can be useful when the
vessels have a small caliber. It however cuts off the distal circulation com-
pletely. The side-to-end anastomosis, created for the first time in 1968, has
become the most commonly used technique. It is indicated when the artery
and the vein are not close to one another [11].
The names of the vessels are preserved after the fistula creation: for
instance, a side-to-end radio-cephalic fistula is created by connecting the
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side of the radial artery with the end of the cephalic vein. This fistula
located in the forearm region is the first choice for fistula creation owing
to its low complication rate [8]. At the elbow region the cephalic vein is
superficial and therefore easy to puncture. Moreover, after the maturation
period the blood flow inside the vein is usually satisfactory [20].
If the fistula cannot be created in the forearm because of poor vessel
quality, the fistula can be placed at other locations in the body. The loca-
tion is always chosen at the most distal available site, in order to preserve
more central vessels in case of failure of the fistula [8, 21]. Surgeons prefer
placing the fistula in the lower arm, in the elbow region or in the upper
arm, as shown schematically in figure 1.6. But the lower extremities can
also be chosen.
An innovative technique that has the potential to increase the amount of
information collected during the pre-operative exam and therefore improve
the success rate of fistulas is the high-resolution ultrasound technique for
venous elastography [22]. Biswas et al. have in fact shown that this tech-
nique provides an accurate map of the stress-strain characteristic of the
venous wall, quantifying the actual state of the vasculature. However, the
method is still under study and is not yet ready to be used routinely.
Figure 1.5: Nomenclature of the different AVG parts next to the anastomosis in an
arteriovenous fistula: the floor (F), the toe (T), the heel (H), the anastomosis angle
θ [19].
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Figure 1.6: Schematic of autologous access types at the upper extremities. The
arterial inflow can be located in the upper arm (I), the lower arm (II), the forearm
(III). The venous outflow can be located in the forearm (IV) or in the upper arm
(V) (modified from [21]).
3 Hemodynamic changes following the creation of a native
AVF
Once created, the fistula acts as a low-resistance short-cut between the ar-
terial and venous systems [23]. The afferent arterial flow rate increases sig-
nificantly during the first 3 to 10 days after the fistula creation [24, 25, 26].
This rise represents the first signature of a maturing fistula.
During the first three to six months following the fistula creation the
vein adapts and remodels because of the larger pressure and pulsatility of
the blood flow. The vein enlarges and dilates in response to the hemody-
namic modifications induced by the newly created, low-resistance circuit
[27]. Its collagen content increases because of the larger mechanical loads:
the venous wall becomes stiffer and its cross-sectional area increases [28].
This natural response of the compliant vasculature provides a vein that can
be punctured 2-3 times per week. Such is not the case for native veins,
which become thrombotic if frequently pierced. At the end of the matura-
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tion period, the venous flow rate has increased by a factor 20 to 50 when
compared to the pre-surgical conditions [14, 29]. It typically reaches values
larger than 500 ml.min−1. If the flow rate and pressure are increased, the
wall shear stresses remain near the physiological values thanks to the vein
enlargement [11, 26].
The vein remodeling, sometimes called ’venous arterialization’, is the
main outcome of the fistula maturation. It is, however, not the only ac-
commodation which occurs inside the patient cardiovascular system. The
low-resistance fistula pathway results in an increase in cardiac output and
a redistribution of the blood flow in the whole vasculature. As a conse-
quence, the entire vascular bed is likely to undergo significant remodeling
but little is known on these phenomena. The collect of clinical data in the
entire cardiovascular system is in fact difficult over several months. Only
acute changes in distensibility of large arteries have been documented [30].
When the maturation process succeeds, the AVF can be used for several
years. But it may, in some cases, fail. The incidence of early failure is about
20% for fistulas in the forearm [8], but it can increase up to 60% in patients
that are diabetic or older than 70 years of age [31]. The aetiology of the fail-
ure remains unclear [27]. However, in several cases intima hyperplasia in
the region close to the anastomosis and/or reduced vein dilation have been
observed. The geometry of the fistula obtained surgically is another aspect
which might prevent fistulas from maturing or accelerate the degeneration
of a mature AVF. The geometry of the AVF anastomosis is indeed crucial
for the post-surgery hemodynamic conditions [14].
4 Flow-related AVF complications and their treatments
4.1 Current detection methods of AVF dysfunctions
Most of the remodeling processes occur during the period of maturation
of the AVF. However, the induced non-physiological hemodynamic condi-
tions may in some cases lead to a continuation of the remodelling over a
time-scale of several years. Such a remodeling may cause the onset of com-
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plications in the mid-long term. They can affect the AVF and lead to local
and/or systemic consequences, the first ones implying the AVF failure, the
second ones putting a threat on the patient survival.
In Europe only, almost 60,000 new vascular accesses are created each
year, and more than 24,000 vascular accesses need to be revisited every
year because of complications [32]. The associated costs are high; early
detection and treatment of rising pathologies are crucial to reduce them.
Detection relies, in clinical practice, on the collect and follow-up of param-
eters recorded during the hemodialysis sessions. Ensuring repeatability of
the conditions over subsequent hemodialysis sessions improves the intra-
and inter-dialysis well-being of the patients and maximizes the long-term
outcomes. The parameters which are currently measured are:
• the median value of venous blood flow measured during the dialysis
session;
• the duration of the dialysis session, automatically computed from the
start and end times recorded in the dialysis monitor;
• the median value of pressure in the needle for blood aspiration;
• the median value of pressure in the needle for blood re-injection;
• the patient weight loss over the dialysis session;
• the dry weight, which is the weight expected at the end of hemodial-
ysis.
All these parameters are usually collected manually but Bellazzi et al. have
proposed an automatized method of measurement [33].
Changes of one or more of the collected parameters over hemodialy-
sis sessions are usually a signature of the onset of complications. Varia-
tions in the venous blood flow directly affect the clearance of toxins during
hemodialysis, which can lead to less effective treatments [34]. The median
values of pressure at both the arterial and venous needles indicate, when
stable, that the vascular access is efficient. Alterations of the quality of
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the vascular access modifies the arterial and venous needle pressures and
has repercussions on the bulk flow [33]. The dialysis time is important
to ensure the correct removal of catabolites (other than urea) and water
[35, 36]. Finally, it is crucial to reach the dry weight target for the hydro-
saline homeostasis: in the interval between two hemodialysis treatments
the patient accumulates water leading to a weight increase. When the dry
weight is reached, one can assume that the accumulated water is entirely
removed. It needs to be underlined that this hypothesis is verified if the
patient maintains his/her weight, which is obtained giving him a diet to
be followed. One risk associated with very high ultrafiltration rates is the
potential increase of cardiovascular stress for the patients [37].
Several dedicated exams can be performed to identify and localize the
rising pathologies usually causing alterations in hemodialysis parameters
[20]:
• Flow test: the flow rate aspired by the pump from the fistula is in-
creased by steps of 50 ml.min−1 till the threshold flow rate of 500
ml.min−1. The test is used to verify that the vein is perfused with a
minimum flow rate of 500 ml.min−1. If it is not the case, a venous
stenosis might be present [28];
• Ultrasound scan: the location of the vascular wall and the direction
and velocity of the flow are calculated. The mean velocity and flow
rate, obtained by integrating the velocity over the cardiac cycle, are
quantified in different branches of the vasculature. The ultrasound
technique is flexible, non-invasive and the associated costs are small.
It is therefore largely used when a pathology is suspected;
• Fistulography/angiography: the state of the vascular tree is observed
by X-rays thanks to the injection of a radio-opaque fluid, since vessels
are otherwise transparent to radiography. This exam is routinely per-
formed before the creation of the fistula to evaluate the state of the
vessels. Fistulography also allows the identification of pathologies as-
sociated with a mature fistula. But radiologists prefer to limit the use
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of X-rays and radio-opaque contrast liquids on the patients and rely
on other imaging technique when possible;
• CT-scan angiography: the 3-dimensional geometry of the patient vas-
culature is reconstructed by taking a series of X-ray images. The im-
ages differ from one another because the X-ray source and detector
scan all possible angles around the patient. As for the angiography, a
contrast agent needs to be used. This exam is useful for the detection
of pathologies of the fistula, but during the exam the patient absorbs
a large amount of X-radiation and receives the injection of a radio-
opaque contrast agent. The use of CT-scan angiography is therefore
limited to its strict necessity;
• Magnetic-resonance imaging: the phase contrast between blood (in
movement) and the vascular wall (at rest) is used to visualize the
three-dimensional geometry of the fistula. It represents a non-invasive
alternative to CT-scan angiography, and is particularly efficient to
identify a thrombus. Information about the age of the thrombus can
also be obtained by the intensity of the registered electromagnetic
signal. However, the application of magnetic-resonance imaging to
arteriovenous fistula is difficult because of the tortuosity and the non-
planar development of the vasculature.
The data that these exams provide are often more qualitative than quan-
titative because of the complexity of the AVF geometry. It is important
to underline that these exams are not routinely performed since they may
be invasive and represent an additional clinical cost. The administration of
contrast agents and radiation can be risky if frequently repeated. Moreover,
the tortuous morphology of fistulas and the large flow conditions when
compared to the healthy case, make these exams difficult and sometimes
unsuccessful. In the remaining part of the section, we present the most
current complications and the treatment usually performed to preserve or
restore the functionality of the fistula.
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4.2 Cardiac failure
Clinical studies have shown that peripheral AVFs increase the cardiac out-
put by about 18% [38], which corresponds to an averaged increase of 640
ml.min−1 [39]. It is a consequence of the bypass of more peripheral, resis-
tive muscular arteries. Patients undergoing hemodialysis therefore present
a higher risk of premature cardiovascular disease [40, 41]. The cardiovas-
cular event with the largest incidence is heart failure and sudden cardiac
death [42], whereas it is myocardial infarction in the general population.
A strong link between the increased cardiac output and early heart fail-
ure has therefore been hypothesized in hemodialysis patients. The risk of
heart failure can however be reduced by bending the venous limb of the
AVF: in a case-report study it has been shown that this correction reduces
the AVF flow rate from 3,710 ml.min−1 to 1,410 ml.min−1 and preserves
the hemodialysis access [39].
4.3 Steal syndrome and ischaemia
The low-resistance venous outflow redirects the majority of the incoming
flow to the central veins, especially if the diameter of the vein is larger
than 75% of the arterial diameter [43]. The tissues located downstream of
the anastomosis might therefore suffer from low perfusion and oxygena-
tion. This phenomenon is called steal syndrome. It can degenerate in
tissue ischaemia or even necrosis when the blood supply is below a cer-
tain threshold. If necrosis occurs, amputation is needed [44]. Most fistulas
remain entirely asymptomatic: ischemia symptoms appear only in 10% of
cases. An augmented collateral circulation may in fact counterbalance the
low perfusion of the arterial branch of the AVF. A gradual improvement of
distal perfusion has even been noted in some cases [45]. Although quite
rare, the steal phenomenon can also be related to the presence of a stenosis
in the distal artery, but in this case, it has been noticed that the stenosis was
present before the AVF creation. It proves the necessity to carefully check
the conformation of the vasculature before the surgery [14, 43].
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When a patient suffers from the steal syndrome only a few therapeu-
tic options are available. The most common technique aims at reducing
the flow going through the vein by increasing its resistance [14, 43, 46, 47].
The increased venous resistance is typically achieved by narrowing, bend-
ing or lengthening the vein. These techniques are based on empirism, so
neither the optimal degree of narrowing, bending angle nor length of the
graft are universally defined [43]. Another technique is called ’distal revas-
cularization - interval ligation’. It consists in feeding the distal artery via
an interposed segment of PTFE graft or saphenous vein after ligating the
distal artery at the AVF anastomosis [14, 48]. If the surgery fails, the fistula
needs to be ligated and created at a different location.
4.4 Hyperflow
The vein can in some cases increase in size after the maturation period.
It leads to an increase in the venous flow rate over time, from 500-1,000
ml.min−1 at the end of the fistula maturation to values above 2,000-3,000
ml.min−1. This condition represents an overcharge for the heart, and typi-
cally occurs in fistulas located in the upper arm [49].
The only surgical solution to this complication is surgical: the venous
diameter needs to be reduced in order to increase the venous resistance
and therefore decrease the venous flow. However, the optimal venous di-
ameter that should be obtained after this procedure is still unknown. If
the vascular conditions make the surgery highly risky, the fistula needs to
be definitely ligated. A new vascular access will be created at a different
location for hemodialysis [50].
4.5 Aneurysm
Aneurysmal dilatation of AVFs occurs in around 5% of the patients, but
this percentage can increase up to 30% in the upper arm [51]. Three factors
have been identified as probable leading causes to aneurysm formation:
the obstruction of the central venous outflow, the repeated piercing of the
same area of the vein or the reduced thickness of the venous wall. The
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dilatation is called a pseudo-aneurysm if it appears at the puncture site as
a direct consequence of the micro-lesions caused at the venous wall at each
session of hemodialysis [52].
The aneurysm may have a direct impact on the quality of the hemodial-
ysis treatment: the overlying skin can degenerate and break down increas-
ing drastically the risk of bleeding and infection. In addition, the fistula
results to be painful and bruising, which affects the patient quality of life.
It has also been reported that patients are bothered by its appearance [53].
Several treatment strategies have been developed with the aim to pro-
long the usability of native fistulas. Surgical techniques include resection,
diameter reduction, reconstruction of the vessel affected by the aneurysm
and aneurysm ligation [51]. Endovascular techniques rely on the place-
ment of prosthetic grafts inside the enlargement. Recently, percutaneous
approaches have been proven successful [54, 55].
4.6 Stenoses
Stenosis formation results in a reduction of the vascular lumen and an
increase in its hydraulic resistance. It is typically caused by neo-intima
development or atherosclerotic plaque formation. End-stage renal disease
patients typically present several comorbidity, such as hypertension and
calcium-phosphate imbalance. These pathologies lead to a diffuse sedi-
mentation of calcium ions at the vascular walls. The calcified regions gen-
erally develop in calcified atherosclerotic plaques. Patients in hemodialysis
are thus affected by stenoses at multiple sites of the vascular tree, these
lesions being not related to altered hemodynamic conditions. Stenoses can
affect both the vein or the artery within the AVF. Since the aetiology may
be different, we will analyze the formation mechanisms and consequences
separately.
4.6.1 Venous stenoses
For many years venous stenoses have been considered to be the main com-
plication affecting arteriovenous fistulas [56]. They typically form in the
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draining vein near the anastomosis [8] or in the central veins [57]. Their
formation has been hypothesized to be associated with two factors: the in-
creased pulsatile pressure [8] and the increased venous flow rate [11]. It is
also possible that a stenosis lesion was already present prior to the fistula
creation. The increase in flow rate would then make it become symptomatic
[11].
Venous stenoses may cause thrombosis and the failure of the hemodial-
ysis access because of insufficient venous flow [58]. It can also lead to diffi-
culties in puncturing, painful arm oedema or prolonged bleeding after nee-
dle removal [17]. It ought to be treated if the diameter is reduced by more
than 50%. Recommendations also stipulate treatment if it is accompanied
with a reduction in the access flow rate [17] and if it leads to a local pressure
drop larger than 5-10 mmHg [59]. The best treatment indicated for venous
stenoses is balloon-angioplasty. It consists in the endovascular insertion of
a balloon folded in a catheter. The balloon is introduced across the steno-
sis and inflated to restore the vessel lumen. Balloon-angioplasty has been
proven to lengthen the period of fistula functionality [57, 60, 61, 59, 62, 63].
For persistent stenoses ultra-high pressure balloons can be used [64]. An-
other endovascular treatment consists in deploying a stent across the steno-
sis. Self expandable stents in Nitinol (SMART R©, Cordis) or stainless steel
(Wallstent R©, Boston Scientific) are usually used. They are deployed after
the preliminary expansion of the stenosis by balloon-angioplasty.
Stents are currently used in case of unsuccessful angioplasty or recur-
ring stenosis. The use of stenting has in fact been questioned since the late
80s [65]. Clinical studies have shown that after six months, the restenosis
rate varies between 15% and 40% [66, 67]. Stenting have hence been used
with parsimony to avoid risks of restenosis and to reduce the treatment
costs. Recently, it has, however, been proven that stent deployment follow-
ing angioplasty is more effective than a simple balloon-angioplasty [62, 68].
But at this stage, clinical practices still remain to evolve and adapt to these
new results.
When thrombosis occurs, it should be treated in the shortest delay, and
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in all cases within 48 hours. The thrombus indeed tends to progress very
rapidly along the venous wall, making its removal difficult [17]. The most
indicated treatments are mechanical/pharmaco-mechanical thrombolysis
[69] or surgical thrombectomy [70]. Both treatment types have a success
rate larger than 80% [17]. The high success rate of endovascular techniques
makes them preferable to the more invasive surgical treatments. However,
a large number of patients are still treated surgically [71].
4.6.2 Arterial stenoses
For a long time, the occurrence of arterial inflow stenoses has been con-
sidered a rare complication in hemodialysis fistulas [17]. Recent studies
have, however, provided a very different picture of the reality. Arterial
stenoses have been shown to occur in 40% of patients with a radio-cephalic
AVF [58, 72, 73, 74]. The occurrence rate is much lower in patients with a
brachio-cephalic fistula (0-4%). The aetiology of arterial stenoses has not
yet been studied and remains unknown. It has been hypothesized that in-
flow stenoses may be linked to the steal syndrome or an increased risk of
heart failure [8, 72].
Inflow arterial stenoses are difficult to detect and localize as they do not
seem to affect parameters monitored during hemodialysis, unless they are
close to the anastomosis. In that case blood recirculation between the aspi-
ration and re-injection needles is observed, causing a significant reduction
in the flow rate available for hemodialysis. For all other cases, an ultra-
sound scan is a possible technique for detection, but it is not part of the
routine exam conducted on hemodialyzed patients [75, 76]. So far, the in-
dications for treatment are the same as those used for venous stenoses: a
lumen narrowing larger than 50% or a pressure drop higher than 5 mmHg
[59].
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5 In vitro and in silico models for the investigation of hemo-
dynamics within AVF
Clinical studies have shown that the fistula creation leads to a remodeling
process within the whole cardiovascular system. Evidence suggests that a
direct link exists between the hemodynamic/mechanical solicitations ob-
served at the vascular wall and the remodeling process. The quantification
of the hemodynamic and mechanical parameters is, however, difficult in
clinical practice. Several questions still lie unanswered:
• What is the optimal location where to create the fistula to ensure its
maturation and reduce the risk of complications?
• What are the systemic consequences of a functioning AVF?
• What are the local hemodynamic conditions within patient-specific
mature AVF? Can failure risks be associated with hemodynamic pat-
terns?
• What is the impact of treatments of failing fistulas on the hemody-
namics inside the fistula itself and in the overall cardiovascular sys-
tem?
• What are the criteria to use in clinical practice to evaluate the degree
of success of a surgical or endovascular treatment of a fistula?
In order to answer these questions, it is necessary to quantify local
hemodynamic parameters and evaluate mechanical loads on the vascular
walls. There is therefore the need to model the blood flow within the vas-
cular network of patients with AVF. Two modelling approaches can be un-
dertaken, either experimental (in vitro model) or numerical (in silico model).
We will review how simulations have contributed to the understanding of
the AVF impact and evolution and discuss the implications they have had.
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5.1 Overview of in vitro and in silico modeling of cardiovascular hemo-
dynamics.
5.1.1 Experimental techniques to investigate hemodynamics
Experimental techniques for flow visualization and velocity measurement
have been largely used to investigate the hemodynamics within arterial bi-
furcations and large vessels ([77, 78, 79] among others). Flow visualization
techniques rely on the use of dyes or on the seeding of the fluid with parti-
cles reflecting light. In the case of fluorescent dye or particles a laser beam
is used to selectively enlighten two-dimensional planes of the investigated
geometry; the flow patters are recorded by a camera. Flow visualization en-
ables the investigation and characterization of regions of flow recirculation
and detachment. This technique has been typically used to investigate the
flow patterns in large arteries or at arterial bifurcations (e.g human carotid
bifurcation, [77]).
More quantitative results have been obtained measuring the velocity
of the fluid. The Laser Doppler Velocimetry (LDV) technique enables the
measurement of the instantaneous velocity of the particles dispersed in
the fluid at a specific point within the flow field. LDV provides a precise
measurement of the velocity, but this measure is punctual. By measuring
the velocities on a pre-defined grid of points, quantities such as the local
wall shear stresses can be obtained precisely [77].
Another technique is Magnetic Resonance Velocimetry (MRV). MRV is
capable of measuring the three component mean velocity field in complex
three-dimensional geometries. This technique is based on the phenomenon
of nuclear magnetic resonance: MRV utilizes a commercial magnetic res-
onance imaging (MRI) machine to take an internal image of a stationary
target. The molecular spins are aligned with a strong uniform magnetic
field (∼1.5 T). Simultaneously, a radio frequency signal adjusted to the
resonance frequency is emitted from the machine. This signal alters the
spin of the atoms and induces a precession motion at a frequency which
is characteristic to each tissue. The MRI device measures this frequency
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and encodes the position of the emitting atoms. The velocity of a moving
target, like in the blood flow, can be measured because moving atoms do
not acquire and loose the phase of the magnetic signal with the same char-
acteristic time, contrary to stationary targets. Velocities can be measured
along single lines, in planes or in full 3D volumes with sub-millimeter res-
olution. The advantage of MRV is that no optical access or flow markers
are required, so measurements can be obtained in vivo, as well as in clear
or opaque MR compatible flow models and fluids [80]. This technique has
been used to investigate the hemodynamics within realistic phantoms of
human aorta and brain aneurysms [79, 81].
The third quantitative technique, which has been developed, is Parti-
cle Image Velocimetry (PIV). PIV enables the measurement of the velocity
field in particular cross-sectional planes within the investigated geometry.
It consists in illuminating a plane with a laser light sheet. Two pictures
of the light reflected by the particles that seed the flow are captured by a
camera at two instants of times separated by a short time delay. The ve-
locity field is obtained by comparing the position of the particles in both
images and calculating the displacement with cross-correlation techniques
[82]. The advantage of PIV with respect to LDV is that the velocity mea-
surement is obtained in 2D planes, and not at a specific point. The tech-
nique has even been extended to characterize the three-dimensional veloc-
ity field (stereoscopic PIV). The standard PIV technique has been largely
used to investigate the hemodynamics within abdominal aortic aneurysms
and cerebral aneurysms [83, 84, 85, 86] among others. Echo PIV has also
been validated experimentally for the in vivo study of quantitative velocity
profiles and shear stresses [87]. The PIV technique has then been used to
quantify the effects of vascular treatments. Charonko et al. have for in-
stance investigated experimentally the effect of stent design on wall shear
stresses [88, 89]. Ionita et al. [90] have focused on the use of asymmet-
ric stent-grafts within phantoms of abdominal aortic aneurysms. But the
same technique has also been used to investigate in vitro the efficiency of
prosthetic heart valves [91, 92, 93].
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5.1.2 Numerical methods
Computational-fluid dynamics models
Computational-fluid dynamics (CFD) models have been initially deve-
loped for mechanical engineering applications to analyze fluid flows, heat
transfer and their associated phenomena. These models solve for the dis-
crete form of the momentum and mass equations and return the field of
motion of the fluid. CFD has emerged in the biomedical field later than
in other industrial sectors, such as the car industry, and its application
to clinics is still limited. It is mainly due to the complexity of human
anatomy and behavior of physiological fluids. Thanks to the hardware and
software improvement that took place over the last 20 years, CFD analy-
sis is increasingly performed to study fluid phenomena inside the human
cardiovascular system [94, 95, 96, 97]. Medical simulations of circulatory
functions offer many benefits. They can lower the chances of postoperative
complications, assist in developing better surgical procedures, and deliver
a good understanding of biological processes, as well as more efficient and
less destructive medical equipments such as blood pumps, valves and other
devices (e.g. [94, 98, 99, 100]).
Computational-fluid dynamics (CFD) simulations have been used to
simulate the hemodynamics in different vessels of the cardiovascular sys-
tem. Researchers have mainly focused on the vessels which are mainly
affected by cardiovascular pathologies. CFD techniques enable the re-
searchers to quantify the hemodynamic parameters that are supposed to be
involved in the onset and development of pathologies, and therefore bet-
ter understand the relationship between hemodynamics and pathological
conditions. Many authors have investigated the hemodynamics in stenotic
lesions affecting coronary (e.g. [101, 102, 103, 104, 105, 106, 107, 108]) and
carotid arteries ([109, 110, 111, 112] among others). Numerical research
has also focused on aortic ([113, 114, 115] among others) and cerebral
aneurysms (e.g. [116, 117, 118, 119]) as well as congenital heart diseases
(e.g. [120, 121, 122, 123, 124]). The related pathologies have been related to
altered hemodynamic factors.
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Fluid-structure interaction models
CFD models consider the vascular wall to be rigid, which is not the
case physiologically. Modeling the interactions between the blood flow
(incompressible fluid) and the deforming vascular structure represents one
of the major challenges in cardiovascular mechanics. Different numerical
methods have been developed to solve the coupled problem.
One of the most well-known used techniques is the Arbitrary Lagrange-
Eulerian (ALE) formulation. In this formulation the Navier-Stokes equa-
tions which solve for the fluid field are written in a reference frame which
moves with the vascular interface. The evolution of the interface between
the blood flow and the vascular structure is determined by the kinematic
and dynamic continuity conditions. Perktold and Rappitsch [125] have
been pioneers in using this formulation for the simulation of the fluid-
structure interactions (FSI) in carotid artery bifurcations, but it has since
then been used in various patient-specific models ([126, 127, 128] among
others). A limitation of this formulation is the large computational time
when the motion of the vascular structure is large.
Another numerical scheme is the immersed boundary method. The
immersed boundary method involves both Eulerian and Lagrangian vari-
ables. The spatial discretization of the immersed boundary equations is
based on a fixed Cartesian mesh for the Eulerian variables, and a moving
curvilinear mesh for the Lagrangian variables. The two types of variables
are linked by interaction equations that involve a smoothed approximation
of the Dirac delta function. The total momentum and total power, which
are identical in both formulations, are used to transfer of data from one
mesh to the other [129]. The immersed boundary method has mainly been
applied to the study of ventricular and heart valves pathologies [130, 131,
132].
The fictitious domain method has firstly been developed by Glowinski
et al. [133]. This method is related to the immerse-boundary method, but
introduces Lagrange multipliers to constrain the motion of the fluid and the
solid at the interface. This formulation is particularly adapted to capture
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rapid motions of the solid domain. It has mainly been used for the study
of aortic valve motion [134, 135].
Deforming-spatial-domain/stabilized space-time formulation has been
developed by Tezduyar et al. [136]. In this formulation the motion of the
boundary interface is defined in terms of velocity and displacement. This
formulation appears to be particularly effective in terms of computational
time. It has been used to study the FSI in patient-specific arteries and
cerebral aneurysms [137, 138].
Another formulation that has been developed by the group of Figueroa
and Taylor is the coupled-momentum method [139]. This formulation em-
beds the solid equations into a variational form of the system of the fluid
equations. It is obtained via the introduction of a fictitious force, which
drives the motion of the solid (this force is related to the traction at the
fluid-solid interface if the wall can be assumed to be thin). This formula-
tion results to be robust for large-scale models, if the thin-wall hypothesis
is reasonable. It has been used by the same group to simulate large-scale
FSI coupled with lumped parameter models at boundaries [140, 139, 141].
The majority of the previous studies consider simplified models of the
vascular wall. The vascular wall, however, is anisotropic and inhomoge-
neous. Holzapfel and his group have developed a mathematical and nu-
merical descriptions of the wall mechanics [142, 143, 144]. The constitu-
tive models are able to capture the anisotropic elastic tissue response in
addition to the inelastic phenomena associated with stretching of the tis-
sue beyond the physiological domain. The anisotropic characteristics of
wall mechanics have been taken into account to investigate the effects of
balloon-angioplasty [142, 145, 146] and stent positioning ([142, 147, 148,
149, 150, 112] among others). In some cases, the structural simulations
have been coupled with CFD simulation in order to investigate the effects
on the hemodynamics of the simulated treatments [104, 151, 152]. Patient-
specific geometries obtained from medical images taken after the clinical
endovascular treatment [153, 154, 155] have also been investigated.
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5.2 Modeling of a newly-created AVF
In clinical practice, surgeons decide where to create the fistula based on
pre-operative scans of the patient vasculature without any quantitative in-
formation on the local hemodynamic conditions. It has been proven that
the success in maturation of a fistula largely depends on the early hemo-
dynamic changes that follow its creation [24, 25, 26]. The lack of clinical
tools that provide detailed maps of the hemodynamics could account for
the significant failure rate [8].
Recently, a Lumped Parameter (LP) model has been developed to pre-
dict the blood flow within a newly-created arteriovenous fistula [156]. The
model is based on the model developed by Bessems et al. [157]. It solves for
the one-dimensional equations of momentum and mass, modelling blood
as an incompressible Newtonian fluid flowing in straight vessels under
fully-developed flow conditions. The downstream vascular resistances and
compliances are modeled with equivalent resistances and capacitors us-
ing an electric analog. The main advantage of an LP model is that it can
quantify the flow distribution within the different branches of the patient
cardiovascular system both before and after the surgery. In order to cor-
rectly set the resistance and compliance values, the pre-operative flow and
pressure conditions need to be known.
Hubert et al. [156] tuned the resistance and capacitor parameter values
to best fit the measurements taken on patients in pre-operative conditions.
The simulations were therefore patient-specific. Two possible locations of
the fistula were modeled: in the forearm or in the upper arm (figure 1.7).
The blood flow distribution was evaluated within the different branches of
the vascular tree, imposing the same cardiac output both before and after
the surgery. The objective of the study was to estimate which of the two
fistula configurations would lead to the more optimal flow conditions. The
results of the simulation were confronted to the choice that was made by a
surgeon in ten clinical cases of fistula creation. It is interesting that in nine
out of the ten cases, the surgeon chose the AVF configuration considered
as optimal by the LP model. It turns out that the fistula actually failed in
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the latter case. In addition, the predicted postoperative flow distribution
corresponded to the postoperative flows in six out of ten cases [156]. Since
the model is robust and easy to implement in a clinical context, it has the
potential to facilitate the routine decision-making process. It could help
predict the flow entering the afferent artery after the fistula creation, and
reduce the risk of non-maturing fistulas.
Figure 1.7: Computational domain for the simulations in the pre-operative condi-
tion, after the creation of a fistula in the upper or lower arm (modified from [156]).
The numbers represent the nodes at which the vessel compliance and resistance
properties have been imposed.
5.3 Modeling of the hemodynamics within a functional AVF
In clinics, the quantification of flow velocity is limited. Clinical exams pro-
vide estimations of flow rates and of cross-averaged velocities. But the
three-dimensional flow patterns are necessary to understand the hemody-
namic conditions that prevail in the fistula. Experimental or numerical
simulations are therefore necessary to quantify the local velocity field, de-
termine the regions of flow recirculation and provide estimates of the wall
shear stresses.
5.3.1 In vitro studies
Flow visualization techniques have been used since the late 80s [158, 159,
160, 161, 162] to provide a qualitative picture of the hemodynamics within
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the fistula. Flow visualization enables the investigation and characteriza-
tion of regions of flow recirculation and detachment. The studies have all
been conducted in simplified models of fistula, with phantoms made of
two coplanar straight vessels. The phantom is perfused with steady-state
and pulsatile flows. An example of the experimental circuit is shown in fig-
ure 1.8. Ojha et al. [158] showed the formation of a stagnation point at the
anastomosis, where the flow splits between the venous and arterial outlets.
The flow exhibited unsteady secondary patterns downstream of the anas-
tomosis. It assumed a spiraling motion inside the distal artery, as shown in
figure 1.9. The formation of secondary flow patterns similar to those aris-
ing in curved vessels was noticed. However, the details of the flow field in
the anastomosis (in which there is an abrupt change in flow direction) were
different from those seen in a gradually curved vessel. When studying the
local flow patterns in the symmetry plane of the anastomosis Sivanesan et
al. showed that the flow pulsatility in AVF is very low [23]. It therefore has
a limited effect on the hemodynamics: steady-state simulations provide a
good estimate of the characteristic flow structures within the AVF (figure
1.10).
Figure 1.8: Schematic of the experimental set-up for the LDA measurements used
by Sivanesan et al. [23].
The flow visualization studies also looked at the influence that the ge-
ometry of the fistula has on the hemodynamics. Hughes et al. [161] showed
that the larger the anastomosis angle, the more pronounced the secondary
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Figure 1.9: Three-dimensional sketch of the dye pathline observed under steady
flow conditions [158].
a. b. c.
Figure 1.10: Flow patterns at the symmetry plane of an AVF at the anastomosis at
the peak systole (a), at late diastole (b) and in case of steady state simulation (c)
[23].
flow in the distal artery. Flow separation can be avoided when the anasto-
mosis angle is smaller or equal to 15˚even at large flow rates.
Quantitative flow measurements were carried out in the late 90s in ide-
alized models of AVF [163, 23]. The velocity was initially measured at
specific locations within the flow using LDV. Estimate of the wall shear
stresses (WSS) were calculated from discrete velocity measurements ob-
tained in the vicinity of the vascular wall in a plane perpendicular to it
(figure 1.11). Physiological wall shear stress values fell in the range 1-2
Pa in healthy arteries [8] and in the range 0.8-3 Pa in healthy veins [164].
Non-physiological values of wall shear stresses have been associated with
endothelial damage (for high values of WSS) or neointima proliferation (for
low values of WSS). Sivanesan et al. [23] evaluated the wall shear stresses
at the inner and outer wall of the vein at different locations away from the
anastomosis center. They have observed that the wall shear stress values at
the outer wall of the vein decrease from a value of 40 Pa near the anasto-
mosis center to 7-14 Pa 24 mm far from the center. The amplitude of the
wall shear stress oscillations also decreases from a value of 50 Pa to 8-9
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Pa. Wall shear stresses were therefore found to oscillate between extremely
high and extremely low values. Similarly, Li and Rittgers [163] investigated
the influence of different flow ratios between the outlets of an end-to-side
arterial bypass graft on the local wall shear stresses at the floor and heel re-
gions of the anastomosis. In particular they focused on flow ratios between
the two outlets equal to 0-100 (I), 25-75 (II) and 50-50 (III). The authors have
shown that both the wall shear stresses and oscillatory shear index at the
arterial floor were significantly larger in case I. Differences between cases II
and III were not significant. At the graft hood, the oscillatory shear index
and wall shear stresses were lower in case I than in cases II and III. But at
this location the wall shear stresses differ between cases II and III, case II
showing lower values than case III.
LDV experiments have therefore provided an accurate evaluation of
wall shear stresses at selected locations. However, LDV cannot provide
directly the velocity field in a plane or the distribution of streamlines, as
the velocity is measured at point locations.
Figure 1.11: Axial positions along graft hood and artery floor for velocity mea-
surements [23].
The first study that obtained two-dimensional measurements of the ve-
locity field was conducted by Kharboutly et al. [165]. The velocity field was
measured by PIV in a patient-specific phantom of AVF (figure 1.12). The
two planes of measurements are indicated on the image of the geometry
inserted in figure 1.12. The velocity fields were compared with numerical
results obtained in the same vessel geometry using a computational fluid
dynamic code. Figure 1.13 shows that a good qualitative correspondence
is achieved throughout the cardiac cycle. It was confirmed quantitatively,
comparing the velocity profiles.
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Figure 1.12: Schematic of the experimental set-up for the PIV measurements used
by Kharboutly et al. [165]. Within the box a magnification of the anastomosis is
shown. The red and the blue lines indicate the 2 planes considered for the analysis
of the hemodynamics (modified from [165]).
Figure 1.13: Velocity vector cartography in the horizontal plane (PH) for the three
time cardiac instants T1 (peak systole), T2 (middle value) and T3 (late diastole)
[165].
As shown in this section, both idealized and patient-specific models
have been used to model the hemodynamics within an AVF. Each model
type has its proper advantages and disadvantages. Idealized models en-
able to complete parametric studies and evaluate the influence of various
parameters (geometry, flow rate, pressure, etc) on the flow conditions. Gen-
eral trends/conclusions can be deduced from the results, which is not pos-
sible from patient-specific models. Patient-specific models, however, en-
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able to measure velocities and wall shear stresses in a realistic vessel mock.
If the imposed flow profile and boundary conditions are well suited, the
hemodynamic quantities thus measured should be a faithful representation
of the flow conditions in the patient’s AVF.
5.3.2 In silico studies
When considering the literature on the hemodynamics in arteriovenous
fistulas, one can notice a much greater number of numerical studies com-
pared to experimental ones. Modeling the unsteady flow conditions inside
a complex AVF geometry may indeed be less challenging numerically. Nu-
merical models also have the advantage that the geometric parameters and
boundary conditions can be varied systematically: parametric studies are
therefore easier to perform in silico than in vitro.
Computational fluid dynamics (CFD) simulations investigated the 3D
hemodynamics inside arteriovenous grafts [162, 166, 167] and autologous
fistulas [19, 165, 168, 169, 170, 171]. These studies aimed at better under-
standing the local hemodynamics and how it evolves in the presence of
intimal hyperplasia, stenosis and vascular alterations. Kharboutly et al.
[170] for instance related regions of low wall shear stresses to calcified re-
gions in a patient-specific AVF wall (figure 1.14). In particular they found a
potential association between calcification regions and high temporal wall
shear stress gradients. Similarly, Ene-Iordache and Remuzzi [19] associated
the zones of flow recirculation inside the AVF to those of wall remodelling
(figure 1.15) in idealized fistula geometries. The importance of the anas-
tomosis angle was also highlighted [20, 168]: in general angles smaller
than 10˚are to be avoided, since they lead to a local increase in wall shear
stresses. This result might appear in contradiction with the one mentioned
in section 5.3.1. But the studies searched for the optimal angle with two dif-
ferent objectives: the in vitro study aimed at minimizing the detached flow
region, while the in silico study aimed at minimizing the wall shear stress.
It suggests that the optimal anastomosis angle is a compromise between
the minimization of the flow detachment and local wall shear stresses.
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Figure 1.14: The wall shear stress distribution is shown on the left-hand side. From
CT-scan angiography data (of which two sections are reported in the centre of the
figure) the 3-D distribution of calcified regions has been obtained, and calcification
plaques ’CP’ have been distinguished by calcification zones ’CZ’, as shown on the
right-hand side [170].
So far surgeons and nephrologists only rely on clinical flow measure-
ment techniques to estimate the flow conditions. The use of in silico models
would provide a more complete and accurate picture of the hemodynamic
conditions. It would be of great support to decide on treatments and plan
surgical acts. Still, patient-specific numerical models have their limits. Var-
ious parameters are not and cannot be taken into account. One instance is
the presence of other pathologies, such as diabetes, which modify the vas-
cular response to physio/pathological sollications. But too little is known
on such co-factors to so far include them in numerical simulations.
5.4 AVF pathologies: optimization of the strategies for detection and
treatment
More recently, simulations have been used as a tool to investigate patho-
logical conditions and optimize surgical and endovascular treatments. Van
Canneyt et al. [172] proposed a method for the early detection of a steno-
sis inside the vein or at the anastomosis. The detection relies on the use
of a brachial sfigmomanometer to measure the pulse pressure. Before be-
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Figure 1.15: a) Contour of the velocity magnitude. The cut-plane shows the recir-
culation zones. b) Areas where the low wall shear stresses ant the large oscillatory
shear index trigger formation of neointima with subsequent increase in wall thick-
ness [19].
ing potentially used routinely on patients, the result of Van Canneyt et al.
would first need to be validated through a clinical study. One would need
to prove that the benefit for the patient outweights the inconvenience of
adding yet another instrument during the hemodialysis session.
This example proves that modeling approaches have a great potential
to study pathologies affecting fistulas and their associated treatment. It is
indeed possible to predict how to optimize the treatment techniques. If
three-dimensional simulations were coupled with lumped parameter mod-
els [172], it would be for example possible to investigate the influence that
pathological fistula have on the cardiac output.
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6 Objectives
We are interested in numerically modeling the hemodynamics within a
patient-specific arteriovenous fistula. We propose a model which takes
into account the compliance of the vascular wall. It represents a novelty
compared to the state-of-the-art, since the numerical models developed so
far for the AVF have considered the wall to be rigid.
We also differentiate the venous from the arterial mechanical properties
and consider the non-Newtonian blood behavior. The investigated patient-
specific geometry presents an 80% stenosis at the proximal radial artery.
We are interested in better understanding the impact of the arterial stenotic
lesion on the hemodynamics. We also want to investigate the effect of the
endovascular treatment of an arterial stenosis.
We firstly simulate the treatment by balloon-angioplasty, and investi-
gate the impact of the degree of residual stenosis which persists after the
treatment. Then we simulate the treatment of the stenosis by balloon-
angioplasty followed by stent positioning. The effects of angioplasty both
without and with stenting are compared.

Chapter 2
Material and methods
1 Geometry
1.1 Patient-specific arteriovenous fistula
1.1.1 Image acquisition, segmentation and volume reconstruction
Nowadays angiography imaging techniques (CT-scan or magnetic reso-
nance) provide a high-quality three-dimensional (3D) volume rendering
of the vasculature of the patient in real time. It is, however, not adapted
for numerical purposes. Angiography images therefore need to be post-
processed using segmentation and reconstruction techniques in order to
obtain the 3-dimensional geometry of the patient-specific vascular tree.
The segmentation and volume reconstruction procedures aim at isolat-
ing the vessel lumen from surrounding tissues and structures. During his
PhD, Zaher Kharboutly developed specific numerical techniques to seg-
ment and reconstruct of patient-specific fistulas [20]. Since the medical
images are encoded in greyscale, the segmentation consists in extracting
the structures that have grey levels contained within a certain range. A
good contrast between the vessel lumen and the other tissues is required
for a successful segmentation procedure. Technically, it is obtained us-
ing the methods called ’active contours’ and ’region growing’ (see [20] for
details). One must note that the reconstructed geometry depends on the
choice of the range of greylevels. It is therefore operator-dependent. More-
over, there may be variabilities in grey levels for images taken at different
times during the cardiac cycle or in sequential cardiac cycles. At the end
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of the segmentation procedure the isolated geometry is cleaned up to re-
move possible vessels, calcified plaques and bone structures that would
have been retained inadequately (figure 2.1).
Figure 2.1: Patient-specific AVF geometry obtained by volume reconstruction [20].
In figure 2.2 we show the fistula geometry after the reconstruction and
clean-up procedure, ready to use in numerical simulations. The different
parts of the investigated vasculature have been identified (proximal radial
artery, distal radial artery and cephalic vein) as well as the location of the
stenosis throat. We call Sia the arterial inlet, Soa the arterial outlet and Sov the
venous outlet.
Figure 2.2: Patient-specific AVF geometry. Sia is the arterial inlet, Soa the arterial
outlet and Sov the venous outlet.
1 – Geometry 55
1.1.2 Partition of the vascular wall
At the end of the volume reconstruction procedure we firstly extract the
vascular wall. We triangulate the lateral surface wall, and partition it within
ANSYS T-Grid by creating cut-planes. This partition aims at differentiat-
ing the mechanical properties of different vasculature segments, as shown
in figure 2.2. We isolate the vein from the artery by splitting the entire
vasculature at the level of the anastomosis (plane C-C in figure 2.2). We
also separate the stenosed portion of the artery as the segment between the
cutting planes A-A and B-B (figure 2.2).
1.1.3 Meshing of the fluid volume and vascular wall
The fluid volume mesh is created with ANSYS T-Grid (ANSYS, Inc.). We
start from the triangulation of the lateral surface wall of the reconstructed
AVF lumen. The volume mesh is made of an hybrid grid, which combines
a prismatic boundary layer and a core meshed with tetrahedrons. Both cell
element types are linear. More details on the mesh generation technique
may be found in Kharboutly et al. [169]. The fluid volume mesh is exported
from T-Grid in MSH format, which can be directly imported in the ANSYS
computational fluid dynamic solver.
The vascular wall is extracted from the volume mesh. It is meshed with
triangles. It shares the same nodes as the fluid mesh at the interface. It
is exported in STL format from T-Grid. It is then meshed with a single
layer of discrete-Kirchhoff theory-based, four-node linear-triangular shell
finite elements: the "Shell 181" elements implemented in ANSYS-Structural
(ANSYS, Inc.). The solid mesh consists of 89× 103 shell elements.
1.1.3.1 Spatial convergence of the mesh grid Different mesh sizes have been
tested in order to guarantee a maximum error of 1% on the velocity magni-
tude and wall shear stresses within a reasonable computational time tcomp.
All meshes have been created using the method described in section 1.1.3.
We have investigated meshes of maximum element length ∆lmax equal
to 1, 2, 4, 5, 7 and 10×10−3 mm. We choose as reference the results obtained
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with the smallest mesh size (10−3 mm). We calculate the relative error εu =
|u− ure f |/ure f on the maximum value of the velocity magnitude (u = vmax)
and time-averaged wall shear stress (u = WSS).
Figure 4.2 shows that the numerical procedure converges with respect to
∆lmax approximately as ∆l4.8max and that the normalized computational time
decreases about linearly with ∆lmax. We have chosen to run the simulations
with the mesh characterized by a maximum element length of 4 × 10−3
mm, since it respects the 1%-error limit (horizontal line in figure 4.2a) for
both the velocity and wall shear stress and runs four times faster than the
reference case (figure 4.2b). The total number of elements for the patient-
specific geometry is then 784× 103.
a. b.
Figure 2.3: (a) Relative error on the maximum velocity (εvmax ) and time-averaged
wall shear stresses (εWSS) as a function of the maximum mesh length ∆lmax. The
horizontal line indicates an error of 10−2, chosen as the threshold. (b) Normalized
computational time tcomp/t
re f
comp as a function of the maximum mesh length ∆lmax.
The reference case corresponds to the mesh with a maximum element length of
10−3 mm.
1.2 Angioplasty balloon
We model the angioplasty-balloon as a cylindrical surface. The cylinder is
created within ANSYS-Geometry (ANSYS, Inc.). Its length is 15 mm and
its diameter 1 mm. The balloon surface is meshed with linear triangular
elements. The triangular elements are modeled as the shell elements "Shell
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181" implemented in ANSYS (ANSYS, Inc.).
1.3 Stent
The stainless steel wire stent Wallstent (Boston Scientific; Natik, MA, USA)
is one the most used to treat stenosed fistula. It is a self-expandable,
braided stent (figure 2.4). We model its geometry as a tubular shape made
from sets of wires spiraling clockwise and anti-clockwise. The stent is
created with the software PyFormex (copyright c©Benedict Verhegge), de-
veloped in Python, a scripting language. Python is well suited to gener-
ate, transform and manipulate large geometrical models of 3D structures
through sequences of mathematical operations. The stent has a length of
12 mm and a deployed diameter equal to 4.2 mm. It is composed of 24
separated wires. Before being exported in ABAQUS format, the structure
is meshed with the sweep method. We obtain the stent meshed with hexa-
hedrons. The details of the script used are shown in annex A.
Once imported in ANSYS-Workbench environment the ABAQUS file of
the stent is re-meshed within ANSYS-Structural with the native algorithm
for ANSYS-Workbench applications. The quality of the ABAQUS mesh is
indeed too poor for numerical simulation in ANSYS. In particular we:
• import each wire within ANSYS-Structural;
• delete the existing mesh;
• mesh the wires with the default sweep, patch conforming algorithm.
We thus obtain the twenty-four wires meshed with tetrahedrons.
2 ANSYS-Workbench environment
We have chosen ANSYS-Workbench as the environment for the fluid and
solid numerical simulations. The version 13.0 of the software has been used
on an Intel(R) Xeon(R) workstation with 64 bit CPU dual core processors
of 2.67 GHz clock speed, 23.9 GB RAM memory and a Microsoft Windows
XP operating system. ANSYS 13.0 (ANSYS, Inc.) combines the strength
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Figure 2.4: Picture of the wire stent Wallstent (Boston Scien-
tific; Natik, MA, USA) as available on Boston Scientific website
(http://bostonscientific.mediaroom.com/).
of native core solvers with project management tools allowing the user to
customize the work-flow [173]. In figure 2.5 we show the home interface of
ANSYS-Workbench.
Within ANSYS-Workbench one can solve fluid, structural, thermal or
electro-magnetic problems. Each type of simulation has its proper inter-
face, called ’Analysis System’. The analysis systems implemented in Work-
bench can be found in the ’Toolbox’ menu (figure 2.5). These systems can
be added to the project stand-alone or combined with others depending
whether the problem to be solved is multi-physics or not. When a stand-
alone system is created, the user defines the geometry, mesh, boundary
and initial conditions, and then runs the solver. The set up of a multi-
physics project requires to build connections between the different analysis
systems. The strength of ANSYS-Workbench is that each analysis system
maintains its proper interface and solves the relative problem with a native
solver. In the case of a fluid-structure problem, the interaction between the
two systems takes place at the interface between the fluid and solid ge-
ometries, where the results of one analysis are passed to the other analysis
[173].
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Figure 2.5: Main interface of ANSYS-Workbench. In the toolbox one can find all
the physics (’Analysis Systems’) or parts (’Component Systems’) which can be
added to the ’Project Schematic’ in order to build-up the specific analysis.
2.1 The use of meshed geometries within ANSYS-Workbench
The fluid and solid meshes described in section 1.1.3 of this chapter need to
be imported within ANSYS-Workbench. We describe separately the import
of the fluid volume mesh within the fluid solver and the import of the solid
mesh within the structural solver.
2.1.1 Import of the volume meshed geometry
When ANSYS-CFX (computational fluid dynamic, CFD, solver) is added
in ANSYS-Workbench the user has firstly to define the fluid geometry and
its associated mesh. For this study we use the geometry of the AVF lumen
meshed as described in section 1.1.3. The MSH file created in T-Grid (AN-
SYS, Inc.) is imported right clicking on the box ’Mesh’ of the CFX system.
This geometry can be scaled to the correct unit system if necessary. Once
imported the mesh file cannot be modified.
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2.1.2 ANSYS FE-Modeler
We use ANSYS FE-Modeler to import the solid geometries (AVF wall, stent,
balloon) and convert them into ANSYS-Structural system [173]. Neither the
vascular wall of the AVF nor the wires of the stent are meshed in a native
format for the Workbench environment. The AVF wall is indeed meshed in
STL format and the stent in ABAQUS format. Such mesh formats cannot
be directly read by ANSYS-Structural. The imported mesh has no units.
The user is therefore in charge of notifying the dimension units during the
import.
2.1.2.1 Steps to be followed within ANSYS FE-Modeler When a mesh is
imported in the ANSYS FE-Modeler application, the menu ’Geometry Syn-
thesis’ allows the user to generate a geometry from a finite element model.
The first step consists in identifying the exterior faces of the imported ge-
ometry(ies) with the ’Skin Detection Tool’ (figure 2.6). This tool enables
the user to select the threshold angle which allows to correctly identify the
imported geometry as a single body. The angle is in fact evaluated among
facets at the external meshed surface of the body. For too small threshold
angles, adjacent facets of the mesh can be separated and the body parti-
tioned in a multi-component body. In same cases this partitioning can be
useful to facilitate the transfer of the mesh in ANSYS-Structural. We have
presently used a large value of threshold angle (≥50o) to ensure that the
bodies are single-component structures.
Once the skin of the bodies is detected, the geometry needs to be con-
verted in a format that can be read in ANSYS-Structural. One has to define
a so-caller ’Initial Geometry’. The ’Initial Geometry’ appears in the tree
menu (see figure 2.6), and it contains all the bodies that have been identi-
fied with the ’Skin Detection Tool’ and that will be transferred to ANSYS-
Structural. The user can decide to group two or more bodies in a ’Part’ and
two or more parts in an ’Assembly’.
The ’Initial Geometry’ can be, if necessary, modified with the transfor-
mation tool using the specific licence called ANSYS Mesh Morpher license
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Figure 2.6: Outline of the ANSYS FE-Modeler.
[173] through the ’Target Configuration’ feature. The ’Initial Geometry’ is
first copied into the ’Target Configuration’, which is then modified. Each
transformation implies a modification of the geometry or of its position in
space in the 3-dimensional reference system. Note that the numbering of
nodes and elements remains unaltered by the transformation. The ’Target
Configuration’ has a parameter associated which is zero when the ’Target
Configuration’ is created. The first transformation which is imposed mod-
ifies the value of the parameter. For instance, if the first transformation is
a translation of 0.01 m the parameter value is modified to 0.01. When the
’Target Configurations’ correspond to the geometrical characteristics that
the user needs for the analysis, the ’Parametrized Configuration’ has to be
updated. It is important to update this configuration before carrying on the
analysis. It is indeed the ’Parametrized Configuration’ that is transferred
to ANSYS-Structural within ANSYS Workbench. This update is made ef-
fective simply by substituting the parameter values in the ’Parameter Set’
section of the Workspace (P1 Mesh.Morpher.1) shown in figure 2.7 with the
value associated to the ’Target Configuration’(1). This parameter is zero by
default and has to be changed to the parameter value associated with the
’Target Geometry’ within the interface of ANSYS FE-Modeler. The update
of these parameters makes the transformation effective for the export in
(1)The user simply clicks on the value of P1 Mesh.Morpher.1 and overwrites it with the value
associated with the target configuration.
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different ANSYS-Workbench systems.
Figure 2.7: ’Parameter Set’ section of the Workspace, in which the value of the pa-
rameter has to be changed to correctly read the transformed geometry in ANSYS-
Structural.
We have used the transformation tools when importing together the
balloon, the artery and the stent since they are created within different
software tools. The balloon and the stent need to be positioned across the
stenosis throat and centred onto it. To ensure that the quality of the trans-
formed mesh is preserved, the extent of the transformations one applies
must be limited [173]. The ’Initial Geometry’ and its associated mesh can
be transferred to other Workbench applications, such as ANSYS-Structural.
2.2 ANSYS-CFX
ANSYS-CFX is the system which solves the computational fluid dynamics
in ANSYS 13.0. The user is guided step-by-step in the setup of the model.
The schematic of the pipeline is shown in figure 2.8. In the following para-
graphs we detail the model setup we have used.
2.2.1 Computational fluid dynamic numerical method
ANSYS-CFX (ANSYS, Inc.) is used to solve the fluid continuity and mo-
mentum equations in their conservative convection-diffusion form [173].
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Figure 2.8: Pipeline of ANSYS-CFX system, the computational fluid dynamic
solver implemented in ANSYS-Workbench.
These equations are solved implicitly with the Rhie-Chow interpolation
method [174]. We presently consider the atmospheric pressure as reference
pressure and we neglect gravity. For time-integration, we use the high-
resolution, second-order backward Euler scheme implemented in ANSYS-
CFX fluid solver (ANSYS, Inc.). This scheme is a second-order accurate,
implicit time-stepping scheme, recommended for non-turbulent flow sim-
ulations [173]. The system of algebraic equations is solved iteratively using
a time-step ∆t equal to 5 ms. At each time step, the residual is calculated
and reported as a measure of the overall conservation of the flow proper-
ties. The maximum allowed residual is 10−4. To reach convergence at each
time step, we set a maximum number of sub-iterations equal to 100, but
convergence is verified in less than 10 iterations at the first time step and
in less than 5 iterations at all the following time steps. All the transient
simulations are initialized with the results obtained running the equivalent
steady flow simulation with time-averaged quantities as boundary condi-
tions.
2.2.2 Model setup
By double-clicking on the ’Setup’ box a window dedicated to the simu-
lation pre-processing opens. Within this window, the user can define all
the simulation conditions. The following paragraphs describe in detail the
setup parameters we have used.
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2.2.2.1 Blood model Blood is assumed to be an isotropic, homogeneous,
non-Newtonian fluid. Blood density is set to 1050 kg.m−3 and its apparent
viscosity µ is assumed to follow Casson model. The apparent viscosity µ
can be expressed as
√
µ =
√
τ0
γ˙
+
√
κ. (2.1)
where τ0 represents the yield stress, γ˙ the shear rate and κ the consistency.
The model parameters have been chosen according to experimental data
obtained at low shear rates: τ0 = 4× 10−3 Pa, κ = 3.2× 10−3 Pa.s [175].
2.2.2.1.1 Validation of the need of a non-Newtonian blood model In a
non-Newtonian model the dynamic viscosity is function of the local shear
rate. For large shear rates, the equivalent dynamic viscosity is constant and
the fluid behaves as Newtonian. For low shear rates, the non-Newtonian
effects are significant and the local equivalent viscosity increases. In figure
2.9 we show the equivalent dynamic viscosity values observed at the AVF
wall. Inside the radial artery the dynamic viscosity is equal to 3.2×10−3Pa.s−1.
It corresponds to the value the model gives for large shear-rates, when the
fluid follows a Newtonian behavior. Within the enlarged vein the non-
Newtonian effect are significant: shear rates are in fact lower than 100 s−1
and the equivalent dynamic viscosity becomes up to 6 times larger than
within the artery. The choice of the non-Newtonian model is therefore jus-
tified by the low shear rate conditions that prevail inside the cephalic vein
and which lead to significant non-Newtonian effects. In this region, the
wall shear stresses would be overestimated by a Newtonian model.
We have quantified the error made on the wall shear stresses if a New-
tonian model was used. The dynamic viscosity µ has been set to 3.2×10−3
Pa.s−1, corresponding to the dynamic viscosity given by the Casson model
at large shear rates. Inside the proximal artery the error is almost zero. The
largest error on the wall shear stresses is found in the enlarged vein: at this
location we observe a spatial-averaged error of 13%, with peaks of 20%. At
the anastomosis the errors are within 15%, with a spatial average of 10%.
This is coherent with the finding of Kabinejadian and Ghista [176].
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Figure 2.9: Dynamic viscosity values obtained at the AVF wall with the Casson’s
model.
2.2.2.2 Modeling of the flow conditions The simulations are run under the
hypothesis of laminar flow. This hypothesis is coherent with the fact that
the prescribed boundary conditions (detailed in section 2.2.2.3 of this chap-
ter) correspond to a systolic Reynolds number of 800, a time-averaged
Reynolds number of 650 and Womersley number of 4. Since the fluid is
not reactive we do not impose combustion, thermal radiation or heat trans-
fer.
2.2.2.3 Boundary conditions No-slip conditions are imposed at the vascu-
lar wall. The section-averaged velocity via is the one that was measured
by echo-Doppler on the patient on the same day as the CT-scan angiog-
raphy [170] and it is shown in figure 2.10. We have prescribed the flat,
time-dependent profile of via at the inlet of the proximal radial artery (Sia in
figure 2.2).
At each of the two outlets Soa and Sov, we impose a flow-dependent pres-
sure condition based on a RC Windkessel model [177]. This model is based
on the hypothesis that the hemodynamic behavior of the vessel network
downstream of the 3D-geometry outlet is related to its compliance and
resistance. If one models the vessel compliance with a capacitor and the
hydraulic resistance as an electrical resistance, one can generate a zero-
dimensional model of the flow through the network based on a simple
electrical analog circuit.
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Figure 2.10: Flat, time-dependent velocity profile via prescribed at the inlet of the
proximal radial artery (Sia in figure 2.2). It corresponds to the section-averaged
velocity measured on the patient.
We have modeled the behavior of the downstream vasculature as a ca-
pacitor C in parallel with a resistance R. The relationship between the
blood flow rate Q and the pressure P is given by the equation
∂P
∂t
=
1
C
(
Q− P
R
)
, (2.2)
which becomes upon discretization
Pi − Pi−1
∆t
=
Qi
C
− Pi
RC
. (2.3)
The index i represents the current time-step and i − 1 the previous one.
The model therefore requires the pressure value at time step i − 1 to be
available to the solver. It is obtained by creating an additional variable
that we have called ’PPrev’. The variable ’PPrev’ allows the storage of the
pressure values at the previous time-step at each point of the geometry. In
the command editor the CCL variable ’PPrev’ is defined as(2)
1 LIBRARY:
&replace ADDITIONAL VARIABLE: PPrev
3 Option = Definition
Tensor Type = SCALAR
5 Units = [Pa]
Variable Type = Specific
7 END
(2)’Additional Variables’ are added in the section ’Fluid Domain’, ’Fluid Model’ in the tree menu
within ANSYS-CFX.
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END
Re-arranging the terms of the equation 2.3, we obtain
Pi =
Pi−1 +
Qi
C
∆t
1+
∆t
RC
. (2.4)
The parameters R and C have been estimated using the technique of Molino
et al. [178]. It requires to know
• the pulse pressure, defined as the difference between the systolic pres-
sure Ps and the diastolic pressure Pd at the considered outlet within
one cardiac cycle;
• the time-averaged pressure P at the flow outlet;
• the time-averaged blood flow rate Q at the same flow outlet.
From the flow rate data measured by echo-Doppler, we obtain the time-
averaged flow rate. Neither the pulse pressure nor the time-averaged pres-
sure can be measured directly on the patient. In order to calculate the pulse
pressure Ps− Pd we run a rigid-wall simulation where the desired flow split
between the arterial and venous outlets is imposed and free pressure out-
let conditions are set at sections Sao and Svo . We find a pulse pressure equal
to 12 mmHg. The same simulation returns also the value of the pressure
drop within the AVF geometry for the imposed flow inlet. According to
the literature, functional fistulas may have a mean pressure in the proxi-
mal radial artery between 50 and 100 mmHg [179]. The range of values
is large, since it is a function of the patient general health conditions. To
cover the entire possible range, we have run 3 simulations with different
time-averaged inlet pressures Pia (table 4.1). For each value of P
i
a, we have
estimated the corresponding values of Poa and P
o
v. At this stage, we have
an estimation of the mean pressure, the pulse pressure and of the flow rate
at each outlet. We can therefore apply the model of Molino et al. [178]
to our data. The values of the constants R and C are calculated for both
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the arterial (denoted by subscript a) and venous (subscript v) outlets of the
considered domain (table 4.1).
No data exists in the literature on the pressure and flow conditions in
fistulas that could help compare the present R and C constants calculated
for the segments downstream of the arterial and the venous outlets. Values
can be calculated in the healthy case from the data provided by Westerhof
[177] for comparison. The present values are of the same order of magni-
tude as in the healthy case. At the venous outlet the constant C tends to
be larger but by maximum an order of magnitude, and the R values only
slightly smaller. Conversely, at the arterial side the constant C is about 5
times smaller than in the healthy case and the value of R increases up to 8
times the healthy case values.
It is also interesting to consider the product of the two constants τ = RC,
which is the time constant of the dynamic response of the vascular tissue. It
is linked to the capacity of the vascular segment to absorb the peak systolic
kinetic energy. We find a time constant τ equal to 0.15 s for the arterial
outlet and 0.08 s for the venous one in the case Pia = 70 mmHg. It is
coherent to find a larger time constant downstream of the artery, owing
to the presence of more elastic vessels downstream of the outlet and of
the capillary bed. In large elastic arteries, the time constant is of order 1:
Ismail et al. [180] found, for instance, τ ∼ 1 s for the vascular network
downstream of the iliac arteries. This is coherent, since the arterial outlet
of the AVF is made of less elastic vessels than those at the outlet of the iliac
arteries.
2.2.2.4 Initialization The velocity field is initialized with the solution of
the steady-state simulation. In this simulation the fluid properties are kept
identical as in the pulsatile simulation. As boundary conditions, we impose
the time-averaged values of the inlet velocity at Sia and of the venous and
arterial pressures at Sov and Soa, respectively. All the simulations are run
taking the atmospheric pressure as the reference pressure.
2 – ANSYS-Workbench environment 69
Table 2.1: Values of the venous and arterial resistances (Rv and Ra) and compli-
ances (Cv and Ca) for the different values of time-averaged inlet pressure P
i
a. The
corresponding inlet pressures at peak systole Pias and diastole P
i
ad are provided for
reference. The pressure values are in mmHg, the resistances in 108 kg.m−4.s−1
and the compliances in 10−11 kg−1.m4.s2.
Pia Pias P
i
ad Ra Ca Rv Cv
55 63 51 11.9 4.98 4.77 11.5
70 78 66 30 5 6.5 12
90 98 86 41 5.04 7.4 12.1
Figure 2.11: Arterial pressure profile Pao (dotted line) obtained at the arterial outlet
Sao and venous pressure profile Pvo (dot-mark line) obtained at the venous outlet
Svo . The ordinate axis does not start from a zero pressure.
2.2.2.5 Hemodynamic parameters As part of the post-treatment, we study
the evolution of hemodynamic quantities which have been shown to affect
vascular remodeling. The wall shear stresses are contained within the plane
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tangent to the vascular wall, defined by the unit vector normal to the vessel
wall n. They can be expressed by the two-component vector
τw = µ
∂v
∂n
, (2.5)
where τw is the viscous stress acting tangentially to the vessel wall and v
the velocity vector. We call wall shear stress WSS the modulus of τw. The
time-averaged value of WSS, called WSS is calculated as
WSS =
∫ T
0
|WSS|dt. (2.6)
In a healthy radial artery, WSS is in the range 1-2 Pa [8], which we will refer
to as the healthy physiological WSS range. In a vein, it has been reported
that neointimal hyperplasia rapidly develops when WSS values are below
0.5 Pa [164].
The oscillatory shear index OSI is defined as
OSI = 0.5(1− |
∫ T
0 WSSdt|∫ T
0 |WSS|dt
), (2.7)
where T is the time period of the cardiac cycle. The OSI index represents
the degree of oscillation in the wall shear stress orientation. Its values fall
in the range [0, 0.5], 0 corresponding to a constant forward flow and 0.5
to a purely oscillating flow. OSI values are typically below 0.2 in healthy
physiological vessels. A value of 0.3-0.35 is considered as the threshold,
above which neo-intimal activation and proliferation might occur [181].
In order to obtain the time-averaged modulus of the wall shear stress
WSS the user needs to introduce an additional variable, that we call ’wall-
shearmag’(3). When an ’Additional Variable’ is created, a few lines of code
need to be written. The user has to define the name of the variable, its type
(scalar on vector) and its units. In the details, the lines of code are:
LIBRARY:
2 &replace ADDITIONAL VARIABLE: wallshearmag
Option = Definition
4 Tensor Type = SCALAR
(3)’Additional Variables’ are added in the section ’Fluid Domain’,’Fluid Model’ in the tree menu
within ANSYS-CFX.
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Units = [Pa]
6 Variable Type = Specific
END
8 END
Once the variable has been created and defined, the user needs to specify
the expression which enable the solver to calculate it. For the ’wallshear-
mag’ the expression is√
(Wall Shear x)2 + (Wall Shear y)2 + (Wall Shear z)2 (2.8)
where Wall Shear x, Wall Shear y and Wall Shear z, are the name that
ANSYS-CFX assign to the three components of the wall shear stress vector
τw.
The temporal gradients of WSS (WSSGt) are defined as
WSSGt =
∂WSS
∂t
. (2.9)
They are typically small in healthy vessels. We will analyze which AVF
zones are exposed to non-vanishing values of temporal gradients.
2.3 ANSYS-Structural
2.3.1 Numerical method
The equation system of the solid problem is solved implicitly using the
Lagrangian multiplier-based mixed u-P formulation in ANSYS-Structural
(ANSYS, Inc.), u standing for the displacement and P for the static pressure.
ANSYS-Structural is divided in several parts in order to help the user in the
set-up of the model. As for ANSYS-CFX, the steps correspond to sequential
interfaces to be opened in ANSYS-Structural. The sequence used to define
the model setup is shown in figure 2.7, where an FE-Modeler system is
connected to the ’Model’ section of the ANSYS-Structural system. These
steps consist in:
• Definition of the mechanical properties of the different parts of the
bodies to be simulated(4);
(4)The definition of the mechanical properties of the different materials is done in the ’Engineering
Data’ section of ANSYS-Structural
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• Definition of the thickness of the shell-element bodies and assignment
the material properties to each body(5);
• Definition of the boundary conditions, loads to be applied and solver
settings(6);
• Run of the solution(7) and post-process of the results(8).
In the following sections we describe the various steps needed for the sim-
ulation.
2.3.2 User-defined mechanical properties: Engineering Materials
When ANSYS-Structural is opened within ANSYS Workbench, one firstly
defines the mechanical properties of the body(ies) involved in the simula-
tion. The physical properties of the material(s) the density and then the
mechanical behavior. ANSYS supports both linear and non-linear constitu-
tive laws. Among the non-linear laws pre-defined in ANSYS one finds the
plastic, multi-linear elastic, hyperelastic, hyperviscoelastic and viscoelas-
tic/viscoplastic laws. The user can also enter additional laws using the
’user defined models’.
In this study we hypothesize that the vascular wall of the AVF behaves
as a homogeneous, incompressible, hyperelastic material. We assume that
both the artery and the vein follow the 3rd-order Yeoh model [182]. The
strain energy function ψ reads
ψ = C10(I1 − 3) + C20(I1 − 3)2 + C30(I1 − 3)3+
D1(J − 1)2 + D2(J − 1)4 + D3(J − 1)6,
(2.10)
where I1 is the deviatoric first principal strain invariant and J the Jacobian.
The parameters are the material constants C10, C20, C30 and the incom-
pressibility parameters D1, D2, D3. Since the vessel wall is assumed to be
(5)The definition of the geometrical characteristics of the different bodies is done in the ’Model’
section of ANSYS-Structural
(6)The definition of the mechanical loads and boundary conditions is done in the ’Setup’ section
of ANSYS-Structural
(7)The solution is run in the ’Solution’ section of ANSYS-Structural
(8)The results post-processing is done in the ’Results’ section of ANSYS-Structural
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incompressible, the Jacobian J is equal to 1. We differentiate the arterial and
venous mechanical properties in order to model the larger compliance of
the artery as compared to the arterialized vein. The model constants, listed
in table 3.1, are the ones that best fit the experimental data of Mc Gilvray
et al. [183] for the vein and Prendergast et al. [184] for the artery. To the
authors knowledge, the mechanical properties of the vein of a mature AVF
have never been quantified. We therefore consider the stress-strain curve
measured by Mc Gilvray et al. when the vein is subjected to pure circumfer-
ential elongation in mice. In the case of mice, the healthy and the phlebitic
conditions are almost undistinguishable since the vein of the mice has a
large content in collagen in both cases. We therefore suppose this mechan-
ical characteristic as a good estimation of the mechanical properties of the
arterialized vein.
Table 2.2: Values of the constants of the hyperelastic 3rd-order Yeoh model used
for the radial artery and the cephalic vein
Constant Artery Vein
C10 0.763×105 Pa 3.784×106 Pa
C20 3.697×105 Pa 5.543×108 Pa
C30 5.301×105 Pa 6.491×109
The behavior of the stenosed part is modeled with a viscoplastic law.
The implementation of the viscoplastic behavior in ANSYS is based on
the Maxwell model [173]. We impose a law which has the same stiffness
as the healthy arterial parts for small deformations. This choice ensures
the mechanical continuity at the interface between the stenosed and non-
stenosed segments. At large deformations we have set the law parameter
values so that they fit the data of Maher et al. [185].
The balloon and the stent are modeled with linear elastic material prop-
erties. For such a material one needs to define the density ρ, the Young
modulus E and the Poisson coefficient ν. These mechanical parameters are
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summarized in table 5.1
Table 2.3: Values of the mechanical properties of the balloon and stent
Balloon Stent
ρ 1000 kg.m−3 7999 kg.m−3
E 9×108 Pa 2×109 Pa
ν 0.3 0.3
2.3.3 Geometrical and material properties assignment
When opening the ’Model’ part in ANSYS-Structural, the user has to as-
sign the proper mechanical properties to each body. If one or more shell
element bodies have been loaded, the user also has to define the thickness
of the elements. These two operations are done in the section ’Geometry’
which is contained within ’Model’. In figure 2.12 we show an example of
geometry project in which we define the properties of ’Surface body 1’.
This body represents the wall of the cephalic vein of the fistula. We have
set the thickness to 0.4 mm and the material properties to vein, which is
the name given to the venous mechanical properties saved in the library in
the ’Engineering Materials’ section. We also set the type of offset for the
shell element. It can be set to be either the centerline of the element, its top
surface or its bottom surface. We have chosen to define the surface as the
top surface as it is the lumen-wall interface.
Since we have partitioned the AVF wall in order to distinguish the ve-
nous and the arterial properties, the vasculature is composed by more than
one body (see section 1.1.2). In order to make the ANSYS solver treat the
parts of the AVF as a single body, we merge the nodes at the interfaces with
the command lines
/gopr
2 nummrg,node,2e-5
etcontrol,SUGGESTION.
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Within the code, line 1 indicates that the command line acts on the geom-
etry; line 2 imposes the merge of nodes located at a distance smaller than
2×10−5 mm and line 3 indicates that ANSYS automatically chooses the
best element technology to be used by the solver.
Figure 2.12: Definition of the geometrical and mechanical properties of the ’Sur-
face body 1’ which corresponds to the wall of the cephalic vein.
2.3.4 Definition of boundary conditions and loads
Within this section of the Structural system, we differentiate the setup ac-
cording to the simulation we run. We describe the details of the settings
we have used for each case of study:
• Balloon-angioplasty;
• Balloon-angioplasty with stenting;
• Evaluation of the equivalent stiffness of the stented artery;
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• Evaluation of the wall internal stresses through a one-way fluid-structure
interaction.
2.3.4.1 Implicit simulation of balloon-angioplasty We simulate the opening
of the balloon once it is positioned across the arterial stenosis. At the begin-
ning of the simulation the balloon is not in contact with the artery (figure
4.3a). Neither translation nor rotation is allowed at the extremities of the
balloon and vessel walls. The balloon is inflated and deflated by an increas-
ing/decreasing linear ramp in pressure. The contact which occurs between
the balloon and the artery during the balloon inflation, is supposed to be
frictionless [146] and solved using the augmented-Lagrange method.
Figure 4.3b shows when the contact occurs between the balloon and
arterial wall. The balloon is further inflated until the maximum pressure
is reached (figure 4.3c). It is then deflated, leaving the vessel wall in its
post-treatment configuration (figure 4.3d).
Different values of the balloon pressure are imposed (6, 5.6, 5.1, 4.7 bar).
They respectively lead to a degree of residual stenosis equal to 0, 10, 20 and
30% after angioplasty. The cross-sections at the stenosis throat are shown
in figure 2.14 for the patient-specific geometry presenting an 80% stenosis
and for the different post-treatment geometries.
The fluid-region resulting from these geometries has been re-meshed
with the same criteria defined in section 1.1.3. It is used within CFD simu-
lations for the evaluation of the effects of the endovascular treatment.
2.3.4.2 Implicit simulation of balloon-angioplasty with stenting The simu-
lation of the stenting treatment is run implicitly in a three-step simulation:
• During the first step the stent body is inactive and we simulate the
inflation of the balloon during balloon angioplasty as described in
section 2.4.1;
• In the second step the pressure within the balloon is kept constant
and the stent body is activated;
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a. b.
c. d.
Figure 2.13: Schematics of the numerically-simulated angioplasty procedure. a)
Initial configuration: positioning of the balloon within the artery. b) Configuration
when the balloon comes into contact with the artery. c) Configuration at maximum
balloon internal pressure. d) Vessel final shape when the balloon is completely
deflated.
80% 30% 20% 10% 0%
Figure 2.14: Vessel cross-sections at the throat of the stenosis for the patient-
specific (80%-stenosis) and treated geometries (30, 20, 10, 0% residual stenosis).
• During the third step the stent deployment within the artery treated
by angioplasty is simulated.
The contact between the artery and the balloon is defined as described in
2.4.1. No contact is defined between the stent and the balloon.
A body is made inactive when it is transparent for the other bodies
involved into the simulation. However, the inactivation of a body requires
at first the definition of the contact in which the inactive body will be
involved when activated. We define the contact between the artery and the
stent as a frictional following the Coulomb theory. The friction coefficient
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is equal to 4.5×10−2. The stent body is identified by adding the command
lines(9)
1 paramC=cid
paramT=tid.
The stent is make transparent to other bodies during the first step of
the simulation in the section B4 of the model outline (see figure 2.12). The
command line which inactivate the stent body are
esel,s,type,,paramC
2 esel,a,type,,paramT
ekill,all
4 allsel.
This command line is applied to the first step of the simulation.
The stent is re-activated by adding the following command lines to sec-
tion B4 of the model outline (see figure 2.12)
esel,s,type,,paramC
2 esel,a,type,,paramT
ealive,all
4 allsel.
These command lines are applied to the second step of the simulation.
When the simulation requires the inactivation/reactivation of one or
more bodies, it is advised to impose the full Newton-Raphson numerical
scheme for the calculation of the solution [173]. It is obtained by adding
the following command line to section B4 of the model outline (see figure
2.12)
nropt, full.
2.3.4.3 Evaluation of the equivalent stiffness of the stented artery We are
interested in evaluating the equivalent stiffness of the stented artery. We
define two models in ANSYS-Structural:
• The stented artery, obtained with the method described in section
2.4.2;
(9)’Connection’ section, see figure 2.12.
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• The artery in its stented configuration without the inner presence of
the stent (bare artery).
We solve for the deformation of the stented artery imposing a ramped
internal pressure in the lumen in an implicit structural simulation (Struc-
tural Mechanics, ANSYS, Inc.). The contact between the artery and the
stent is imposed to be bonded and solved using the Augmented Lagrange
algorithm already implemented in ANSYS-Structural (ANSYS, Inc.). We
then run the same simulation for the bare artery and search which me-
chanical properties need to be set to obtain the same deformation as the
stented artery.
2.3.4.4 One-way fluid-structure interaction simulation We are interested in
the mechanical solicitations that the vascular wall of the AVF undergoes
under the hydrodynamic pressure field. The solution of the pressure field
needs to be available (resolution of the fluid-problem, section 2.2). The one-
way fluid-structure interaction simulation is built up in ANSYS-Workbench
connecting a CFX-results system to the ’Configuration’ section of ANSYS-
Structural, as shown in figure 2.15. The fluid solution at the time step of
interest is loaded in CFX-results. The user has to open the CFX interface
and select the vascular wall as the boundary on which the variable to be
exported (the pressure in the case of study) has to be calculated.
When the ’Configuration’ interface is opened, one can see ’Import Load’
in the tree menu (figure 2.16). By right-clicking the user can select ’Include
Pressure’. The surface on which the pressure is applied as boundary con-
dition needs to be specified: one needs to select the internal face of the
AVF wall. The ’Imported Pressure’ needs to be refreshed and then the
simulation can be run.
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Figure 2.15: Screen-shot of the connection that need to be created within ANSYS-
Workbench to run the one-way simulation returning the AVF wall displacements
and internal stresses for a pressure field previously calculated within a fluid-
dynamic simulation.
2.4 Fluid-structure interaction
2.4.1 Numerical method
The transient fluid-structure interactions are simulated inside the AVF us-
ing ANSYS-Workbench V13.0 (ANSYS, Inc.), coupling ANSYS-CFX and
ANSYS-Structural implicitly [173]. The schematic of the links made in
ANSYS-Workbench to run such a simulation are shown in figure 2.17. The
software is based on an arbitrary Lagrangian-Eulerian formulation. It uses
a partitioned approach with stagger iterations within each time step. Dur-
ing each stagger iteration:
• The displacement vectors are transferred from the structural to the
fluid solver, where the fluid problem is solved for the current time-
step;
• The load vectors are then transferred from the fluid to the structural
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Figure 2.16: Detail of the tree menu of the ’Configuration’ interface of ANSYS-
Structural. The load imported from the fluid domain is specified.
solver, where the structural problem is solved;
• The convergence of all the field equations (fluid and structural) is
evaluated.
Figure 2.17: Links between the Structural and CFX solvers in order to run FSI
simulations within ANSYS-Workbench (ANSYS, Inc.).
Stagger iterations are repeated until all the field equations have con-
verged and the coupling conditions are satisfied at the fluid-solid interface:
(1) displacements of the fluid and solid domains are compatible, (2) forces
acting on the interface are at equilibrium, (3) the fluid obeys the no-slip
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condition.
The finite element structural solver uses a Lagrangian multiplier-based
mixed u-P formulation. The simulation is performed assuming large dis-
placements. Each FSI simulation is run over six consecutive cardiac cycles,
corresponding to a simulated time of 4.8 s. A time-step equal to 5×10−3 s
is defined for both the fluid and the solid solver.
2.4.1.1 Optimization of the time step for the fluid-structure interaction simula-
tion We have searched for the optimal time-step for which (i) the numeri-
cal model is stable, (ii) the computational time is the smallest, (iii) the tem-
poral resolution is sufficient to capture the time-dependent flow features.
We have tested 3 values of the time step: 10−3, 5×10−3 and 10−2 s. We find
that the simulation is unstable with a time step of 10−2 s, but remains stable
with the two smaller values. The numerical scheme is therefore condition-
ally stable, with a limit of stability between 5×10−3 and 10−2 s. Reducing
the time step by a factor of 5 hardly has an effect on the accuracy of the
results: the results obtained with a time step of 5×10−3 s differ by less than
1% from those obtained with 10−3 s. It, however, has a direct impact on the
computational time, which increases linearly with the number of iterations.
We have therefore chosen to run all the following simulations with the time
step of 5×10−3 s in order to optimize the computational time without loss
in accuracy. The simulation time is approximately 70 CPU hours.
2.4.1.2 ANSYS-Structural: setup for FSI simulation The internal surface of
the vascular wall has been defined to be the interface between the fluid and
the solid physics. It is set to receive the load from the external software
and send back the resulting displacement. Neither translation nor rotation
is allowed at the vascular extremities (corresponding to sections Sai , S
a
o and
Svo in figure 2.1). The external tissues are supposed to be at atmospheric
pressure, which is the pressure of reference in the FSI simulation. The
gravity has been neglected.
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2.4.1.3 ANSYS-CFX: setup for FSI simulation Blood model and flow con-
ditions are the same as described in sections 2.2.2.1 and 2.2.2.3. The wall
boundary is defined as a ’Multi-physics Interface’. The fluid solver is set
to send the loads at the interface to the solid solver and receive from it the
displacement.
3 Experimental simulation
3.1 AVF geometry
A phantom having the same geometry as described in chapter 1 has been
fabricated. A CAD model of the geometry has been created by Innovaltech
(IUT de l’Aisne, Saint-Quentin, France) from the volume reconstruction
of the AVF lumen is exported in STL file format. The vascular walls are
generated with a thickness of 3 mm which is required for the rigidity of
the mould. A phantom made in poly(methyl methacrylate) (PMMA) is
fabricated by rapid prototyping. The 3D printing of the object is obtained
by depositing PMMA microcapsules. The capsules are liquefied by a laser
beam where the material needs to be added.
The 3D phantom is shown in figure 2.18. Its transparency is sufficient
to enable the measurement of the inner velocity field. One can still no-
tice some imperfections (grooves). They are a consequence of the tech-
nique of material deposition used during rapid prototyping. However, the
transparency of the mould is optimized by conducting all the experiments
within a water bath. The phantom is rigid. We will therefore simulate
numerically the hemodynamics in a CFD simulation with ANSYS CFX.
3.2 PIV: Principles
Particle Image Velocimetry (PIV) is a technique that allows the estimation
of the velocity field in a 3-dimensional flow by calculating the velocity vec-
tors in a cut-plane, as introduced in chapter 1, section 5.1.1. The typical PIV
setup consists in a Charge Coupled Device (CCD) camera for image acqui-
sition, a double pulsed laser for lighting the flow field seeded with particles
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Figure 2.18: Phantom of the AVF: the 3-dimensional mould is obtained by rapid
prototyping.
and a PC for synchronization with the laser pulse and image recording. A
software enables to control the laser and camera, determine the velocity
field and post-process the data.
The PIV technique relies on the capture of two images (A and B) at two
sequential times t1 and t2, where t2 = t1 + ∆t. A fast doubled shuttered
CCD camera is typically used to record the images with double exposure.
∆t can be in the range from hundreds to thousands of µs, depending on
the velocity of the fluid motion. Images A and B are employed to detect
the variation of the position of tracer particles (for instance nylon or ly-
copodium) dispersed within the flow. The information about the particle
displacement during the period ∆t is then processed in order to estimate
the velocity field within particular regions of the fluid [186]. The time lag
∆t between the successive firing of the two lasers is an important parame-
ter because it is directly involved in the calculation of the velocity. During
this time, a particle that has been recorded in the image A, moves to an-
other position, recorded in the image B. An estimate of ∆t can be obtained
from the value of the mean velocity and targeting a mean displacement
of the particles of 5 pixels between two successive frames. The minimum
time delay between the two laser pulses is dictated by the time resolution
of the camera. Moreover, since the camera aperture is larger during the
first frame (frame A), the second frame (frame B) has a lower background
intensity [187].
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The images are analyzed with the two-frame cross-correlation tech-
nique. It calculates the displacement correlation peak RD [186]. Cross-
correlation technique includes several steps:
• Divide each double-frame image into interrogation spots and copy the
interrogation spot to memory for analysis;
• Compute the correlation;
• Find the displacement peak RD
• Determine the displacement ∆x, which corresponds to the displace-
ment to be imposed at the interrogation spot in frame B to make the
particles overlap the correspondent interrogation spot in frame A;.
The second, third and fourth steps must be repeated for each interroga-
tion spot in which the image has been divided [187]. The velocity of the
particles u is then calculated as
u =
∆x
∆t
. (2.11)
The spatial resolution of the PIV analysis is defined by the size of the
first interrogation spot [186]. In order to obtain reliable velocity field mea-
surements, a spot should contain from 7 to 10 particle pairs, where one
pair refers to a particle imaged at both t1 and t2 [82]. The particle concen-
tration must in fact be sufficiently high to detect the main characteristics
of the flow but not to elevated to avoid speckle phenomena. Note that
the velocity of a particular interrogation spot is a function of the average
displacement of the particles in the spot. In order to obtain good image
quality, it is also important to ensure that the particles and the fluid have
the same density. This condition guarantees that the fluid and the particles
have the same velocity by avoiding gravity effects.
3.3 PIV: Experimental setup
The experimental setup has been installed in the Biomechanics and Bio-
engineering Laboratory (CNRS UMR 7338) at the Université de Technolo-
gie de Compiègne (figure 2.19). The experiments have been carried out by
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Tommaso Vassallo, a master student who did his final stage in the labo-
ratory. The laboratory is provided with a specific room for particle image
velocimetry measurements.
Figure 2.19: Experimental setup for the PIV measurements: (1) pump, (2) fluid, (3)
AVF, (4) laser, (5) laser guiding arm, (6) camera.
3.3.1 Pump
The steady flow is provided by the peristaltic pump Easy-Load R© 7518-10
from Masterflex R© (Cole-Parmer Instrument Company). It can provide a
constant flow rate in the range 0-1250 ml.min−1. We have chosen to sim-
ulate physiological, time-averaged flow-rates that can be provided by the
available pump. The arterial inlet flow-rate has been set to 800 ml.min−1.
3.3.2 Fluid
All the experiences have been conducted using an aqueous glycerine so-
lution (68% water, 32% glycerine). Its viscosity has been measured to be
3.75×10−3 Pa.s, and its density 1083.2 kg.m−3. We seed the solution with
lycopodium particles (Lycopodium, SIGMA-ALDRICH) with a concentra-
tion of 0.7 g.l−1.
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3.3.3 Laser
The light source is the double laser Nano S PIV Pulsed Nd:Yag from the
Litron Lasers (UK) provided in the pack LaVision Flowmaster PIV System.
It is powered by the LPU450-PIV twin power supplier, which drives the two
laser units with a combined throughput of about 450 W. The laser system
is controlled remotely via the PC (’external trig’ mode). The Nano laser
heads have a verified electronic intra-cavity safety shutter. It is possible to
stop the laser emission by closing the shutter (http://www.litron.co.
uk/pages/nanopiv.html).
The function of the laser is to light the field of motion of the fluid. The
wavelength of Neodimium Yttrium-Aluminium-Garnet (Nd-YAG) pulsed
laser beam is 1064 nm (infrared light). For PIV applications a wavelength of
532 nm (green light in the visible spectrum) is usually used. It is obtained
with an appropriate crystal called 2nd-harmonic crystal. The laser beam
is then transformed in a focused sheet through a system of optical lenses.
This sheet is used to lighten a selected plane within the geometry [187].
For this study, a divergence lens with a focal length of -10 mm has been
chosen. It has to be orthogonal to the camera, which records a sequence of
double-frame (A and B) images. To ease the positioning of the laser plane,
a guided arm is employed (see figure 2.19).
3.3.4 Camera
The camera used for the image acquisition is the Charged Coupled Device
(CCD) camera Imager pro X 2M (LaVision). It is a high sensitivity, high
resolution digital camera. The pixel resolution is 1660 x 1200 pixels, and
the frame rate is 29 frames.s−1. The camera is positioned orthogonally to
the laser sheet, in order to minimize sources of noise and avoid blurred
frames. For a better visualization of the field of motion, a 105 mm F2.8 DG
MACRO (Sigma) objective is used. It allows a good focus onto the regions
of interest of the AVF geometry.
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3.3.5 Protocol for image acquisition and velocity vector field calculation
The image acquisition is managed in the ’external trig’ mode, which means
that the laser and the camera are completely managed from the PC. All the
parameters for image acquisition and analysis have been defined using the
software DaVis 7.2. The first operation to be performed when the software
is started is the calibration of the field of view. It is done grabbing an
image of the field of view in which a ruler has been inserted. A project for
image acquisition is then created and the recording process is started via a
dedicated panel. We set the number of acquired image pairs to 20 and the
correlation technique to ’double frame’. The trigger synchronizes the laser
and the camera.
We have optimized the time interval ∆t between frames A and B in
each region of interest of the AVF. The larger the velocity, the smaller the
time interval. We have set ∆t to be equal to 150 µs in the stenosis and
anastomosis, and to 7000 µs for the enlarged vein.
The laser power has also been adjusted to maximize the luminosity of
the reflected light without having risks of damaging the camera sensor
because of excessive lightness. We have obtained the optimal intensity of
light when we set 40% of the maximum power at the stenosis, 35% at the
anastomosis and 38% at the vein.
Once the images are recorded, it is necessary to create a PIV project for
the calculation of the velocity vectors field and import the acquired images.
We created a specific user-defined mask for each region to compute the
velocity vectors within the lumen. The velocity vectors are calculated with
a three-pass cross-correlation algorithm. The interrogation spot is set to be
circular 32×32 pixels in size. The overlap of the interrogation spots has
been set to 50%.
Spurious vectors have been eliminated and replaced with the spatial-
average value of the neighbours using the median filter implemented within
the software. This filter computes the mean value of the velocity at the
nine points of measure which are the closest to the spurious vector. We
have time-averaged velocity field at each location among the 20 instant of
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measurement to reduce the effects of eventual artefacts, and calculated the
standard deviation [187]. More quantitative date have been obtained by
extracting the velocity profiles at specified cross-section locations.

Chapter 3
Simulation of the fluid-structure interactions within
the AVF
In this chapter we study the fluid-structure interactions within a patient-
specific arteriovenous fistula. We transcribe the text as it has been sub-
mitted to the ’International Journal for Numerical Methods in Biomedical
Engineering’.
1 Introduction
Hemodialysis is conducted in patients with end-stage renal disease in or-
der to filter blood waste products and compensate for the ill-functioning
kidneys. To enable hemodialysis, a partial extracorporeal circulation needs
to be set up towards the artificial kidney. It requires a permanent vascular
access that is easily available for a repeated use and that provides a blood
flow larger than 500 ml.min−1 [188, 189]. The most standard technique is
to create in the arm an arteriovenous fistula (AVF) by connecting a vein
onto an artery (e.g. the cephalic vein onto the radial artery in the case of
an end-to-side AVF) [23]. Subjected to arterial pressure, the vein gets ar-
terialized after three to six months [27]. Once mature, the fistula behaves
as a low resistance, high compliance pathway between the high pressure
arterial system and the low pressure venous system [23].
The lifespan of an AVF is limited from a few days to about 10 years
because of the onset of several complications [23]. Some complications
may affect directly the AVF, such as atherosclerotic plaques, stenoses or
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aneurysms [71, 23]. In practice, the AVF failure is caused by an insufficient
or excessive blood flow inside the vein, compromising either the hemodial-
ysis procedure [8] or the cardiac load.
Hemodynamics plays an important role in the evolution and long-term
efficiency of the AVF [8]. Non-invasive in vivo hemodynamic measurement
techniques, such as echo-Doppler, can provide averaged velocity values
[190] but neither velocity profiles nor wall shear stresses (WSS). The hemo-
dynamics inside patient-specific fistulae has previously been investigated
through computational fluid dynamics (CFD) simulations [166, 170, 171].
These studies have provided a comprehensive knowledge of the spatial and
temporal distribution of the hemodynamics inside the AVF and shown di-
rect correlations between altered wall shear stress patterns and local vessel
damages. They, however, assume the vascular wall to be rigid, which is not
the case physiologically. No study has yet investigated the influence of the
wall compliance on the hemodynamics in an AVF.
Over the last years, quite a few numerical models simulating the fluid-
structure interactions (FSI) in the cardiovascular system have otherwise
been developed ([191, 126, 192, 193, 194, 195, 138] among others). They are
performed with a three-fold objective: to investigate how hemodynamic
factors influence the onset and progression of cardiovascular diseases, to
predict the outcome of surgical interventions and to evaluate the effect
and efficacy of medical devices [153, 196, 197, 137]. Recently, some studies
[191, 198] have started to use more elaborate vessel wall models, such as the
anisotropic constitutive laws derived by the group of Holzapfel [145, 199].
Our present objective is to study the influence of the wall compliance on
the hemodynamics and wall mechanics in a patient-specific radio-cephalic
AVF. Our goal is to perform the FSI simulation with one of the numer-
ical software that clinicians could use to evaluate the hemodynamic and
structural conditions within the AVF during the patients’ follow up. For
this purpose, we have chosen to simulate the FSI with the commercial code
ANSYS Workbench (ANSYS, Inc.). We have modeled the hyperelastic be-
havior of the vessel walls using the Yeoh constitutive law. We have made
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the deliberate choice not to implement more elaborate constitutive laws
(e.g. [145, 199]), as they are not yet available by default in ANSYS Work-
bench. We have, however, differentiated the wall thickness and mechanical
properties of the cephalic vein and radial artery.
In a second part of the study, we have analyzed whether it is possible
to reduce the computational time of the simulation in the perspective of
translating the numerical tool to clinicians. We have relaxed independently
the different assumptions concerning the material properties and the strong
coupling of the fluid and solid physics, and compared the results with
those obtained with the more physiologically-correct model.
2 Material and Methods
2.1 Patient-specific AVF geometry and meshing
The case of study is a mature end-to-side radio-cephalic fistula. The med-
ical images of the complete AVF lumen have been acquired by CT-scan
angiography at the Polyclinique Saint Côme (Compiègne, France). During
the clinical measurements, the patient was at rest in supine position.
The images have been segmented and the complete AVF lumen has been
reconstructed following the method described by Kharboutly et al. [169]
(figure 3.1). Throughout the paper, the subscript v stands for vein and a for
artery. The AVF presents an 80%-stenosis along the proximal radial artery
and an enlargement in the cephalic vein. The artery is 170 mm long and
has an internal diameter of 5.95 mm at the inlet and 6.25 mm at the outlet.
The outlet venous diameter is 10 mm.
The fluid mesh is generated using the software T-Grid (ANSYS, Inc.).
We first mesh the lateral surface of the lumen and then generate the volume
mesh of the fluid domain. The latter consists of an hybrid mesh, with
prismatic cells in the boundary layer and tetrahedral cells in the vessel core
(see [169] for more details on the mesh generation).
The structural part of the vessel wall is then modeled as a monolayer of
discrete-Kirchhoff theory-based shell finite elements. They are four-node
2 – Material and Methods 94
Figure 3.1: Schematics of the vascular geometry. Sia represents the arterial inlet, Soa
the arterial outlet and Sov the venous outlet.
linear triangular shell elements. Different thicknesses have been imposed
for the arterial and venous shell elements. Thickness data have been taken
from the literature, as no direct measurement was possible in vivo. We
have modeled the vein with a thickness of 0.4 mm, which is typical for a
cephalic vein prior to the AVF creation. Indeed, the vein thickness tends to
remain altogether constant during the fistula maturation [28]. The arterial
thickness is supposed to be equal to 1/10th of the actual inlet diameter,
i.e. 0.6 mm [200]. The fluid and solid meshes share the same nodes at the
interface.
We have investigated the convergence of the numerical results with the
mesh spatial resolution. The convergence study, reported in Decorato et al.
[201], has shown that a maximum mesh size of 4× 10−3 mm guarantees er-
rors below 0.8% both for the maximum velocity magnitude and WSS. This
characteristic mesh size appears as a good compromise between numerical
accuracy and computational time. The whole mesh is hence composed of
784× 103 fluid elements and 89× 103 shell elements for the walls.
2.2 Numerical method
The transient fluid-structure interactions are simulated inside the AVF us-
ing ANSYS Workbench V13.0 (ANSYS, Inc.). It couples ANSYS CFX and
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ANSYS Structural implicitly [173]. The software is based on an arbitrary
Lagrangian-Eulerian formulation. It uses a partitioned approach with stag-
ger iterations within each time step. During each stagger iteration:
• The displacement vectors are transferred from the structural to the
fluid solver, where the fluid problem is solved for the current time-
step;
• The load vectors are then transferred from the fluid to the structural
solver, where the structural problem is solved;
• The convergence of all field equations (fluid and structural) is evalu-
ated.
Stagger iterations are repeated until all the field equations have converged
and the coupling conditions are satisfied at the fluid-solid interface. The
latter requires that (1) displacements of the fluid and solid domains are
compatible, (2) forces acting on the interface are at equilibrium, (3) the
fluid obeys the no-slip condition.
The simulations are run neglecting gravity. The reference pressure is
the atmospheric pressure. As initial condition, we use the results obtained
from a steady fluid-only simulation, in which we impose the time-averaged
values of the velocity and pressures as boundary conditions.
We have searched for the optimal time-step for which (i) the numerical
model is stable, (ii) the computational time is the smallest, (iii) the tem-
poral resolution is sufficient to capture the time-dependent flow features.
We have tested 3 time steps: 10−3, 5×10−3 and 10−2 s. We find that the
simulation is unstable with the time of 10−2 s, but remains stable with the
two smaller values. The numerical scheme is therefore conditionally sta-
ble, with a limit of stability between 5×10−3 and 10−2 s. Reducing the time
step by a factor of 5 hardly has an effect on the accuracy of the results: the
results obtained with a time step of 5×10−3 s differ by less than 1% from
those obtained with 10−3 s. It, however, has a direct impact on the compu-
tational time, which increases linearly with the number of iterations. We
have therefore chosen to run all the following simulations with the time
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step of 5×10−3 s in order to optimize the computational time without loss
in accuracy.
Each FSI simulation is run over six consecutive cardiac cycles. The re-
peatability of the results is verified after 3 cardiac cycles with cycle-to-cycle
differences inferior to 1%. The results shown in the following are obtained
by phase-averaging the field values over the 4th, 5th and 6th cardiac cycles.
The total simulation time is approximately 70 CPU hours on an Intel(R)
Xeon(R) workstation with 64 bit CPU dual core processors of 2.67 GHz
clock speed, 23.9 GB RAM memory and a Microsoft Windows XP operat-
ing system.
2.3 Blood model
Blood is modeled as an isotropic, homogeneous, non-Newtonian fluid. It
is assumed to follow Casson model
√
τ =
√
τ0 +
√
κγ˙, (3.1)
where τ0 represents the yield stress, γ˙ the shear rate and κ the consis-
tency. The apparent viscosity µ is obtained from equation 3.1 and can be
expressed as
√
µ =
√
τ0
γ˙
+
√
κ. (3.2)
The model parameters have been chosen according to experimental data
obtained at low shear rates: τ0 = 4×10−3 Pa, κ = 3.2×10−3 Pa.s [175]. In
section 4.1 we will compare the results obtained using Casson blood model
with those predicted modeling blood as a Newtonian fluid. Blood density
is set to 1050 kg.m−3.
2.4 Vessel wall properties
We simulate the vessel wall hyperelasticity assuming both the artery and
the vein to follow the 3rd-order Yeoh model [182]. The strain energy func-
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Table 3.1: Values of the constants of the hyperelastic 3rd-order Yeoh model used
for the radial artery and the cephalic vein
Constant Artery Vein
C10 0.763×105 Pa 3.784×106 Pa
C20 3.697×105 Pa 5.543×108 Pa
C30 5.301×105 Pa 6.491×109
Figure 3.2: Arterial and venous mechanical properties. Data are adapted from
[183] for the vein, [184] for the artery
.
tion ψ reads
ψ = C10(I1 − 3) + C20(I1 − 3)2 + C30(I1 − 3)3+
D1(J − 1)2 + D2(J − 1)4 + D3(J − 1)6,
(3.3)
where I1 is the deviatoric first principal strain invariant and J the Jacobian.
The parameters are the material constants C10, C20, C30 and the incompress-
ibility parameters D1, D2, D3. The vessel wall is assumed to be incompress-
ible (i.e. J = 1). We have differentiated the arterial and venous mechanical
properties (figure 3.2) in order to correctly model the larger compliance of
the arterialized vein. The model constants, listed in table 3.1, are the ones
that best fit experimental data ([183] for the vein and [184] for the artery).
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2.5 Boundary conditions
All the boundary conditions imposed for the fluid and solid domains are
summarized in table 3.2. For the fluid flow, we impose a time-dependent
flat velocity profile Via at the inlet and time-dependent pressure profiles at
the arterial and venous outlets (figure 3.3). The velocity, prescribed at the
inlet of the proximal radial artery (Sia in figure 3.1), is the one that was mea-
sured by echo-Doppler on the patient on the same day as the CT-scan an-
giography [170]. The imposed velocity corresponds to a systolic Reynolds
number of 800, time-averaged Reynolds number of 650 and Womersley
number of 4. A space-varying velocity profile following the Womersley
solution [202] is recovered in the radial artery 8 diameters downstream of
the inlet boundary. A fully developed profile therefore enters the stenosis,
located about 16 diameters from the entrance.
The in vivo measurements do not provide any pressure data, as pressure
measurements are invasive, but only the value of the flow split between
the arterial (Soa) and venous (Sov) outlets (30%-70% respectively). In order
to deduce the pressure waveforms at the outlets, we have conducted a
CFD simulation using ANSYS-CFX (ANSYS, Inc.). As inlet velocity, we set
Via. At the two outlets, we impose a R-C Windkessel model, following the
method described in Decorato et al. [201]. The values of the parameters of
the Windkessel model have been calculated so that
• the flow split between the arterial and venous outlets is 30%-70%;
• the time-averaged inlet pressure Pia is about 70 mmHg [8].
Neither rotation nor translation is allowed at the vascular extremities of
the solid domain. The external tissues are supposed to be at atmospheric
pressure, which is the pressure of reference in the FSI simulation.
2.6 Wall shear stresses
The wall shear stresses are contained within the plane tangent to the vas-
cular wall, defined by the unit vector normal to the vessel wall n. They can
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Table 3.2: Boundary conditions imposed at the extremities of the fluid and solid
domains (see figure 3.1 for the surface definitions)
Boundary Fluid domain Solid Domain
Sia
Time-dependent
velocity profile Via
0-translation,
0-rotation
Soa
Time-dependent
pressure profile Poa
0-translation,
0-rotation
Sov
Time-dependent
pressure profile Pov
0-translation,
0-rotation
Vessel wall No-slip condition
Atmospheric
pressure
be expressed by the two-component vector
τw = µ
∂v
∂n
, (3.4)
where v is the velocity vector. We call wall shear stress WSS the modulus
of τw. In healthy arteries, physiological values of WSS are typically 1-2 Pa
[8]. The physiological range is rather 0.8-3 Pa in healthy veins [164].
The oscillatory shear index OSI
OSI = 0.5(1− |
∫ T
0 WSSdt|∫ T
0 |WSS|dt
), (3.5)
where T is the time period of the cardiac cycle. The OSI index represents
the degree of oscillation in the wall shear stress orientation. Its values fall
in the range [0, 0.5], 0 corresponding to a constant forward flow and 0.5
to a purely oscillating flow. OSI values are typically below 0.2 in healthy
physiological vessels. A value of 0.3-0.35 is considered as the threshold,
above which neo-intimal activation might occur [181].
The time derivatives of WSS (WSSGt) are defined as
WSSGt =
∂WSS
∂t
. (3.6)
They are typically small in healthy vessels. We will analyze which AVF
zones are exposed to non-vanishing values of wall shear stress time deriva-
tives.
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Figure 3.3: Waveforms of the inlet velocity profile Via (continuous line) and outlet
pressures Poa (dotted line) for the radial artery and Pov (marked line) for the cephalic
vein.
2.7 Internal wall stresses
To study the stresses within the vessel wall, we consider the Cauchy stress
tensor σ. The stress tensor can be reduced to its principal components σi
(i = 1, 2, 3) in the principal coordinate system. We study the distribution of
the maximum component of the principal stresses
σmax = maxi(σi), (3.7)
and consider its time-averaged value σmax.
3 Physiologically-correct, patient-specific FSI
3.1 Hemodynamics
The mean velocity entering the radial artery does not vary significantly
over the cardiac cycle, which is typical of peripheral arterial flows: it ranges
from 0.42 m.s−1 at peak diastole to 0.62 m.s−1 at peak systole. As a conse-
quence, only moderate differences in the mean velocity are found over time
across different segments of the AVF. In order to visualize the flow patterns,
31 velocity streamlines are shown at peak systole in figure 3.4 and at late
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Figure 3.4: Velocity streamlines at peak systole. The time of measurement is in-
dicated by the red dot on the inlet velocity profile. On the bottom left, a zoom
on the region of the anastomosis shows that the flow impacts on the bifurcation
generating a stagnation point.
diastole in figure 3.5. The stenosis causes a local increase in the flow veloc-
ity, as well as a region of recirculation downstream of it. The flow impacts
on the bifurcation between the radial artery and cephalic vein, called the
anastomosis, generating a stagnation point (red box in figure 3.4).
The particularity of most mature AVFs is to present an enlarged vein:
it is associated with the largest zone of flow recirculation. If we compare
figures 3.4 and 3.5, we observe a change in streamline distribution in the
cephalic vein with a stronger recirculation motion and helical flow at late
diastole (shown in cross-section A, figure 3.5).
We have analyzed the evolution of the static pressure along the vascu-
lature. We observe a global static pressure drop between the arterial inlet
and the venous outlet of 16.6 mmHg. About 70% of the pressure drop is
caused by the stenosis. The vein enlargement does not lead to a significant
additional pressure drop.
3.2 Wall shear stresses analysis
3.2.0.1 Wall shear stresses The WSS map is shown in figure 3.6. The WSS
values fall within the healthy physiological range in the proximal radial
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Figure 3.5: Velocity streamlines at late diastole. The red dot on the inlet velocity
profile indicates the corresponding time of measurement. The bottom left insert
shows the flow recirculation inside the vein (section plane A): the velocity arrows
have been projected within the two-dimensional plane.
artery, upstream of the stenosis. Still the vessel tortuosity leads locally to
WSS up to 10 Pa. The highest WSS is found at the level of the stenosis,
where it approaches 60 Pa. The anastomosis is the other region subjected
to high WSS (≈ 18 Pa) especially on its venous side: it is a consequence of
the incoming flow impacting onto the bifurcation. Lee and Roy-Chaudhury
[56] have suggested that the large WSS lead to an increase in the oxidative
stress resulting in inflammation and peri-anastomotic neointimal forma-
tion.
On the venous side, the patient presents a venous enlargement over
most of the cephalic vein. This entire region is subjected to WSS generally
below 0.15 Pa and OSI values larger than 0.4 (figure 3.7). The combination
of extremely low WSS and high OSI values has been associated with intima
hyperplasia [164].
3.2.0.2 Wall shear stress time derivatives In the case of AVF, wall shear
stress time derivatives have been shown to have a larger influence than
spatial gradients [203, 204]. We will therefore concentrate on WSS tempo-
ral gradient WSSGt. Wall shear stress time derivatives are about nil across
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Figure 3.6: WSS map at peak systole. The highest WSS are found at the stenosis.
A logarithmic gray-scale has been used to highlight the low WSS values calculated
in the enlarged region of the vein.
Figure 3.7: OSI spatial distribution in the cephalic vein.
the AVF (data not shown) apart from two locations. The region that ex-
periences particularly high WSSGt with large temporal variations is the
anastomosis (figure 3.8). The second highest value is found in the enlarged
venous region, but their maximum amplitude is only 10 Pa.s−1 and they
appear mainly in the diastolic phase of the cardiac cycle. Previous studies
have associated wall shear stress time derivatives with endothelial cell pro-
liferation and neointimal formation [204]. A thicker neointimal layer may
modify the flow split in the long run by altering the vessel resistances. It
could thus have large clinical consequences: on the one hand, too low ar-
terial flow can cause necrosis of hand tissues; on the other, too low venous
flow prevents the hemodialysis from taking place.
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Figure 3.8: WSSGt time variation at point B in the anastomosis () and point C in
the vein enlargement (∗). Points B and C are defined in figure 3.1.
3.3 Internal wall stresses analysis
The map of vascular wall displacement is represented at peak systole in
figure 3.9. The maximum displacement in the artery is 0.62 mm, which
corresponds to a maximum strain of 14%. On average the strain in the
artery is of the order of 10%. It is about eight times smaller in the vein,
which is a consequence of the larger stiffness of the venous wall. In the
vein, the maximum displacement is only about 0.05 mm, (maximum strain
of 3%). We have analyzed the corresponding values of the maximum com-
ponent of the principal stresses σmax at the vascular wall at peak systole
(data not shown in a graph). They fall in the range 5.5-7.0 kPa inside the
artery, with a space-averaged value of 5.7 kPa. Within the cephalic vein
they are equal to 8.0-13.5 kPa with a space-averaged value of 11.5 kPa.
We hypothesize, based on the results of previous studies [205, 206, 207],
that healthy large vessels remodel their internal structure to achieve a
quasi-uniform internal stress of constant value. To determine this base-
line stress value, we have considered the part of the radial artery located
8 to 16 diameters from Sia, i.e. where the flow is fully-developed and un-
perturbed by the stenosis. This region is also the least influenced by the
existence of the anastomosis. Figure 3.10 shows the internal wall stresses
normalized by the baseline stress. Results show that the stresses inside the
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Figure 3.9: Spatial distribution of the vascular wall displacement. The map is
shown in a logarithmic scale.
venous wall are, on average, larger than their baseline value by a factor of
2 and that they can be up to 2.4 times larger.
Non-physiological internal wall stresses can generate wall remodeling
through their impact on smooth muscle cells: the cells are responsive to
the level of stresses and modulate their migration rate, proliferation and
synthesis of collagen [208, 205, 209]. One limitation that we face to an-
alyze the present results is that most of the research on wall remodeling
has been conducted in arteries, which are muscular vessels. Less is known
on the remodeling of veins. Still the last four decades of clinical practice
of AVF prove the high capability of remodeling of veins under increased
hemodynamic stresses, since veins are able to get arterialized over a period
of 3-6 months [27, 28]. We presently find non-nominal values of internal
wall stress in the cephalic vein, which would indicate that the vein contin-
ues its remodeling. This perpetuation of the phenomenon could result in
excessive wall remodeling downstream of the anastomosis and explain the
enlargement of the vein.
3.4 Discussion on the FSI simulation
In this section we have modeled the fluid-structure interactions in a patient-
specific AVF geometry, taking into account the physiological non-linearities
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Figure 3.10: Spatial distribution of the internal wall stresses σmax normalised by
the baseline stress.
in the material properties. We have proven that it is feasible to solve
the multi-physics numerical simulation using the commercial environment
provided by ANSYS, Inc. We have differentiated the venous and arterial
mechanical properties in order to obtain realistic results for the internal
stresses in the vascular wall. We have shown that the venous shear and
internal stresses both differ from their baseline values and that the vein is
likely to continue remodeling its wall internal structure.
Setting relevant mechanical properties for the different vessel portions
has proven to be challenging due to the lack of available data in the lit-
erature. It is known that the vein is subjected to a significant increase in
stiffness as a consequence of the fragmentation of the elastin content and
increase in collagen content, as the vein enlarges [28, 210]. But few quanti-
tative data exist as reported in the introduction. Similarly, it has not been
possible to take into account the presence of external tissues to the AVF: no
study has yet characterized the mechanical properties of the tissues below
the elbow region.
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4 Relaxation of various hypotheses in the simulation
In the previous section, we have shown that although feasible, a coupled
fluid-structure simulation is highly challenging and results in large com-
putational times. The calculation takes 70 CPU hours to run on 4 cores.
The objective is to eventually translate the simulation tool to clinicians, but
a routine use will not be possible in practice if the computational time is
not reduced. In this section we investigate whether it is possible to re-
duce the computational time by relaxing some of the hypotheses, while
maintaining the clinical relevance of the simulation. We will compare the
physiologically-correct model (section 3) with simulations assuming first
blood to be Newtonian and secondly the vessels to have uniform proper-
ties (same thickness and mechanical properties all along the vasculature).
We will then evaluate the accuracy of uncoupled fluid or structural simu-
lations.
4.1 Comparison between Newtonian and non-Newtonian blood model-
ing
Blood is a non-Newtonian fluid, but in some cases its non-Newtonian be-
havior can be neglected. Blood behaves like a Newtonian fluid under large
shear rates (≥ 300 s−1). This is typically the case in arteries with a diameter
larger than 0.5 mm. A shear rate value of 100 s−1 has been identified as
the threshold below which non-Newtonian effects need to be modeled, but
they begin to be significant for shear rates γ˙ ≤ 300 s−1.
From a numerical point of view, the main problem of implementing a
non-linear Casson model is the numerical instability that it induces. But
once the non-Newtonian simulation is rendered stable, its computational
time is comparable to that of the Newtonian case.
We have run a new simulation, in which blood is set to be Newtonian
with a dynamic viscosity µ = 3.2× 10−3 Pa.s (same value as that of the
Casson model at large shear rates). All other parameters of the simulation
are otherwise identical to the physiologically-correct one (section 3).
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In the patient-specific case, we observe a maximum shear rate inside the
cephalic vein of 90 s−1. At the anastomosis level, the maximum shear rate
is 190 s−1, and inside the radial artery it is 300 s−1. If we assume blood
to be Newtonian, the WSS values are increased by 13% on average in the
cephalic vein (20% at maximum) and 10% at the anastomosis (15% at max-
imum). These results are in agreement with those found by Kabinejadian
and Ghista [176].
The present comparison indicates that non-Newtonian effects are im-
portant on the venous side, because of the low shear rate values. These
results prove that the Casson model is necessary if one is interested in the
quantification of the WSS distribution downstream of the anastomosis. It
is, however, not needed to estimate the hemodynamics in the radial arterial.
Needless to mention that the rheological model hardly has any influence
on the wall internal stresses.
4.2 Comparison between the reference case and a homogeneous wall
model
Differentiating arterial and venous wall properties substantially increases
the time of preparation of the simulation and therefore the probability to
introduce numerical errors. It indeed requires to segment the vascular ge-
ometry into different sub-parts, to which different properties are assigned.
In order to ensure the numerical stability, one also needs to guarantee the
correspondence of the boundary nodes between the segmented parts and
their connection during the simulation.
In this sub-section, we aim at estimating the error on the hemodynamics
and wall mechanics, if one models the vessel wall with uniform properties.
A new simulation is run imposing the entire vascular wall to have the arte-
rial geometrical and mechanical properties described in section 2.4. Blood
is still supposed to follow the Casson model. The same fluid and solid me-
chanics boundary conditions are imposed as for the reference case (section
3).
Comparing the overall hemodynamic conditions predicted by both sim-
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ulations, we only observe small differences. The error on the flow rate
entering the cephalic vein at the anastomosis is inferior to 1% and no dif-
ference is calculated on the venous wall shear stresses. The maximum error
is found on the hemodynamic conditions predicted at the stenosis: the uni-
form wall simulation overestimates the WSS by 14%, and underestimates
the stenosis pressure drop by 7.5% (table 3.3). The latter is shifted in time
and occurs at t/T = 0.25 instead of t/T = 0.15 in the reference case. This
is a consequence of the smaller venous compliance.
More significant is the effect on the internal maximum principal stresses.
When one models the vein with a compliance and thickness identical to the
arterial one, one obtains non-dimensional internal stresses close to 1: they
appear to be in the physiological range. We have independently studied
the influence of wall thickness and seen that its contribution is negligible
on the hemodynamics and weights for less than 2% on the maximal wall in-
ternal stresses values (data non shown). We conclude that it is necessary to
impose wall properties that are as realistic as possible in order to properly
estimate the risk of perpetuation of wall remodeling in the vein clinically.
This is important, all the more so as it does not increase the computational
time.
The main limitation of this conclusion is the difficulty in estimating the
actual venous wall properties: the tissue is that of a vein subjected to arte-
rial hemodynamic conditions. It is impossible to infer its properties from
measurements on other venous tissues. Furthermore, the vein appears to
be in constant remodeling, suggesting that its properties evolve over time.
4.3 Comparison between FSI and uncoupled fluid or structural simula-
tions
To quantify the influence of wall compliance on the hemodynamics, we
have conducted a CFD simulation using the fluid solver ANSYS CFX (AN-
SYS, Inc.). The rigid wall CFD simulation has been performed using the
same settings for ANSYS-CFX as in the FSI simulation, but deactivating
the multifield coupling. In particular we have imposed the same boundary
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Table 3.3: Comparison of the results provided in the reference case and in the case
of homogeneous wall properties at peak systole.
Parameter Reference Case Homogeneous Wall
Velocity at stenosis 2.12 m.s−1 2.11 m.s−1
WSS at stenosis 60.3 Pa 69.2 Pa
σmax normalised
by baseline stress
≈ 2 ≈ 0.9
conditions described in section 2.5 and similarly assumed blood to follow
the Casson model.
Comparing the two simulations, we notice that the local velocity and
WSS values are globally overestimated by the CFD study. The largest dif-
ferences found at peak systole are indicated in table 3.4. The rigid-wall
simulation overestimates the peak velocity at the stenosis by ≈ 20% and
the peak WSS values by ≈ 15%. The differences are, however, of a much
smaller extent (≈ 2%) in the zones of low velocity and WSS. The flow
distribution across the two exits is well predicted (error ≤ 2%).
Although the quantitative data fail in accuracy, the CFD simulation pro-
vides a coherent qualitative picture of the hemodynamic conditions that
prevail in the vasculature. It gives sound predictions for the zones dom-
inated by low hemodynamic conditions. These zones have a high clini-
cal relevance, since they are prone to complications, such as neo-intimal
formation. Another advantage is the computational time, the rigid-wall
simulation running twelve times faster than the fully-coupled FSI.
We have independently run a structural static simulation (ANSYS-Struc-
tural; ANSYS, Inc.). Instead of running the simulation with a two-way cou-
pling as for the FSI simulation, we have presently used a weak one-way
coupling. This method enables to impose the distribution of pressure at
the AVF internal vessel walls calculated by the CFD simulation at a given
instant of time. We have run the structural simulation with the peak sys-
tolic pressure field as lateral boundary condition. All the other bound-
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Table 3.4: Comparison of the results provided in the reference case (FSI simulation)
and in the rigid-wall case (CFD simulation) at peak systole.
Parameter FSI CFD
Velocity at stenosis 2.12 m.s−1 2.52 m.s−1
WSS at stenosis 60.3 Pa 69.3 Pa
Flow rate percentage in
cephalic vein
≈ 70% ≈ 68%
ary conditions are kept unchanged. The analysis of the wall displacement
and internal constraints show that the difference with the reference case
at peak systole is below 1% all along the vasculature. The structural sim-
ulation therefore predicts the results very accurately. It, however, cannot
provide directly the time-evolution of the wall displacement and stresses.
Like for the CFD simulation, the computational time is drastically reduced:
the structural simulation runs in only one hour.
5 Conclusions
We have performed an FSI numerical simulation in a patient-specific AVF,
modeling the vessel wall with non-uniform hyperelastic properties and the
non-Newtonian behavior of blood. Such a simulation is challenging be-
cause of the large region of interest, the non-linear effects of the fluid and
solid constitutive laws and the instabilities of the FSI coupling. In order to
evaluate the importance of taking all these factors into account, we have
compared the results with simplified versions of the simulation.
Our results confirm that AVFs are subjected to complex hemodynamics.
The enlarged portion of the cephalic vein is subjected to WSS smaller than
a tenth of the physiological values and OSI larger than 0.4. It also experi-
ences non-zero time derivatives of WSS. The anastomosis is subjected to
a stagnation point flow along with high time derivatives of WSS. These
regions are therefore the more likely to suffer from intima hyperplasia.
The simulation has shown that the cephalic vein is conjointly subjected
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to internal wall stresses that are about the double to their baseline level.
This condition is likely to promote continuous remodeling of the wall in-
ternal structure and therefore represents a risk of AVF failure.
Comparing the results with simplified versions of the simulation brought
various conclusions:
• A non-Newtonian blood model is needed to predict the hemodynam-
ics in the venous part of the AVF, owing to the low values of shear
rates. The Casson model is, however, not useful on the arterial side.
• The use of homogeneous wall properties simplifies the preparation
of the model, but does not provide a significant gain in computa-
tional time. It, however, significantly underestimates the internal wall
stresses. When simulating the FSI in an AVF, one needs to take into
account the very different wall properties of the venous and arterial
parts of the vasculature. Such an issue will also come into play for
other vascular diseases that profoundly alter the vessel mechanical
properties over an extended region.
• Although the CFD simulation generally overestimates velocities and
wall shear stresses, it still gives an informative map of the regions
affected by wall shear stress values, which can lead to neointimal for-
mation.
• A one-way coupling structural simulation provides the precise distri-
bution of internal wall stresses, but only at one instant of time. It does
not provide the time evolution of the stress distribution.
• Running an uncoupled fluid and structural simulation has the ad-
vantage to run significantly faster than the FSI simulation (15 hours
instead of 70).
One issue that has been faced in the present study is the lack of data
on the mechanical properties of vascular tissues. In the future, it would be
interesting to device new techniques to characterize the tissues in vivo non
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invasively. This is a necessary step for clinicians to one day fully rely on
the results of numerical simulations in the making of therapeutic choices.

Chapter 4
Simulation of the treatment by balloon angioplasty
of a stenosed AVF
In this chapter study the effects of the endovascular treatment of a stenosed
AVF by balloon-angioplasty. We transcribe the text as it has been submitted
to the journal ’Cardiovascular Engineering & Technology’.
1 Introduction
Hemodialysis is one of the treatment options adopted for end-stage renal
disease patients. It involves filtering blood waste products through a partial
extracorporeal circulation. Blood is circulated through the artificial kidney
up to three times a week, for which a permanent vascular access must be
created. The most common approach is the suturing of a vein onto an
artery in an autologous side-to-end arteriovenous fistula (AVF) [23]. The
fistula is preferably created in the forearm, as radio-cephalic AVF tend to be
less subject to complications than more proximal AVF, such as the brachio-
cephalic AVF [211]. Autologous fistulas need three to six months to mature
[27], during which period the vein dilates and the wall collagen content
increases [28]. The fistula acts as a short-cut between the high pressure
arterial vasculature and the low pressure venous tree. This pathway is
characterized by a low resistance and a high compliance [23].
The lifespan of an AVF is limited from a few days to about 10 years be-
cause of the onset of several complications [23]. Atherosclerotic plaque for-
mation, which is typically associated with thrombosis, stenosis formation
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either upstream or downstream of the junction and aneurysm formation
have all been observed [23, 71]. Stenoses affecting the vein have been re-
ported in 10-20% of patients [23]. They directly compromise the hemodial-
ysis treatment, by reducing the venous blood flow [8]. Arterial stenoses
are rare in patients with a brachio-cephalic fistula (0-4% of occurrence) but
their incidence is greater in patients presenting a radio-cephalic AVF at
around 30% [75]. Relatively little is known about arterial stenoses, but they
can lead to a steal syndrome and increase the risk of cardiac failure in the
mid-long term [8, 72].
Venous stenoses are detected owing to the changes they induce on
hemodialysis parameters. The venous flow-rate can indeed be reduced to
values below 100 ml.min−1 [8]. No technique exists so far to detect arterial
stenoses. Their localization therefore requires a dedicated imaging exam,
which is not routinely performed at present. Duplex ultrasound scanning
is advised to be used as it is more accurate than angiography [76].
Several treatments exist to prolong the AVF functionality and reduce the
associated risk of thrombosis [8]. In clinical practice, a stenosis is treated
when more than 50% of the arterial lumen is compromised [74] or when
it leads to a pressure drop larger than 5 mmHg (10 mmHg for peripheral
veins) [59]. Although these criteria are well assessed for venous stenoses,
they are still under discussion for arterial stenoses. The lumen criterion
is considered to be universally valid [59] but less can be said about the
optimal pressure drop across an arterial stenosis.
The treatment of a stenotic lesion can either be surgical or endovascu-
lar, the former being more invasive and usually performed when the vas-
cular anatomy is likely to affect the success rate of the endovascular pro-
cedure [8]. As endovascular treatments radiologists can perform balloon-
angioplasty with or without stenting. Angioplasty consists in the inflation
of a non-compliant balloon to restore the stenosed vessel patency. It can be
combined with the positioning of a metal stent. The latter is currently used
in case of failure of the simple angioplasty. The efficacy of stenting is based
on clinical experience and is still controversial. The use of stenting has been
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questioned since the late 80s [65], and has only recently been proven to be
more effective than the simple balloon-angioplasty [62]. Nevertheless, in
clinical practice balloon angioplasty remains commonly the most used en-
dovascular treatment. After treatment, the diameter at the stenosis throat is
rarely restored to its physiological value, and a residual stenosis remains.
Treatment is considered successful when the degree of residual stenosis is
below 30% [8, 72, 59, 62].
One of the reasons for the lack of more rigid guidelines for the treatment
of stenosed arteriovenous fistulas is the difficulty associated with obtaining
patients’ hemodynamic data through non-invasive, routine exams. Com-
putational fluid-dynamic (CFD) simulations have the potential to provide
information and have been reported to be effective in the evaluation of
hemodynamics [166, 170, 171]. However, to the author’s knowledge, but
no study has yet considered the case of a stenosed AVF. In the present
study, the hemodynamics inside a patient-specific AVF presenting a steno-
sis inside the afferent artery is computed. The treatment of the stenosis by
balloon-angioplasty is simulated with varying pressures used to inflate the
balloon. We simulate the hemodynamics for degrees of residual stenosis
are obtained ranging from 0 to 30%.
2 Material and methods
2.1 Geometry and mesh
The investigated vasculature consists of a mature side-to-end radio-cephalic
AVF. The vascular lumen was segmented and reconstructed from com-
puted tomography (CT) scan angiography images [170]. The images were
obtained on a patient that was at rest in supine position at the Polyclin-
ique St Côme (Compiègne, France). The patient-specific vascular geometry
presents an 80% stenosis on the arterial side as indicated in figure 4.1a.
The patient-specific lumen is meshed starting from the triangulation of
the lateral face of the reconstructed AVF lumen. The mesh is made of
an hybrid grid created in ANSYS T-Grid. We firstly mesh the boundary
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a. b.
Figure 4.1: a) Reference case geometry. The surface Sia is the arterial inlet section,
Soa the arterial outlet section and Sov the venous outlet section. The dotted line
indicates the cross-sectional plane at the stenosis throat. The velocity waveform via
set at the arterial inlet (Sia) has been measured on the patient by echo-Doppler. b)
Magnification of the mesh at the distal arterial outlet (Soa).
layer with 7 layers of prismatic elements of decreasing thickness along the
radius. We then mesh the core with tetrahedrons (figure 4.1b). Both cell
element types are linear.
Different mesh sizes are tested in order to guarantee a maximum error
of 1% on the velocity magnitude and wall shear stresses and acceptable
computational time tcomp. We have investigated meshes of maximum el-
ement length ∆lmax equal to 1, 2, 4, 5, 7 and 10× 10−3 mm. The results
obtained with the smallest mesh size (10−3 mm) are used as reference. In
general, we define the relative error εu on the quantity u as |u− ure f |/ure f .
We calculate the relative error for u equal to vmax the maximum amplitude
of the velocity vector v, which occurs at the stenosis, and WSS, the time-
averaged wall shear stress. The wall shear stress WSS is defined as the
modulus of the two-component vector
τw = µ
∂v
∂n
, (4.1)
where τw is the viscous stress acting tangentially to the vessel wall and n
the unit vector normal to the vessel wall. The time-averaged wall shear
stress is defined as
WSS =
1
T
∫ T
0
|WSS|dt, (4.2)
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where T is the period of the cardiac cycle. Figure 4.2 shows that the numer-
ical procedure converges as ∆lmax to the power 4.8 and that the normalized
computational time decreases about linearly with ∆lmax. In this study the
simulations are run with the mesh characterized by a maximum element
length of 4× 10−3 mm, since it respects the 1%-error limit (horizontal line
in figure 4.2a) for both the velocity and wall shear stress and runs four
times faster than the reference case. The total number of elements used
presently for the patient specific geometry is then 7.84× 105. A magnifica-
tion of the mesh at the distal arterial outlet (Soa) is shown in figure 4.1b.
The vascular wall is modeled as a monolayer of shell elements. It is
meshed with discrete-Kirchhoff theory-based, four-node linear-triangular
shell finite elements. The fluid and solid domains share the same nodes
at the interface. The solid mesh consists of 8.9× 104 shell elements. Prior
to meshing, the AVF wall is divided in three zones in order to impose
different mechanical properties to the healthy artery, the stenosed arterial
portion and the vein.
2.2 Numerical method to simulate balloon-angioplasty
The treatment by balloon-angioplasty is simulated numerically using AN-
SYS-Structural (ANSYS, Inc.). A balloon is positioned at the stenosis; it
is inflated and deflated by imposing an internal pressure in an implicit
structural simulation. The simulation is conducted with the Lagrangian
multiplier-based mixed u-P formulation.
The balloon is modeled as a cylinder with linear elastic mechanical
properties. It is created as a separate body using ANSYS FE-Modeler (AN-
SYS, Inc.). It is positioned at the center of the stenosis, as shown in figure
4.3a.
The healthy artery is assumed to follow a hyperelastic, Fung-type law.
The law constants are chosen to best-fit experimental data for healthy ar-
teries [184]. The stenosed part is modeled with a viscoplastic law, which
is based on the Maxwell model in ANSYS. At small deformations it has
the same stiffness as the healthy arterial parts in order to ensure the me-
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a. b.
Figure 4.2: (a) Relative error on the maximum velocity (εvmax ) and time-averaged
wall shear stresses (εWSS) as a function of the maximum mesh length ∆lmax. The
horizontal line indicates an error of 10−2, chosen as the threshold. (b) Normalized
computational time tcomp/t
re f
comp as a function of the maximum mesh length ∆lmax.
The reference case corresponds to the mesh with a maximum element length of
10−3 mm.
chanical continuity at the interface between the two segments. At large
deformations we have set the parameter values in order to fit the data of
Maher et al. [185].
Neither translation nor rotation is allowed at the extremities of the bal-
loon and vessel walls. At the beginning of the simulation the balloon is not
in contact with the artery (figure 4.3a). The balloon is inflated and deflated
by an increasing/decreasing linear ramp in pressure. Figure 4.3b shows
when contact occurs between the balloon and arterial wall. The contact
problem is solved using the augmented-Lagrange method; it is supposed
to be frictionless [146]. The balloon is further inflated until the maximum
pressure is reached (figure 4.3c). It is then deflated, leaving the vessel wall
in its post-treatment configuration (figure 4.3d). Different values of the bal-
loon pressure are imposed (6, 5.6, 5.1, 4.7 bar). They respectively lead to
a degree of residual stenosis equal to 0, 10, 20 and 30% after angioplasty
(figure 4.3e).
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a. b.
c. d.
e.
Figure 4.3: Schematics of the numerically-simulated angioplasty procedure. a)
Initial configuration: positioning of the balloon within the artery. The plane in-
dicates the stenosis throat. b) Configuration when the balloon comes into contact
with the artery. c) Configuration at maximum balloon internal pressure. d) Vessel
final shape when the balloon is completely deflated. e) Vessel cross-sections at
the throat (plane indicated in figure 4.3a) of the stenosis for the patient-specific
(80%-stenosis) and treated geometries (30, 20, 10, 0% residual stenosis).
2 – Material and methods 122
2.3 Numerical method to simulate the hemodynamics inside the AVF
ANSYS-CFX (ANSYS, Inc.) is used to solve the continuity and momen-
tum equations in their conservative convection-diffusion form [173]. These
equations are solved implicitly with the Rhie-Chow interpolation method
[174]. We use the high-resolution, second-order backward Euler scheme
implemented in ANSYS-CFX fluid solver (ANSYS, Inc.). This scheme is
a second-order accurate, implicit time-stepping scheme, recommended for
non-turbulent flow simulations [173]. The system of algebraic equations is
solved iteratively using a time-step ∆t equal to 5 ms. At each time step,
the residual is calculated and reported as a measure of the overall con-
servation of the flow properties. The maximum residual allowed is 10−4.
Convergence is verified in less than 10 sub-iterations at the first time step
and in less than 5 iterations at all the following time steps.
Blood is assumed to be an isotropic, homogeneous, non-Newtonian
fluid. The choice of the non-Newtonian model is justified by the low shear
rate conditions that prevail inside the cephalic vein: in this region, the wall
shear stresses would be overestimated by a Newtonian model. Its apparent
viscosity µ is assumed to follow the Casson model. The apparent viscosity
µ can be expressed as
√
µ =
√
τ0
γ˙
+
√
κ. (4.3)
where τ0 represents the yield stress, γ˙ the shear rate and κ the consistency.
Blood density is set to 1050 kg.m−3. The model parameters have been
chosen according to experimental data obtained at low shear rates: τ0 =
4× 10−3 Pa, κ = 3.2× 10−3 Pa.s [175].
The velocity field is initialized with the solution of the steady-state sim-
ulation. In this simulation the fluid properties are kept identical. As bound-
ary conditions, we impose the time-averaged values of the inlet velocity at
Sia and of the venous and arterial pressures at Sov and Soa, respectively. In all
the simulations the atmospheric pressure is set as the reference pressure.
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2.4 Boundary conditions
The time-dependent velocity via set at the arterial inlet Sia is the one mea-
sured on the patient by echo-Doppler in the proximal radial artery (figure
4.1a). It is imposed as a flat velocity profile. This velocity corresponds
to a time-averaged inlet flow rate Qia of 1.1 l.min−1. At each of the two
outlets Soa and Sov, a flow-dependent pressure condition based on a RC
Windkessel model is imposed [177]. This model is based on the hypoth-
esis that the hemodynamic behavior of the vessel network downstream of
the 3D-geometry outlet is related to its compliance and resistance. If one
models the vessel compliance as a capacitor and the hydraulic resistance as
an electrical resistance, one can generate a zero-dimensional model of the
flow through the network based on a simple electrical analog circuit.
The behavior of the downstream vasculature is presently modeled with
a capacitor C in parallel with a resistance R. The relationship between the
blood flow rate Q and the pressure P is given by the equation
∂P
∂t
=
Q− P
R
C
. (4.4)
The equation is discretized using a first order scheme.
In order to estimate the parameters R and C, we use the model by
Molino et al. [178]. It requires to know
• the pulse pressure, defined as the difference between the systolic pres-
sure Ps and the diastolic pressure Pd at the considered outlet within
one cardiac cycle;
• the time-averaged pressure P at the flow outlet;
• the time-averaged blood flow rate Q at the same flow outlet.
From the flow rate data measured by echo-Doppler, we obtain the time-
averaged flow rate. Neither the pulse pressure nor the time-averaged pres-
sure can be measured directly on the patient. In order to calculate the pulse
pressure Ps− Pd we run a rigid-wall simulation where the desired flow split
2 – Material and methods 124
between the arterial and venous outlets is imposed and free pressure out-
let conditions are set at sections Sao and Svo . We find a pulse pressure equal
to 12 mmHg. The same simulation returns also the value of the pressure
drop within the AVF geometry for the imposed flow inlet. According to
the literature, functional fistulas may have a mean pressure in the proxi-
mal radial artery between 50 and 100 mmHg [179]. The range of values
is large, since it is a function of the patient general health conditions. To
cover the entire possible range, we have run 3 simulations with different
time-averaged inlet pressures Pia (table 4.1). For each value of P
i
a, we have
estimated the corresponding values of Poa and P
o
v. At this stage, we have
an estimation of the mean pressure, the pulse pressure and of the flow rate
at each outlet. We can therefore apply the model of Molino et al. [178]
to our data. The values of the constants R and C are calculated for both
the arterial (denoted by subscript a) and venous (subscript v) outlets of the
considered domain (table 4.1).
No data exists in the literature on the pressure and flow conditions in
fistulas that could help compare the present R and C constants calculated
for the segments downstream of the arterial and the venous outlets. Values
can be calculated in the healthy case from the data provided by Westerhof
[177] for comparison. The present values are of the same order of magni-
tude as in the healthy case. At the venous outlet the constant C tends to
be larger but by maximum an order of magnitude, and the R values only
slightly smaller. Conversely, at the arterial side the constant C is about 5
times smaller than in the healthy case and the value of R increases up to 8
times the healthy case values.
It is also interesting to consider the product of the two constants τ = RC,
which is the time constant of the dynamic response of the vascular tissue. It
is linked to the capacity of the vascular segment to absorb the peak systolic
kinetic energy. We find a time constant τ equal to 0.15 s for the arterial
outlet and 0.08 s for the venous one in the case Pia = 70 mmHg. It is
coherent to find a larger time constant downstream of the artery, owing
to the presence of more elastic vessels downstream of the outlet and of
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Table 4.1: Values of the venous and arterial resistances (Rv and Ra) and compli-
ances (Cv and Ca) for the different values of time-averaged inlet pressure P
i
a. The
corresponding inlet pressures at peak systole Pias and diastole P
i
ad are provided for
reference. The pressures values are in mmHg, the resistances in 108kg.m−4.s−1 and
the compliances in 10−11 kg−1.m4.s2.
Pia P
i
as P
i
ad Ra Ca Rv Cv
55 63 51 11.9 4.98 4.77 11.5
70 78 66 30 5 6.5 12
90 98 86 41 5.04 7.4 12.1
the capillary bed. In large elastic arteries, the time constant is of order 1:
Ismail et al. [180] found, for instance, τ ∼ 1 s for the vascular network
downstream of the iliac arteries. This is coherent, since the arterial outlet
of the AVF is made of less elastic vessels than those at the outlet of the iliac
arteries.
The same R and C values are used for all the simulations, both before
and after the treatment by angioplasty. The post-angioplasty simulations
therefore model the situation shortly after treatment, before the occurrence
of any physiological adaptation in the distal circulation.
2.5 Hemodynamic parameters
In order to evaluate the hemodynamic risk associated with a stenosed AVF,
clinicians use the pulsatility index (PI), which is estimated from the patient
blood velocity profile [26]. It is defined as
PI =
vs − vd
v
, (4.5)
where vs is the peak systolic velocity, vd the late diastolic velocity and v
the time-averaged velocity. Clinically, an increased PI value can indicate a
possible complication at the fistula [26]. This index has proven to help in
the detection of venous stenoses. Fistulas without a venous stenosis have a
reference PI value around 0.4 [23].
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The use of CFD simulations makes it possible to also evaluate the clas-
sical hemodynamic parameters based on the wall shear stress. The wall
shear stresses (WSS) and their time-average value WSS have been defined
in section 2.1. In a healthy radial artery, WSS is in the range 1-2 Pa [8],
which we will refer to as the healthy physiological WSS range. In a vein, it
has been reported that neointimal hyperplasia rapidly develops when WSS
values are below 0.5 Pa [164].
3 Results
3.1 Comparison of pre- and post-angioplasty geometries
The success rate of the treatment by balloon-angioplasty is mainly mea-
sured by the change in cross-section of the stenosis. Figure 4.3e shows the
evolution of the cross-sectional area A within the plane of cut, as indicated
in figure 4.1a. It is the plane perpendicular to the flow direction that passes
through the stenosis throat. The degree of residual stenosis is obtained by
comparing the value of A with the average cross-section of the parent ves-
sel upstream of the treated stenosis. From the cross-sectional area, one can
calculate the equivalent vessel diameter Deq, which is the diameter of the
disk with the same cross-section:
Deq =
√
4A
pi
. (4.6)
The various stenosis degrees correspond to an equivalent vessel diameter
Deq = 2.65, 4.97, 5.31, 5.54 and 5.94 mm, when the stenosis is reduced from
80% to 0%.
3.2 Comparison of pre- and post-angioplasty hemodynamic conditions
Results are first shown for an inlet mean pressure of Pia = 70 mmHg. The
influence of the boundary conditions will be examined in the next section.
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a. b.
c.
Figure 4.4: Streamlines at peak systole in the a) patient-specific and b) 0% residual
stenosis geometries. c) Evolution of the peak systolic velocity vs and late diastolic
velocity vd with the degree of residual stenosis.
3.2.1 Blood flow
The streamlines, shown in figures 4.4a,b at peak systole for the patient-
specific native (80% stenosis) and fully treated (0% stenosis) geometries re-
spectively, provide a qualitative picture of the flow field distribution within
the AVF. The flow field away from the stenosis appears not to be signifi-
cantly influenced by the angioplasty treatment. This is confirmed by com-
paring the time-averaged flow rate at the venous outlet in the two cases:
it is reduced by only 4% when the arterial lumen cross-section is fully re-
opened. The main difference is observed locally at the stenosis, where the
velocity magnitude is reduced following the removal of the stenosis. Figure
4.4c indicates the evolution of the peak systolic velocity vs and late dias-
tolic velocity vd with the degree of residual stenosis. Both velocities follow
a similar trend when the stenosis is treated and decrease up to 14 - 16%.
3.2.2 Wall shear stresses
Figures 4.5a,b show the spatial distribution of the time-averaged wall shear
stress (WSS) along the fistula wall for the patient-specific (80% stenosis)
and fully treated (0% stenosis) geometries. The proximal and distal parts
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a. b.
c.
Figure 4.5: Spatial distribution of the time-averaged wall shear stress WSS for the
a) patient-specific and b) 0% residual stenosis geometries. c) Evolution of the time-
averaged wall shear stress WSS at the stenosis throat with the stenosis degree.
of the artery experience physiological values of WSS in the range 1-2 Pa
[8]. The main exception is the stenosis, where the largest WSS values are
observed. At this location, the maximum instantaneous value is 47 Pa (30
Pa if space-averaged across the stenosis neck). The anastomosis also expe-
riences high WSS, but the maximum instantaneous value remains below 20
Pa. On the contrary, the vein experiences WSS values below 1 Pa or even
0.5 Pa in the dilated venous region.
In figure 4.5c we show the WSS values at the stenosis location when the
stenosis degree is corrected by angioplasty. The treatment reduces the WSS
values to nearly physiological values. However, the angioplasty treatment
does not modify the WSS distribution within the AVF. This is coherent with
the fact that it has a pure local effect at the level of the stenosis, as shown
in section 3.2.1.
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a. b.
Figure 4.6: a) Location of planes B1 and B2. b) Stenosis pressure drop at the
different degrees of residual stenosis. The horizontal line indicates the current
clinical criterion, above which the lesion is treated by angioplasty.
3.2.3 Pressure drop across the stenosis
The pressure drop across the stenosis is evaluated as the difference in av-
erage pressure between plane B1, located 1 mm upstream of the stenosis,
and plane B2, 1 mm downstream. The two planes are locally orthogonal to
the main direction of the flow (figure 4.6a). Figure 4.6b shows the pressure
drop PB1 - PB2 as a function of the degree of stenosis. The pressure drop
across the stenosis increases almost linearly with the degree of stenosis.
It is interesting to notice that a degree of stenosis below 20% needs to be
reached to have a pressure drop below 5 mmHg.
3.3 Effect of the peripheral vascular boundary conditions on the hemo-
dynamics inside the AVF
The effect of varying the mean arterial pressure is investigated by chang-
ing the values of the resistance and compliance at the arterial and venous
boundary conditions (table 4.1). The values of resistance and compliance
have been obtained maintaining the pulse pressure constant.
In table 4.2 we compare the most important quantitative parameters:
the value of the time-averaged venous blood flow, which is an indicator of
the flow split between the distal artery and the vein, the peak systolic ve-
locity at the stenosis and the pressure drop across the stenosis. We observe
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Table 4.2: Comparison of the time-averaged venous blood flow Qv at Sov, peak
systolic velocity vs and stenosis pressure drop in the patient-specific geometry,
when the peripheral R and C values are modified.
Pia (mmHg) 55 70 90
Qv (ml.min−1) 750 752 754
vs (m.s−1) 2.20 2.20 2.20
PB1 - PB2 (mmHg) 12.1 12 12
that none of the quantities are affected by the mean arterial pressure. The
results therefore do not depend on the values set to the R and C constants
in the Windkessel model.
4 Discussion and conclusions
We have analyzed the effects of an arterial stenosis affecting an arteriove-
nous fistula on the blood flow. We have simulated numerically the hemo-
dynamics in a patient-specific AVF with an 80% stenosis along the afferent
artery. The originality of the study is to model the removal of the stenosis
by balloon-angioplasty through an implicit numerical simulation. The bal-
loon is considered to be cylindrical when unloaded. The post-treatment ge-
ometry of the vessel is efficiently computed by mimicking the viscoplastic
behavior of the arterial wall in the simulation. Since the stenosis removal is
rarely complete in clinical practice, we have investigated different degrees
of residual stenosis ranging from 30% to 0%. It is the range of stenosis
correction that is considered as successful clinically.
To evaluate the influence of the arterial stenosis on the hemodynamics,
we have compared the flow field within the patient-specific and treated
geometries. Windkessel models are set as boundary conditions at the two
outlets of the AVF to recreate physiological flow conditions. Different cou-
ples of R and C values have been imposed to investigate whether a different
time-averaged inlet pressure might influence the hemodynamics within the
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fistula. The flow distribution across the branches of the fistula is not influ-
enced by the mean arterial pressure, which is not surprising as the inlet
pressure can be seen as the reference pressure.
We have shown that the arterial stenosis has no significant effect on the
general hemodynamics within the AVF, leaving unchanged the blood flow
split between the distal artery and the vein. This is coherent with a recent
study that showed that arterial stenoses only affect the arterial outflow
when they are located within 5 mm from the anastomosis [75]. Our result
explains why the fistula of the patient under study was still functioning
despite the presence of an 80% stenosis: having no effect on the venous
flow rate, the stenosis did not impact the efficiency of the hemodialysis
treatment.
The hemodynamic effect of the stenosis remains therefore purely local.
A complete removal of the stenosis causes a 15%-decrease of the velocity
amplitude at the throat, as indicated by the evolution of the systolic and
diastolic velocities in figure 4.4c. If one calculates the corresponding pul-
satility index (PI) according to equation (4.5), one can notice that it remains
constant (PI = 0.3) regardless of the presence of the stenosis. It falls inside
the physiological range [23] both before and after the balloon-angioplasty
treatment. This index, introduced by clinicians to detect venous stenosis
[26], therefore has no relevance in the case of arterial stenoses.
Quantifying the wall shear stresses WSS shows the drastic effect of the
stenosis on the stenosis neck. At this location, the time-averaged stress
WSS is 5 times larger than in the fully corrected case (0%-stenosis) - see
figure 4.5c. Singh et al. [212] have shown that a time-averaged stress of
15 Pa is the threshold, above which the endothelial cells are irremediably
damaged and atherosclerotic plaques might form. The present study in-
dicates that the stenosis needs to be corrected with a degree of residual
stenosis below 20% for the WSS to be below the threshold value of 15 Pa
at the neck.
But the most direct effect that the arterial stenosis has on the hemody-
namics is undoubtedly on the pressure drop. The pressure drop can be
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considered as its hemodynamic signature, i.e. the index that signifies its
presence. This concept was already put forward by Young [213] for arterial
stenoses in general. For the patients, an increase in pressure drop in the
afferent artery leads to an increase in the cardiac work. The problem is that
hemodialysis patients already have an increased cardiac work because of
the very presence of the AVF (the fistula decreases the downstream vas-
cular resistance). So it appears that the presence of an arterial stenosis
further increases the risk of premature cardiac diseases and failure, which
is already high in this patient population [41, 40]. In particular heart failure
and sudden cardiac death are the critical events with the largest incidence
and not myocardial infarction as for the rest of the population [42].
In clinics, a stenosis is currently treated when the pressure drop across
the lesion is above 5 mmHg [59]. This criterion, originally set for venous
stenoses, is used by default for arterial stenoses. We have found that a
pressure drop of 5 mmHg corresponds to a 20% residual stenosis (figure
4.6b). Still stenosis degrees up to 30% are tolerated after angioplasty. The
present study would therefore suggest that the criterion for stenosis treat-
ment probably needs to be looked upon and adapted to the case of arterial
stenosis, in order not to put patients at a higher risk of heart failure. It
could also be worth including the peak WSS in the reflection. But more
cases would need to be studied to check whether the present results hold
on.
Another point that needs to be improved is the detection of arterial
stenoses. We have seen that arterial stenoses cause an increase in pressure
drop in the concerned artery, but such a quantity is difficult to measure
clinically. It could be of interest to investigate whether the formation of an
arterial stenosis is associated with an increase in systemic pressure. If so
the monitoring of the blood pressure evolution could become indicative of
the presence of a stenosis, if changes are looked for over long time periods.
Chapter 5
Simulation of the fluid-structure interactions after
the endovascular treatment of a stenosed AVF
In this chapter study the effects of the endovascular treatment of a stenosed
AVF by balloon-angioplasty with and without the positioning of a self-
expandable stent. We transcribe the text as it has been submitted to the
journal ’Journal of Biomechanical Engineering’.
1 Introduction
Hemodialysis is the therapy typically adopted for end-stage renal disease
patients, while waiting for a kidney transplantation. It consists in supply-
ing the kidney filtering function through a partial extracorporal circulation.
Blood circulation to the hemodialyzer is achieved through a permanent
vascular access. Various types of vascular access exist. One option is to
create an arteriovenous fistula (AVF), which connects a vein onto an artery.
AVFs have a low complication rate when compared to other options, such
as grafts and central venous catheters [13, 14, 17, 15, 16]. But fistulas can be
affected by different pathologies over time, one of them being the formation
of stenoses.
Stenoses result in the reduction of the vascular lumen and lead to an in-
crease in hydraulic resistance. They are typically caused by neo-intimal de-
velopment or atherosclerotic plaque formation in regions of altered hemo-
dynamics [11, 8, 56, 57]. Such flow conditions prevail, for instance, in the
outflow vein of the fistula. But end-stage renal disease patients also present
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several comorbidities, such as hypertension and calcium-phosphate imbal-
ance [214, 215]. These pathologies lead to a diffuse sedimentation of cal-
cium ions at the vascular walls. The sedimentation generally develops in
calcified atherosclerotic plaques. The combined effects of altered hemody-
namics and vascular wall calcification explain why patients in hemodialysis
may be affected by stenoses at multiple sites along the vascular tree.
Stenoses are typically treated, when they occlude more than 50% of the
lumen [74] or when they induce a local pressure difference ∆P above 5
mmHg [59]. The most common treatment option is balloon-angioplasty.
A balloon folded in a catheter is inserted endovascularly, guided across
the vasculature up to the stenosis and inflated to restore the vessel lumen.
Balloon-angioplasty has been proven to lengthen the period of fistula func-
tionality [57, 60, 61, 59, 62, 63]. Ultra-high pressure balloons can be used
for persistent stenoses [64].
Another endovascular treatment consists in deploying a stent across the
lesion. Stenting usually follows the preliminary expansion of the stenosis
by balloon-angioplasty. Two types of self-expandable stents are used to
treat AVF stenoses: stents in Nitinol (e.g. SMART R©, Cordis) or in stainless
steel (e.g. Wallstent R©, Boston Scientific) [65, 68]. The efficacy of stenting
has been questioned since the late 80s [65] and it has only recently been
proven to be more effective than balloon-angioplasty alone [62, 68].
Our present objective is to evaluate and compare the effects of both en-
dovascular treatments on the hemodynamics and wall mechanics. We sim-
ulate the fluid-structure interactions (FSI) within the fistula before and after
each treatment and compare them to the untreated case. For the stented
vessel, we first simulate the opening of the vessel by balloon-angioplasty,
where we position the stent inside the corrected geometry and deploy it.
We then search for the mechanical behavior of the stented arterial section
and determine its equivalent stiffness. We conduct the FSI simulation in
the stented AVF geometry, modeling the presence of the stent by impos-
ing the equivalent stiffness to the stented portion of the artery. The local
influence of the presence of the stent struts is thus neglected. Details on
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the numerical methods are provided in section §2. The influence of the
two treatments on the vessel shape, hemodynamics and internal stresses
is described in section §3. The results and their clinical consequences are
then discussed in section §4.
2 Material and methods
2.1 Geometry
We consider a patient-specific mature side-to-end radio-cephalic AVF pre-
senting an 80% stenosis on the arterial side. The images have been obtained
by computed tomography (CT) scan angiography at the Polyclinique St
Côme (Compiègne, France) [170]. The data have been obtained in confor-
mity with the ethical standard at the time of measurement. The geometry
of the vascular lumen has been segmented and reconstructed. The vascu-
lar wall has then been extracted and divided into three zones, the healthy
artery, the stenosed arterial portion and the vein, in order to impose differ-
ent mechanical properties to each portion.
We model the angioplasty balloon as a cylindrical surface. The cylinder
is created within ANSYS-Geometry (ANSYS, Inc.). Its length is 15 mm and
its diameter 1 mm.
We simulate the stenting treatment with a stainless steel Wallstent R©
wirestent (Boston Scientific; Natik, MA, USA), which is one the most used
to treat stenosed fistulas. It is a self-expandable braided stent. We model its
geometry as a tubular shape made of sets of wires spiraling clockwise and
anti-clockwise. The stent is created with the software PyFormex (copyright
c©Benedict Verhegge). The stent has a length of 12 mm and a deployed
diameter of 4.2 mm. It is composed of 24 separate wires.
2.2 Mesh
The lumen of the AVF is meshed in ANSYS T-Grid (ANSYS Inc.) by ex-
trusion from the triangulation of the inflow lateral surface. The mesh is
made of an hybrid grid of linear elements with prismatic elements in the
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boundary layer and tetrahedrons in the vessel core [201]. The vascular wall
is meshed with a monolayer of shell elements starting from the nodes of
the lateral surface of the AVF lumen. This condition ensures that the fluid
and solid domains share the same nodes at the interface.
The balloon surface is meshed with linear triangular elements. The
triangular elements are modeled as shell elements in ANSYS Workbench
13.0 (ANSYS, Inc.).
The stent is meshed in hexahedrons in Pyformex with the sweep method.
The quality of the elements is, however, not sufficient for simulations in
ANSYS. We therefore remesh the wires within ANSYS: we import each of
the 24 wires within ANSYS-Structural, delete the existing mesh and mesh
it with tetrahedrons with the default sweep patch-conforming algorithm.
2.3 Rheological and mechanical properties
Blood is assumed to be an isotropic, homogeneous, non-Newtonian fluid
that follows Casson model. The apparent viscosity µ is given by
√
µ =
√
τ0
γ˙
+
√
κ, (5.1)
where γ˙ is the shear rate, τ0 the yield stress and κ the consistency. The
model parameters have been adjusted to fit experimental results at low
shear rates: τ0 = 4×10−3 Pa, κ = 3.2×10−3 Pa·s [175]. Blood density is set
to 1050 kg.m−3.
Apart from the stenosed arterial region, we hypothesize that the vascu-
lar walls of the vein and artery are both made of a homogeneous, incom-
pressible, hyperelastic material. They are assumed to follow the 3rd-order
Yeoh model [182] and the artery to be more compliant than the vein. Since
no measurement of the wall mechanical properties has been conducted in
an AVF, the law constants are chosen to best-fit experimental data obtained
on a healthy artery and on a post-phlebitic vein (see [216] for more details).
The stenosed part is modeled as viscoplatic with a Maxwell constitutive
law. The law parameters are set to retrieve the same stiffness as the healthy
arterial wall at small deformation and to fit the data of Maher et al. [185] at
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Table 5.1: Values of the mechanical properties of the balloon and stent
Balloon Stent
ρ 1000 kg.m−3 7999 kg.m−3
E 9×108 Pa 2×109 Pa
ν 0.3 0.3
large deformation. This choice ensures continuity of the mechanical prop-
erties at the interface between the stenosed and non-stenosed segments.
The balloon and the stent are modeled with linear elastic material prop-
erties. The values of the density ρ, Young modulus E and Poisson coeffi-
cient ν are listed in Tab. 5.1.
2.4 Simulation of the endovascular treatment of the stenosis
2.4.1 Balloon-angioplasty
We simulate the opening of the balloon using ANSYS Structural (ANSYS
Inc.). We first position the balloon unfolded across the arterial stenosis
without any contact with the wall. It is inflated imposing a linearly in-
creasing internal pressure with a maximum pressure of 5.1 bar. During
opening, the balloon comes into contact with the artery. The contact is sup-
posed to be frictionless [146] and solved using the augmented-Lagrange
method.
At each instant of time, the structural simulation consists in finding
the mechanical equilibrium between the deformable artery and the elastic
balloon implicitly. When the maximum pressure is reached, the balloon
is deflated with a linearly decreasing pressure. The degree of residual
stenosis is equal to 20% after treatment.
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2.4.2 Balloon-angioplasty followed with stent positioning
Stent deployment is modeled with ANSYS Structural (ANSYS Inc.) in a
two-step implicit simulation. The balloon inflation is first simulated as
described in section §2.4.1, while keeping the stent inactivated (i.e. trans-
parent to the balloon and vessel). The stent is only activated at the end of
this first step. During the second step, the balloon is deflated. The equi-
librium shape of the artery is searched for, as the balloon recoils and the
artery comes into contact with the elastic stent; it is function of the mechan-
ical properties of the artery and stent. We define the contact between the
artery and stent as frictional following the Coulomb theory. The friction
coefficient is equal to 4.5×10−2. Conversely, no contact is defined between
the stent and the balloon.
2.5 Evaluation of the equivalent stiffness of the stented artery
We determine the equivalent stiffness of the stented artery following an
inverse analysis approach using ANSYS-Structural. To do so, we set up two
simulations of vessel inflation, both based on the geometry of the stented
artery obtained following section §2.4.2. The difference is that the stent is
only present in the first simulation (which is used as reference): the second
simulation is conducted with a bare artery.
In the first simulation, we solve for the deformation of the stented artery
imposing a linearly increasing pressure in the lumen in an implicit struc-
tural simulation. The contact between the artery and the stent is imposed
to be bonded, which guarantees that the artery and stent deform together
under the imposed pressure. We then simulate the inflation of the bare
artery and search which mechanical properties need to be set to obtain the
same deformation as for the stented artery.
2.6 Simulation of the fluid-structure interactions
We simulate implicitly the fluid-structure interactions in the geometries ob-
tained after balloon-angioplasty with and without stenting. The numerical
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method has been described in details in [216]. Briefly, we couple implic-
itly the fluid and solid domains in ANSYS-Workbench (ANSYS, Inc.). The
finite element structural solver uses a Lagrangian multiplier-based mixed
u-P formulation. The simulation is performed assuming large displace-
ments. The fluid solver is based on the Rhie-Chow interpolation method
to calculate the fluid field solution implicitly [174]. We consider the at-
mospheric pressure as reference pressure and neglect gravity. The fluid-
structure interactions are solved iteratively using the arbitrary Lagrangian-
Eulerian formulation. Iterations are repeated within each time-step until
all the field equations have converged and the coupling conditions are sat-
isfied. Each FSI simulation is run over six consecutive cardiac cycles, with
a time step equal to 5×10−3s for both the fluid and the solid solver.
As boundary condition, we impose (i) 0-rotation and 0-translation at
the vascular wall extremities; (ii) the time-dependent velocity profile mea-
sured on the patient at the inlet; (iii) the time-dependent pressure outlet
profiles. The issue is that no patient pressure value is obtained in vivo, as
pressure measurement is invasive. We therefore calculate the outlet pres-
sures conducting a rigid-wall simulation in ANSYS CFX, applying Wind-
kessel models at the two outlets. The constants of the Windkessel model
are tuned following the method described in Decorato et al. [201]; they
are obtained knowing from the measured value of the flow split between
the arterial and venous outlets (30%-70% respectively) and prescribing an
expected time-averaged inlet pressure.
3 Results
3.1 Post-treatment AVF geometry
A residual stenosis of 20% is achieved in both the stented and non-stented
cases. Figure 5.1 shows the stenosed artery before treatment (a), after
balloon-angioplasty (b) and after balloon-angioplasty plus stenting (c). The
initial position of the balloon is indicated by the cylinder. Comparing Fig.
5.1 (b) and (c), one can observe that the geometry of the vessel is almost
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Figure 5.1: Geometry of the patient-specific afferent artery of the fistula (a) be-
fore treatment (b) after balloon-angioplasty and (c) after balloon-angioplasty with
stenting. Both post-treatment cases present a residual stenosis equal to 20%.
Figure 5.2: Pressure-strain relationship of the stented artery (’×’ marks) as com-
pared to the patient-specific non-treated case (’·’ marks).
unchanged by the presence of the stent. No clear changes in the vessel
curvature can be noticed.
3.2 Equivalent stiffness of the stented artery
Figure 5.2 compares the stress-strain curves for the stented and non-stented
artery. It shows that the ’stented’ region obeys to Hooke’s law. The lin-
ear elastic mechanical behavior of the stent therefore prevails over the vis-
coplastic behavior of the vessel. The equivalent Young modulus Eeq of the
stented artery is 437 MPa. The stented region results to be 8.7 times stiffer
than the stenosed artery at small deformations. The Wallstent R© therefore
increases locally the vessel stiffness of the vessel after deployment. The
equivalent stiffness of the stented artery Eeq is imposed to the stenosed
region of the artery in the FSI simulation of the stented geometry.
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3.3 Hemodynamics
Influence of balloon-angioplasty
In order to evaluate the influence of the stenosis treatment, we have de-
tailed the values of a few key hemodynamic parameters provided by the
FSI simulations (Tab. 5.2). Comparing the results before and after balloon-
angioplasty, one can observe that the treatment has a significant effect in
the stenosis region. It reduces the maximum velocity at the stenosis vmax
by about 10%, which induces a 50% decrease in the wall shear stresses
WSSstenosis.
Angioplasty also leads to a 60% decrease in the pressure difference
across the stenosis ∆P (Tab. 5.2). For a residual degree of stenosis of 20%,
the pressure difference is below 5 mmHg, indicated in the literature as the
threshold value for treatment [59]. The treatment can thus be regarded as
successful.
Table 5.2 shows that the venous flow rate Qv remains unchanged. In-
deed, we find that angioplasty hardly impacts the hemodynamics down-
stream of the stenosis (see also [201]).
Additional effect of stenting
The sole influence of stenting can be obtained by comparing the FSI results,
when angioplasty is followed or not by stenting (Tab. 5.2). Hardly any
difference can be noticed between the two treatments. They both lead to
the same maximum velocity vmax and wall shear stresses WSSstenosis at the
stenosis. They engender the same flow distribution between the arterial
and venous outlets, as shown by the similar values of venous flow rate Qv.
The pressure drop at the stenosis ∆P is neither affected by stent positioning:
the treatment of the stenosis can be considered as successful in both cases,
since ∆P remains each time below 5 mmHg.
3.4 Internal wall stresses
The local strain and internal wall stresses are evaluated after balloon-angioplasty
with and without stent positioning and compared to the untreated case.
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Table 5.2: Comparison of the most relevant hemodynamic parameters after
balloon-angioplasty with and without stenting to the non-treated case.
80%-
stenosis angioplastyangioplasty
+ stent
vmax (m.s−1) 2.12 1.89 1.90
WSSstenosis (Pa) 27 12 12.4
Qv (ml.min
−1) 779 772 772.2
∆P (mmHg) 11.7 4.92 4.95
Table 5.3: Spatial-averaged values of the strain and normalized stresses at the
stenosis at peak systole.
80%-stenosis angioplasty angioplasty + stent
strain 15% 9% 3%
σmax
σart
1.1 5 14
The internal stresses are evaluated using the maximum component of the
Cauchy stress tensor σmax. They are normalized by the mean stress in the
healthy artery (σart). In Tab. 5.3, we compare the spatial-averaged strain
and stresses provided by the three FSI simulations at peak systole in a
region around the stenosis throat (10 mm in length). We observe that the
maximum strain decreases by 40% after balloon-angioplasty and by 80% af-
ter balloon-angioplasty with stenting. Conversely, the normalized internal
stress σmax/σart at the stenosis results to be 5 times larger after angioplasty
alone and 14 times larger, when a stent is deployed.
In Fig. 5.3 we compare the time-averaged distribution of the normalized
internal stress σmax/σart after the two treatments. After balloon-angioplasty,
the stenosis region is subjected to an internal stress σmax, which is up to 11
times larger than the baseline value σart. This residual stress is due to the
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a. b.
Figure 5.3: Time-averaged distribution of the maximum component of the Cauchy
stress tensor σmax normalized by the mean stress of the healthy artery at the steno-
sis post balloon-angioplasty (a) and post balloon-angioplasty with stent position-
ing (b).
permanent plastic deformations that occur within the vessel wall during
balloon inflation. The positioning of a stent further increases the residual
stress. The stress σmax can be as large as 19 times the baseline value σart
within the stented region. It is a consequence of the increase in vessel
wall stiffness induced by the stent. Within the cephalic vein the stress
distribution is the same before and after the treatment. It is about twice as
large as σart.
Away from the stenosis, the stress σmax decreases and regains the values
observed in the healthy artery (σart). In the region upstream of the stenosis,
the baseline stresses are completely recovered over a distance of 1.2 mm
in the case of the simple balloon-angioplasty and of 2.5 mm in the case
of stenting (Fig. 5.3). The mean gradient of the internal wall stresses is
therefore only doubled following stenting: on average the stress gradient
remains of the same order of magnitude as after balloon-angioplasty. The
stent locally causes a larger stress gradient at the interface between the
stented and non-stented portions of the artery: it is about 3.5 times larger
after stent positioning. Downstream of the stenosis, the baseline stress
values are recovered after a distance of 1.3 mm after both treatments. This
implies that the mean spatial gradient of the internal wall stresses is 3 times
larger after stent positioning than after the simple balloon-angioplasty.
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4 Discussion
The results of this study show that positioning a self-expandable stent (e.g.
Wallstent R©) after balloon-angioplasty has a negligible effect on the vascu-
lar geometry. The shape and curvature of the vessel are hardly modified.
The stent does not straighten the vessel, which indicates a small bending
rigidity of the general structure. This is coherent with what has been found
by Duerig and Wholey [217]. The wirestent device is designed to have a
high radial stiffness to prevent the re-occlusion of the vessel and a large
axial flexibility to follow the curvature of the vasculature after the deploy-
ment.
The inverse analysis provides a quantitative proof of what is guessed
from the shape of the stented wall. The equivalent stiffness of the stented
artery is only about 10 times larger than the bare artery (i.e. non-stented).
This corroborates the in vivo results obtained by Vernhet at al. for Wallstent R©
stents implanted in the rabbit abdominal aorta [218]. The relatively small
increase in the local vascular stiffness is due to the smaller rigidity of self-
expandable stents as compared to balloon-expandable ones [217]. Self-
expandable stents also have the advantage to subject the vascular wall to
an expansion force sustained over time. They do not suffer from radial re-
coil, as it can be the case for balloon-expandable stents [217, 150]. Another
advantage is the relatively small trauma caused to the endothelial cells by
the stent deployment, in contrast to balloon-expandable stents [217].
The comparison of the results of the fluid-structure interaction simula-
tions after balloon-angioplasty followed or not by stent positioning shows
that, immediately after treatment, the two treatment options have equiva-
lent effects on the hemodynamics both locally at the stenosis and globally
in terms of distal flow split. These results are supported by recent clinical
studies [62]. The hemodynamics is therefore hardly influenced by the local
increase in stiffness of a portion of the vasculature.
The fact that the venous outflow Qv keeps the value it had before treat-
ment is particularly relevant for hemodialysis: the fistula remains func-
4 – Discussion 145
tional despite the presence of an arterial stenosis. This is very different to
the case of venous stenoses, which drastically reduce the venous outflow.
Arterial stenoses, however, induce a large pressure drop in the afferent
artery leading to an increase in the cardiac work. This issue is particu-
larly critical for hemodialyzed patients, as they already have an increased
cardiac work because of the very presence of the AVF [38]. The fistula in-
deed decreases the downstream vascular resistance, leading to an increase
in cardiac output. So it appears that the presence of an arterial stenosis
further increases the risk of premature cardiac disease and failure. It there-
fore seems crucial to treat arterial stenoses to reduce the pressure drop and
thus the risk of heart failure [59, 12].
When considering the influence of the two treatments on the wall me-
chanics, we observe a larger difference than on the hemodynamics. The
study has shown that residual stresses build up within the vascular wall
following balloon-angioplasty: the internal wall stresses at the stenosis
throat are, on average, five times the baseline value at peak systole (Tab.
5.3). Stenting causes an increase in the maximum internal wall stresses and
in their spatial gradient, which is associated with the increase in vessel wall
rigidity it brings. In the case of a Wallstent R© stent, the increase is mod-
erate (they are at maximum tripled). There should therefore be a limited
risk of in-stent restenosis. Restenosis has been shown to mainly appear
in the case of axially rigid balloon-expandable stents [104]: the latter can
cause local alteration in wall shear stresses in the two regions upstream
and downstream of the stent and endothelial damage, which are prone
to neointima proliferation [104, 219]. But contrary to balloon-explandable
stents, the self-expandable wirestent Wallstent R© has a high axial flexibility.
In clinics it has been observed that balloon-angioplasty alone often fails
because of the viscoelastic recoil of the vessel within 6-12 months after the
treatment [62]. It has been proven recently that the additional use of stent-
ing renders balloon-angioplasty more efficient, especially in the long term
[62, 68]. From the present results, one can hypothesize that the stent en-
ables to keep the vessel open. The beneficial impact of the stent is likely to
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be small immediately after treatment and to kick in in the months following
the treatment, as the vessel recoils.
FSI simulations cannot model the viscoelastic recoil and predict the
long-term response of the vascular wall. In the future it would be inter-
esting to build a model of the evolution of the vessel, taking into account
the endothelial response to hemodynamic solicitations as well as the wall
response to altered internal stresses.
5 Conclusions
We have implicitly simulated the treatment of an AVF presenting an 80%-
arterial stenosis by balloon-angioplasty with and without stent positioning.
We have shown that implanting a self-expandable stent has the advantage
of preserving the curvature of the treated vessel and causing a moderate
increase in the local stiffness of the artery. Comparing the flow conditions
predicted by the FSI simulations, we have found that the two treatments
are equivalent. They preserve the functionality of the fistula, as none of
them perturbs the flow distribution in the AVF; they both reduce the pres-
sure difference across the stenosis below its critical value (∆P ≤ 5 mmHg),
which lowers the risk of heart complications in the long run. The compar-
ison of the internal wall stresses after the two treatment options indicates
that stent positioning leads to a maximum three-fold increase in the wall
internal stress σmax at the stenosis throat. This is moderate enough for in-
stent restenosis to be unlikely to develop over time. The beneficial effect of
stenting observed in clinics must come from the fact the the stent prevents
the natural elastic recoil of the vessel after angioplasty and therefore the
occurrence of restenosis.
Chapter 6
In vitro study of the hemodynamics in a
patient-specific AVF
1 Introduction
Experimental Particle Image Velocimetry (PIV) is a valid tool for the study
of the hemodynamics in complex vessels. It provides complementary re-
sults to numerical simulation techniques. A preliminary study has been
conducted in a rigid-wall phantom that was the reproduction of the patient-
specific AVF we considered for the numerical simulations. We have carried
out the experiences in steady-state conditions. The CFD simulations have
been computed to validate the experimental results.
2 Materials and methods
A flow inlet equal to 800 ml.min−1 is imposed at the arterial inlet Sia. At
the boundary outlets of the numerical model we have imposed the same
pressure values obtained in the experimental setup. The experiments are
conducted assuming blood to be an isotropic, homogeneous, Newtonian
fluid.
2.1 AVF geometry
A phantom made in poly(methyl methacrylate) (PMMA) is fabricated by
rapid prototyping, as described in chapter 2, section 3.1. The CAD model
of the geometry has been created by Innovaltech (IUT de l’Aisne, Saint-
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Quentin, France) from the volume reconstruction of the AVF lumen is ex-
ported in STL file format. The vascular walls are generated with a thickness
of 3 mm which is required for the rigidity of the mould. The phantom,
when the fabrication ends, is rigid, and its transparency is sufficient to
enable the measurement of the inner velocity field.
2.2 PIV: Principles and setup
Particle Image Velocimetry (PIV) is a technique that allows the estimation
of the velocity field in a 3-dimensional flow by calculating the velocity
vectors in a cut-plane. The typical PIV setup consists in a Charge Cou-
pled Device (CCD) camera for image acquisition, a double pulsed laser for
lighting the flow field seeded with particles and a PC for synchronization
with the laser pulse and image recording. A software enables to control the
laser and camera, determine the velocity field and post-process the data.
The details of the principles for image capture and treatment have been
described in chapter 2, section 3.2.
The experimental circuit has been installed in the Biomechanics and
Bioengineering Laboratory (CNRS UMR 7338) at the Université de Tech-
nologie de Compiègne. We have used a steady-state pump (see chapter 2,
section 3.3.1), the light source double laser Nano S PIV Pulsed Nd:Yag from
the Litron Lasers (UK) provided in the pack LaVision Flowmaster PIV Sys-
tem (see chapter 2, section 3.3.3) and the Charged Coupled Device (CCD)
camera Imager pro X 2M (LaVision) for image acquisition (see chapter 2,
section 3.3.4). The protocol for image acquisition and post-treatment has
been detailed in chapter 2, section 3.3.5. All the experiences have been con-
ducted using an aqueous glycerine solution (see chapter 2, section 3.3.2). Its
viscosity has been measured to be 3.75×10−3 Pa.s, and its density 1083.2
kg.m−3. We seed the solution with lycopodium particles (Lycopodium,
SIGMA-ALDRICH) with a concentration of 0.7 g.l−1.
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2.3 Results: comparison
We qualitatively compare the results obtained numerically and experimen-
tally at three locations of interest in the AVF: the stenosis in the afferent
radial artery, the anastomosis and the enlarged vein. Figures 6.1, 6.2 and
6.3 show the comparison between the experimental (a) and numerical (b)
results in the three zones. A good qualitative agreement can be noticed.
The same maximum velocity is measured with both techniques. A similar
flow split between the distal artery and the cephalic vein is obtained by the
experimental and numerical simulations.
a. b.
Figure 6.1: Qualitative comparison between the experimental (a) and the numeri-
cal velocity vectors field (b) at the stenosis in the proximal radial artery.
In order to quantitatively compare the results in vitro and in silico, we
have extracted the velocity profile at defined cross-sectional diameters. Fig-
ures 6.4a, 6.5a and 6.6a show the cross-sectional planes A-A, B-B and C-C
defined at the stenosis, at the anastomosis and in the enlarged vein respec-
tively. In figures 6.4b, 6.5b and 6.6b we show the comparison between the
numerical (CFX) and experimental (PIV) velocity profiles along the diam-
eter in the chosen cross-sectional planes. We plot the velocity amplitude
along the curvilinear abscissa x. The distance x has been normalized by
the length of the diameter (DA−A at the stenosis, DB−B at the anastomo-
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a. b.
Figure 6.2: Qualitative comparison between the experimental (a) and the numeri-
cal velocity vectors field (b) at the anastomosis.
a. b.
Figure 6.3: Qualitative comparison between the experimental (a) and the numeri-
cal velocity vectors field (b) at the enlarged vein.
sis and DC−C at the enlarged vein). The curves representing the velocity
profiles measured by PIV also show the standard deviation (black bars).
One can notice a good agreement between the two profiles. The averaged
relative difference has been found to be equal to 14% at the stenosis, 18%
at the anastomosis and 22% at the enlarged vein. Figure 6.6 shows that the
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match between the two simulations is less perfect in the enlarged vein. The
main reason is the extremely low amplitude of the velocities in the vein:
such low velocity fields are always a challenge to measure experimentally.
Another issue is the difficulty to identify the same exact cut plane in the
numerical simulation as in the experiment. A small offset of the plane
positioning can modify greatly the flow distribution, as the flow is highly
perturbed in the vein enlarged region. PIV simulations, however, globally
estimate velocity values which are lower than those calculated numerically.
This evidence is coherent with what has been found by Ford et al. [84].
a. b.
Figure 6.4: a) Cross-sectional diameter A-A defined at the stenosis. b) Comparison
of the numerical (CFX) and experimental (PIV) velocity profiles extracted at the
cross-sectional diameter A-A.
3 Discussion
The experimental and numerical results have shown a satisfactory agree-
ment. With the PIV technique we correctly detect the major characteristics
of the fluid dynamics within the fistula: the high velocity at the stenosis
and flow recirculation at the anastomosis and inside the vein are correctly
estimated. The objective is now to conduct the experiment under unsteady
flow conditions. The analysis of the results has highlighted that it is dif-
ficult to extract the same plane from the experimental and numerical re-
sults to enable the quantitative comparison of the velocity magnitude. We
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a. b.
Figure 6.5: a) Cross-sectional diameter B-B defined at the anastomosis. b) Com-
parison of the numerical (CFX) and experimental (PIV) velocity profiles extracted
at the cross-sectional diameter B-B.
a. b.
Figure 6.6: a. Cross-sectional diameter C-C defined at the vein. b) Comparison
of the numerical (CFX) and experimental (PIV) velocity profiles extracted at the
cross-sectional diameter C-C.
have in fact noticed that a small offset of the plane positioning can modify
greatly the flow distribution, especially where the flow is highly perturbed
(e.g. in the enlarged region within the vein). Despite the errors that are in-
evitably made in the plane determination, we find a more than satisfactory
agreement between the PIV and CFD results.Comparing the velocity pro-
files at specific cross-sections we have also shown that PIV measurements
globally underestimates the velocity values.This is coherent with previous
results from literature [84].
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In perspective, the same setup could be used for PIV measurements
within a compliant phantom. In this case the first difficult is the fabrication
of the phantom itself, especially if the mechanical properties of the different
vessels need to be differenciated. Secondly, one needs to design a system
for the positioning of the compliant phantom which prevents the fluttering
of the phantom under the pulsating inner flow, as it would interfere with
the measurements.

Chapter 7
Conclusions and perspectives
1 Main outcomes of the study
Clinical procedures for the treatment of AVF complications are today mainly
based on empiric knowledge, since it is still difficult to obtain quantita-
tive hemodynamic data from in vivo imaging exams. During the last 20
years, several in vitro and in silico models have been developed to inves-
tigate and better understand the hemodynamics within the AVF. None of
these studies has however considered, to our knowledge, the vascular wall
compliance.
During the first part of the study we have investigated the hemodynam-
ics and wall mechanics in a mature AVF. We have modeled numerically the
fluid-structure interactions in a patient-specific AVF geometry. The veloc-
ity profile measured on the patient is imposed at the arterial inlet. At the
boundary outlets, we impose the time-variable pressure profiles obtained
from a computational fluid-dynamic simulation in which the second-order
Windkessel model has been implemented. It allows to take into account the
resistances and compliances of the vessels downstream of the fistula. Blood
is considered to behave as a non-Newtonian fluid because of the low shear
rates observed within the vein. The results of FSI simulations show that
the fistula is subjected to several regions of flow recirculation, especially
within the enlarged vein. It directly affects the wall shear stresses, which
are very low in the vein. In parallel, the oscillatory shear index increases.
The venous wall also experiences large internal wall stresses, which are
about twice the baseline value. Both the hemodynamic and wall stresses
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might therefore favour the remodeling of the venous wall.
The large computational cost of the fluid structure interaction simula-
tion makes the transfer to clinicians difficult. It currently limits the use
of numerical simulation as a diagnostic tool. We have therefore inves-
tigated whether the fully-coupled FSI could be simplified maintaining a
sufficient accuracy in the evaluation of both the hemodynamics and wall
mechanics. We have shown that fluid uncoupled simulation provides the
time-evolution of the hemodynamic parameters in the AVF with 10-15%
accuracy. The structural uncoupled simulation can provide the wall inter-
nal stresses with a greater accuracy, but only at one instant of time within
the cardiac cycle. The FSI simulations have the advantage to provide the
complete picture of the stresses acting in and on the vascular wall and
to guarantee the equilibrium at the interface between the simulated blood
flow and vascular wall at each time step, but they require longer computa-
tional times.
The considered patient-specific geometry presents an arterial stenosis.
In literature, little is known about this kind of lesion, and its incidence on
hemodialysis efficiency has only recently been assessed [72, 75]. However,
the effects of the arterial stenoses on the hemodynamics in arteriovenous
fistulas have not yet been investigated. In the second part of the study
we have therefore focused our attention on the influence of the stenosis,
and analyzed the hemodynamics in the stenosed fistula. We have then
simulated numerically the endovascular treatment by balloon-angioplasty.
Clinically, balloon-angioplasty rarely corrects the stenosis fully and a de-
gree of stenosis remains after treatment. Residual degrees of stenosis below
30% are considered as successful. We have inflated the balloon with dif-
ferent pressures to simulate residual stenoses ranging from 0 to 30%. The
results show that the arterial stenosis has little impact on the blood flow
distribution: the venous flow rate remains unchanged and thus permits
hemodialysis. The stenosis at the afferent artery, therefore, does not com-
promise the efficacy of the hemodialysis. This shows that arterial stenoses
behave very differently to venous stenosis. Venous stenoses are known to
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significantly reduce the venous outflow. Clinicians therefore monitor and
compare hemodynamic parameters that are related to the venous flow dur-
ing the hemodialysis. Venous stenoses are suspected when a reduction in
the venous flow is observed. Arterial stenoses must have remained unno-
ticed until recently, because they do not have the same complication on
the hemodialysis treatment. Contrary to venous stenosis, arterial stenoses
cause an increase in the local pressure difference, which can lead to an in-
crease in cardiac work. We have quantified the local increase in pressure
due to the stenosis, and calculated the pressure drop after treatment by
balloon-angioplasty. We have questioned the criteria used in clinical prac-
tice for the evaluation of a successful balloon-angioplasty. We have shown
that for the investigated case a 30% residual stenosis leads to a large lo-
cal pressure drop, even if this degree of residual stenosis is considered
successful in clinical practice. The current clinical criteria is therefore not
universally valid. To guarantee a pressure drop below 5 mmHg, which is
considered as the threshold stenosis pressure difference clinically [59], the
residual stenosis degree must be 20% maximum.
Balloon-angioplasty is not the only endovascular treatment which can
be adopted by clinicians. The use of stents has been introduced since late
80s [65], but for about 30 years the use of stent has been largely questioned.
We have simulated numerically the balloon-angioplasty followed by the po-
sitioning of the self-expandable stent Wallstent R© (Boston Scientific; Natik,
MA, USA). Our results show that balloon-angioplasty with or without stent
positioning have the same impact on the hemodynamics. The stent has only
a local effect on the internal wall stresses at the stenosis, which are about
3.5 the stresses at the stenosed artery post balloon-angioplasty. Addition-
ally, self-expandable stents hardly straighten the vascular geometry.
Stents are used when angioplasty does not succeed but or to prevent
the viscoelastic recoil of the artery, occurring sometimes 6-12 months after
the simple angioplasty [62]. But the large internal stresses observed af-
ter stent positioning might induce in-stent restenosis and cause the failure
of the treatment. In the literature it has been shown that axially-flexible
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stents have a negligible effect for inducing neointima proliferation leading
to in-stent restenosis [104]. If the restenosis is avoided, it is reasonable to
conclude that the stent positioning might be more effective than the sim-
ple angioplasty in the long term. This conclusion is supported by recent
clinical observations [62, 68].
The study we have carried out presents several aspects of novelty:
• The difference in mechanical properties of the vein and the artery have
been taken into account;
• The imposed boundary conditions are directly measured (velocity in-
let) or derived from pressure and flow information measured on the
patient (Windkessel model);
• The impact of an arterial stenosis has been quantified;
• The endovascular treatments by balloon-angioplasty without/with
stenting have been simulated implicitly;
• The impact of the two possible endovascular treatments are investi-
gated, quantified and compared.
In the last part of the study we have also set up an the experimental
bench for the evaluation of the hemodynamics within the AVF using PIV.
The comparison between experimental and numerical results has shown
a good agreement. The experimental setup is ready for further investiga-
tions, typically in unsteady flow conditions.
2 Perspectives
The numerical tool developed for the study of the fluid-structure interac-
tions and the effect of the endovascular treatment of a stenosis offers many
perspectives. In the next future, the simulations could be easily adapted
to the new version of ANSYS-Workbench: ANSYS 14.5. This version is
available since November 2012, and contains improvements in the cou-
pling algorithm used to solve the fully-coupled FSI simulations. The use
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of parallel calculation has also been made more robust and effective. The
increased computational robustness should significantly reduce the com-
putational time. Moreover, improved meshing capabilities and robust au-
tomation tools are likely to reduce the time that the user spends preparing
the model.
It would be interesting to apply the numerical FSI simulation we have
developed to the study of the hemodynamics and wall mechanics within
fistula geometries of different patients. This study might enable the identi-
fication and quantification of hemodynamic and wall mechanic parameters,
both local and global, that are altered when compared to the physiological
baseline. The clinical criteria for the evaluation of the functionality of the
fistula might thus be improved.
Similarly, it would be interesting to compare the results of the simula-
tions with the clinical follow-up of patients. Such an investigation should
enable the refinement of the criteria today used to identify regions which
are prone to neointima formation and wall remodeling. Moreover, it might
enable researchers to understand how eventual systemic pathology of the
patient might alter the vascular wall response to hemodynamic and me-
chanical solicitations.
Another possible perspective for the numerical simulations we devel-
oped is the simulation of the treatment of other pathologies. Similarly
to what we have done for arterial stenoses, one might simulate numeri-
cally the treatment of other pathologies that affect fistulas. For instance,
the reduction of the venous diameter in case of hyperflow could be sim-
ulated. The investigation of the effects on the hemodynamics of different
final venous diameter might enable researchers to quantify the optimal di-
ameter based on quantitative hemodynamic parameters. Similarly to what
we did for the residual stenosis post balloon-angioplasty, the reduction of
the venous diameter for the treatment of the hyperflow can be simulated.
The venous diameter to be obtained after the treatment could therefore be
optimized.
In our simulations we have used literature data for the mechanical prop-
2 – Perspectives 160
erties of the healthy and stenosed artery as well as for the vein. Recently,
high-resolution ultrasound techniques have been proven to be effective in
the evaluation of the mechanical properties of the vessels of fistulas for
hemodialysis in vivo [22]. The model of fluid-structure interaction simula-
tion that we have developed should be adapted to the patient-specific case
also in terms of wall mechanics.
Thanks to the more efficient and robust calculation algorithms, the re-
modeling of the vasculature under the hemodynamic and internal stresses
conditions may be taken into account in a multi-scale model coupled to
the FSI simulation. However, if multi-scale models which describe wall
adaptations when subjected to non-physiological hemodynamic parame-
ters are quite clear, less is known about the response to altered wall inter-
nal stresses. This type of model might help clinicians predict the evolution
and adaptation of the vascular wall in response to the hemodynamic and
mechanic stimuli.
Finally, the developed models might potentially be introduced in clini-
cal routine as tools to help surgeons in the decision-making process. This
step might require the automatic segmentation and volume reconstruction
from patient-specific geometries. The setup of the patient-specific numeri-
cal simulation should also be automated, and the flow at the afferent artery
as well as the time-varying pressure conditions at the arterial and venous
outlets automatically set as boundary conditions. A clinical study that
proves the efficacy of the use of numerical simulations as a predictive tool
should be carried out. Once the efficacy is proven, numerical predictive
tools could be used in clinical routine.
Appendix A
Pyformex
In order to reproduce the geometry of a typical wire stent which is used in
case of stenoses in AVFs (Wallstent, Boston Scientific), we use the open-
source code PyFormex (http://www.nongnu.org/pyformex/) [220].
The code can be divided in two main parts:
• The generation of the 3-dimensional geometry;
• The generation of the mesh;
• The export of the meshed geometry.
1 3-D geometry generation
The first part of the code consists in the definition of the variables that
can be given as input by the user and the creation of the geometry. It is
part of PyFormex software (copyright c©Benedict Verhegge). The code is
commented in order to clarify what is done by each sequence of command
lines.
1 #!/usr/bin/env pyformex --gui
3
# needed if we import this from another script
5 from formex import *
from plugins import curve
7 from plugins.trisurface import TriSurface
from plugins.fe_abq import *
9 import simple
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11 class DoubleHelixStent:
"""Constructs a double helix wire stent.
13
A stent is a tubular shape such as used for opening obstructed
15 blood vessels. This stent is made from sets of wires spiraling
in two directions.
17 The geometry is defined by the following parameters:
L : approximate length of the stent
19 De : external diameter of the stent
D : average stent diameter
21 d : wire diameter
be : pitch angle (degrees)
23 p : pitch
nx : number of wires in one spiral set
25 ny : number of modules in axial direction
ds : extra distance between the wires (default is 0.0 for
27 touching wires)
dz : maximal distance of wire center to average cylinder
29 nb : number of elements in a strut (a part of a wire between two
crossings), default 4
31 The stent is created around the z-axis.
By default, there will be connectors between the wires at each
33 crossing. They can be switched off in the constructor.
The returned formex has one set of wires with property 1, the
35 other with property 3. The connectors have property 2. The wire
set with property 1 is winding positively around the z-axis.
37 """
def __init__(self,De,L,d,nx,be,ds=0.0,nb=4,connectors=True):
39 """Create the Wire Stent."""
D = De - 2*d - ds
41 r = 0.5*D
dz = 0.5*(ds+d)
43 p = math.pi*D*tand(be)
nx = int(nx)
45 ny = int(round(nx*L/p)) # The actual length may differ a bit
from L
# a single bumped strut, oriented along the x-axis
47 bump_z=lambda x: 1.-(x/nb)**2
base = Formex(pattern(’1’)).replic(nb,1.0).bump1(2,[0.,0.,dz],
bump_z,0)
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49 # scale back to size 1.
base = base.scale([1./nb,1./nb,1.])
51 # NE and SE directed struts
NE = base.shear(1,0,1.)
53 SE = base.reflect(2).shear(1,0,-1.)
NE.setProp(1)
55 SE.setProp(3)
# a unit cell of crossing struts
57 cell1 = (NE+SE).rosette(2,180)
# add a connector between first points of NE and SE
59 if connectors:
cell1 += Formex([[NE[0][0],SE[0][0]]],2)
61 # create its mirror
cell2 = cell1.reflect(2).translate([2.,2.,0.])
63 base = cell1 + cell2
# reposition to base to origin [0,0]
65 base = base.translate(-base.bbox()[0])
# Create the full pattern by replication
67 dx,dy = base.bbox()[1][:2]
F = base.replic2(nx,ny,dx,dy)
69 # fold it into a cylinder
self.F = F.translate([0.,0.,r]).cylindrical(dir=[2,0,1],scale
=[1.,360./(nx*dx),p/nx/dy])
71 self.ny = ny
73 def getFormex(self):
"""Return the Formex with all bar elements.
75
This includes the elements along all the wires, as well as the
77 connectors between the wires.
"""
79 return self.F
81 def getWireAxes(self):
"""Return the wire axes as curves.
83
The return value is two lists of curves (PolyLines), representing
the
85 individual wire axes for each wire direction.
"""
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2 Generation of the mesh of the multi-wires stent
In the second part of the script, which we developed during the PhD, con-
sists in the mesh creation through a sweep method on each wire and its
export as an ABAQUS input file. The code is reported below. Comment
lines are provided.
import connectivity
2 M = self.F.toMesh()
ML = [ M.withProp(i) for i in [1,3] ]
4 wires = [ connectivity.connectedLineElems(Mi.elems) for Mi in ML
]
wireaxes = [ [ Formex(M.coords[wi]).toCurve() for wi in wiresi ]
for wiresi in wires ]
6 return wireaxes
8
if __name__ == "draw":
10
# show an example
12
wireframe()
14 reset()
16 res = askItems([
(’L’,80.,’’,{’text’:’Length of the stent’}),
18 (’D’,10.,’’,{’text’:’Diameter of the stent’}),
(’n’,2 ,’’,{’text’:’Total number of wires’}),
20 (’b’,30.,’’,{’text’:’Pitch angle of the wires’}),
(’d’,0.2,’’,{’text’:’Diameter of the wires’}),
22 ])
24 if not res:
exit()
26
globals().update(res)
28 if (n % 2) != 0:
warning(’Number of wires must be even!’)
30 exit()
32 H = DoubleHelixStent(D,L,d,n,b)
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clear()
34 view(’iso’)
for w,c in zip(H.getWireAxes(),[’black’,’magenta’]):
36 print ’w is :’, w[1]
print ’c is :’, c
38 #draw(w,color=c)
40 HH=H.getWireAxes()
clear()
42 draw(HH[1],color=’red’) #HH[0] contains left-handed wires, HH[1]
the right-handed
44
F = simple.sector(0.11,360.,8,8,h=0.0,diag=’up’) #defines a
circular face
46 CS = TriSurface(F) #meshes the face with
triangles
3 Export for ANSYS environment
The last part of the script has been developed in order to export the meshed
wires in a format readable within ANSYS Workbench. As explained in
section 2.4.2 we however had to re-mesh the wires with a native mesh for
ANSYS Structural simulations. Here below we report, commented, the part
of the script developed for the export.
for i,x in zip(HH[0], range(n)): #iterates the
components of HH (which are n) and the integer x from 0 to n-1
increasing them conjointly
2 pathi = i #the current wire is defined as
path
structure1i = CS.sweep(pathi,normal=[0.,0.,1.],upvector
=[1.,0.,0.]) #sweeps the circular meshed face CS along
the current path
4 elem1i = structure1i.eltype = ’C3D8’ #defines the element
type
export({’wireR’:structure1i})
6 ai = exportMesh(str(x)+’wireR.inp’,structure1i) #write the
abaqus input file changing its name at each iteration
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8
’’’the procedure is repeated for the left-handed wires’’’
10 for z,y in zip(HH[1], range(n)):
pathz = z
12 structure2z = CS.sweep(pathz,normal=[0.,0.,1.],upvector
=[1.,0.,0.])
elem12z = structure2z.eltype = ’C3D8’
14 export({’wireL’:structure2z})
bz = exportMesh(str(y)+’wireL.inp’,structure2z)
16
#End
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